SESSION 1 SCHEDULE
Tuesday
SESSION 1: PROGRESS IN TRANSCATHETER VALVE IMPLANTATION, CORONARY ARTERY STENTING AND ASCENDING AORTIC DISEASE TREATMENT
x
6:40 AM - 6:44 AM Opening Remarks
  Presenter(s):Frank J. Veith, MD  
  View Slides in PDF      
6:45 AM - 6:50 AM Status Of Transcatheter Tricuspid Valve Implantation: Initial Experience
  Presenter(s):Horst Sievert, MD  
  View Slides in PDF      
6:51 AM - 6:56 AM Progress In Transcatheter Aortic Valve Implantation (TAVI): A Cardiac Surgeon’s Perspective: Which Patients Still Need Open Valve Surgery
  Presenter(s):Allan Stewart, MD  
  View Slides in PDF      
6:57 AM - 7:02 AM Progress In TAVI: An Interventional Cardiologist’s View: Which Patients Still Need Open Valve Surgery
  Presenter(s):George Dangas, MD / Roxana Mehran, MD  
  View Slides in PDF      
7:03 AM - 7:08 AM Key New Developments In Coronary Artery Stenting: Are Too Many Patients Receiving Coronary Stents As Indicated By The ORBITA Trial
  Presenter(s):Gregg W. Stone, MD  
  View Slides in PDF      
7:09 AM - 7:14 AM Highlights Of Optimal Current Management Of Type A Aortic Dissections
  Presenter(s):Joseph S. Coselli, MD  
  View Slides in PDF      
7:15 AM - 7:20 AM Dynamic Imaging Of The Ascending Aorta: What Are The Implications For Endograft Treatment
  Presenter(s):Rachel E. Clough, MD, PhD, FRCS  
  View Slides in PDF      
7:21 AM - 7:26 AM Advances In Ascending Aortic And Arch Endografting
  Presenter(s):Eric E. Roselli, MD / Lars G. Svensson, MD, PhD  
  View Slides in PDF      
7:27 AM - 7:32 AM Progress And Challenges In Ascending Aortic Endograft Treatment
  Presenter(s):Rodney A. White, MD  
  View Slides in PDF      
7:33 AM - 7:38 AM Feasibility And Status Of A Combination Endovascular Aortic Valve Plus Stent Graft Conduit For Treatment Of Type A Aortic Dissections: What Patients Are Candidates
  Presenter(s):Martin Czerny, MD / Bartosz Rylski, MD, PhD  
  View Slides in PDF      
7:39 AM - 7:44 AM Is Endovascular Treatment Of The Aortic Valve And Root Feasible (An Endo-Bentoll Procedure): Where Does It Stand
  Presenter(s):Ali Khoynezhad, MD, PhD  
  View Slides in PDF      
7:45 AM - 7:51 AM Panel Discussion
END OF SESSION 1
 
SESSION 2 SCHEDULE
Tuesday
SESSION 2: NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC ARCH LESIONS AND AORTIC DISSECTIONS
x
7:52 AM - 7:57 AM Choice Of Treatment For Aortic Arch Aneurysms: Open, Hybrid, Frozen Elephant Trunk, Endo: When And How
  Presenter(s):Roberto Chiesa, MD  
  View Slides in PDF      
7:58 AM - 8:03 AM Options For Treatment Of Aortic Arch Pathology: When Open, Hybrid, Fenestrated Or Branched TEVAR (F/B TEVAR) Or Chimney TEVAR (Ch/TEVAR)
  Presenter(s):Chang Shu, MD  
  View Slides in PDF      
8:04 AM - 8:09 AM Caval Balloon Occlusion to Enable Accurate Deployment Of Arch And Ascending Aortic Endograft: It May Be Better Than Rapid Pacing: How To Do It
  Presenter(s):Timothy A. Resch, MD, PhD / Bjõrn Sonesson, MD, PhD  
  View Slides in PDF      
8:10 AM - 8:15 AM Update On Total Endovascular Aortic Arch Repair With 2 And 3 Branch Endograft Designs (Global Experience): When Does The Procedure Work And When Doesn’t It
  Presenter(s):Stephan Haulon, MD  
  View Slides in PDF      
8:16 AM - 8:21 AM Branched And Fenestrated Endografts For Treatment Of Complex Arch Lesions
  Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD  
  View Slides in PDF      
8:22 AM - 8:27 AM New Developments In Branched Arch Endografting: How To Deal With Dissected Branches
  Presenter(s):Tilo Koelbel, MD, PhD  
  View Slides in PDF      
8:28 AM - 8:33 AM Update On Improved Precurved Fenestrated N2X Endograft For Aortic Arch Lesions: Advantages And Results: When Available Outside Japan
  Presenter(s):Yoshihiko Yokoi, MD  
  View Slides in PDF      
8:34 AM - 8:39 AM Updated Experience With Chimney TEVAR (Ch/TEVAR) To Repair Aortic Arch Lesions: Midterm Results And How To Make Them Work
  Presenter(s):Mario L. Lachat, MD / Nicola Mangialardi, MD  
  View Slides in PDF      
8:40 AM - 8:45 AM How To Treat Acute Type B Aortic Dissections (TBADs) With Retrograde Intramural Hematoma (IMH) Extending Into The Arch And Ascending Aorta
  Presenter(s):I-Hui Wu, MD, PhD  
  View Slides in PDF      
8:46 AM - 8:51 AM Surgeon Modified Endografts For Treatment Of Ascending And Arch Aneurysms And Dissections: Value Of A Transapical Approach
  Presenter(s):Ludovic Canaud, MD, PhD  
  View Slides in PDF      
8:52 AM - 8:58 AM Panel Discussion
END OF SESSION 2
 
SESSION 3 SCHEDULE
Tuesday
SESSION 3: AORTIC DISSECTIONS (TYPE B AND TYPE A) AND THEIR TREATMENTS
x
8:58 AM - 9:03 AM New Findings From IRAD On Management Of Uncomplicated TBAD Patients: Predictors Of Progression; When Early TEVAR; When Medical Treatment And Observation
  Presenter(s):Santi Trimarchi, MD, PhD  
  View Slides in PDF      
9:04 AM - 9:09 AM New Developments And Horizons In The Treatment Of TBADs: Predictors Of Progression: Which Patients Should Not Have Early TEVAR
  Presenter(s):Michael D. Dake, MD  
  View Slides in PDF      
9:10 AM - 9:15 AM A New Classification System For Aortic Dissections: Implications For Treatment
  Presenter(s):Mark A. Farber, MD  
9:16 AM - 9:21 AM Optimal Management Of Type A Aortic Dissections (TAADs): New Developments In Frozen Elephant Trunk Grafts
  Presenter(s):Joseph S. Coselli, MD  
  View Slides in PDF      
9:22 AM - 9:27 AM Frozen Elephant Trunks Combined With TEVAR: Why Is It The Best Treatment For Some Acute TBADs: Which Ones
  Presenter(s):Martin Czerny, MD / Bartosz Rylski, MD, PhD  
  View Slides in PDF      
9:28 AM - 9:33 AM Why TEVAR Alone Is Not Enough For The Long-Term Management Of Type B Aortic Dissections (TBAD): Update On The Advantages And Disadvantages Of The PETTICOAT Composite Device Concept
  Presenter(s):Joseph V. Lombardi, MD  
  View Slides in PDF      
9:34 AM - 9:39 AM Update On The STABILISE Technique For Treating TBADs: Balloon Over-Dilatation Of The Distal Open Stent To Disrupt The Dissection Flap And Seal The False Lumen: Midterm Results And Precautions In >100 Patients
  Presenter(s):Jean-Marc Alsac, MD, PhD  
  View Slides in PDF      
9:40 AM - 9:45 AM Update On DISTAL EXTENDED BRANCH PETTICOAT Technique To Treat False Lumen Dilatation In Complex Aortic Dissections By Placing Covered Balloon Expandable Stents In Renal And Visceral Branches: Technique And Improved Results
  Presenter(s):Lars R. Kock, MD  
  View Slides in PDF      
9:46 AM - 9:51 AM Long-Term Success After TEVAR For TBAD Or Ascending Aortic Replacement For TAAD Usually Requires Secondary Adjunctive Measures: What Are They And What Are The Implications
  Presenter(s):Götz M. Richter, MD, PhD  
  View Slides in PDF      
9:52 AM - 9:57 AM Retrograde Arch Branch TEVAR vs. In Situ Fenestration: Advantages And Limitations Of Each
  Presenter(s):Jean M. Panneton, MD  
  View Slides in PDF      
9:58 AM - 10:04 AM Panel Discussion
10:04 AM - 10:15 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 3
 
SESSION 4 SCHEDULE
Tuesday
SESSION 4: MORE NEW DEVELOPMENTS IN THE TREATMENT OF TBADs AND THORACIC AORTIC DISEASE; TEVAR AND THORACOABDOMINAL ANEURYSMS (TAAAs)
x
10:15 AM - 10:20 AM Highlights Of The New SVS Guidelines For TEVAR
  Presenter(s):Guillermo A. Escobar, MD / Gilbert R. Upchurch, MD / Thomas L. Forbes, MD  
  View Slides in PDF      
10:21 AM - 10:26 AM Update On Natural History Of Intramural Hematomas (IMHs) And Penetrating Aortic Ulcers (PAUs): When Should They Be Treated By TEVAR And When Not: Prognosis After Treatment
  Presenter(s):Frank R. Arko, MD  
  View Slides in PDF      
10:27 AM - 10:32 AM Most Focal Thoracic Disease (IMHs, PAUs And Pseudoaneurysms) Should Be Treated By Endografts (TEVAR)
  Presenter(s):Robert S. Crawford, MD  
  View Slides in PDF      
10:33 AM - 10:38 AM Long-Term Results Of Cervical Debranching Procedures With TEVAR: Patency, Complications And Tips For Performing
  Presenter(s):Ashraf Mansour, MD  
  View Slides in PDF      
10:39 AM - 10:44 AM What Preop CTA Features Can Predict Outcome Of TEVAR For TBAD In Terms Of Remodeling And Distal Endograft Induced Re-Entry Tears
  Presenter(s):Wei Guo, MD  
  View Slides in PDF      
10:45 AM - 10:50 AM Distal Endograft Induced Re-Entry Tears After TEVAR For TBADs: What Factors Cause Them: How Can They Be Prevented And Treated
  Presenter(s):Chun Che Shih, MD, PhD  
  View Slides in PDF      
10:51 AM - 10:56 AM How To Prevent And Treat Retrograde Aortic Dissection Occurring With TEVAR
  Presenter(s):Ali Azizzadeh, MD  
  View Slides in PDF      
10:56 AM - 11:04 AM Panel Discussion
Moderator(s): Ramon Berguer, MD, PhD / Götz M. Richter, MD, PhD  
11:04 AM - 11:09 AM Most Patients Requiring TEVAR Fall Outside IFUs: Does It Matter
  Presenter(s):Dittmar Boeckler, MD  
  View Slides in PDF      
11:10 AM - 11:15 AM Staged Hybrid Repairs Of Type II TAAAs With Proximal TEVAR And Open Limited Distal Repair: Advantages And Results
  Presenter(s):Gilbert R. Upchurch, MD  
  View Slides in PDF      
11:16 AM - 11:21 AM Importance Of Air Emboli In Causing Strokes After TEVAR: New Technology (Flush Solution) And Techniques To Prevent Air Emboli From Devices
  Presenter(s):Tilo Koelbel, MD, PhD / Fiona Rohlffs, MD  
  View Slides in PDF      
11:22 AM - 11:27 AM When Are Endografts The Right Option For Treatment Of Marfans Patients
  Presenter(s):James H. Black III, MD  
  View Slides in PDF      
11:28 AM - 11:33 AM Secondary Aortic Interventions After TEVAR: How Can They Be Prevented; Why Are They Necessary And Do They Improve Outcomes
  Presenter(s):Salvatore T. Scali, MD / Martin R. Back, MD / Adam Beck, MD  
  View Slides in PDF      
11:34 AM - 11:39 AM New Findings Regarding Re-Interventions For Failed TEVARs
  Presenter(s):Ronald M. Fairman, MD / Grace Wang, MD  
  View Slides in PDF      
11:40 AM - 11:45 AM Open Conversion For Failed TEVARs And Endograft TAAA Repairs: Tips And Tricks: When Indicated And When Should Open Repair Be Done Primarily
  Presenter(s):Michael J. Jacobs, MD  
  View Slides in PDF      
11:46 AM - 11:51 AM Number, Size And Location Of Dissection Entry Tears Influences Flap Motion And False Lumen Flows: What Is The Clinical Significance: Studies In An In Vitro TBAD Model
  Presenter(s):Ravi K. Veeraswamy, MD  
  View Slides in PDF      
11:52 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break - 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 4
 
SESSION 5 SCHEDULE
Tuesday
SESSION 5: NEW DEVELOPMENTS IN EVAR AND AAA
x
1:00 PM - 1:05 PM Decades Of AAA RCTs And Registries: What Do They Tell Us; What Do They Tell Us That Is Wrong; And What Don’t They Tell Us
  Presenter(s):Frank J. Criado, MD, FACS, FSVM  
  View Slides in PDF      
1:06 PM - 1:11 PM Maintenance Of Durability Of All Types Of Endovascular Repair By A Simple, Safe And Patient Friendly Method Recommended To The NICE Aortic Guidelines
  Presenter(s):Roger M. Greenhalgh, MD  
1:12 PM - 1:17 PM Late Results Of The DREAM And OVER RCTs Did Not Show The Same Late Survival Benefit For OR As EVAR 1: Possible Reasons And Should EVAR Be The Treatment Of Choice For All Anatomically Suitable AAA Patients
  Presenter(s):Jan D. Blankensteijn, MD  
  View Slides in PDF      
1:18 PM - 1:23 PM EVAR Results Have Improved Since 2004: EVAR Should Be The Treatment Of Choice For All AAA Patients With Suitable Anatomy
  Presenter(s):Jean-Pierre Becquemin, MD, FRCS  
  View Slides in PDF      
1:24 PM - 1:29 PM Drugs To Slow AAA Growth: Will Metformin Do It And How Is Metformin Related To Decreased AAA Incidence In Diabetes
  Presenter(s):Ronald L. Dalman, MD  
  View Slides in PDF      
1:30 PM - 1:35 PM High LDL Cholesterol (LDL-C) And Triglycerides Can Promote AAA Growth: Could Statins And PCSK-9 Inhibitors Slow It
  Presenter(s):Richard Bulbulia, MA, MD, FRCS  
  View Slides in PDF      
1:36 PM - 1:41 PM Different Patterns Of AAA Neck Dilatation After OR And EVAR With Various Self-Expanding Or Polymer Sealing Devices: Why It Matters And Which Is Best With Short Sealing Zones
  Presenter(s):David J. Minion, MD  
  View Slides in PDF      
1:42 PM - 1:48 PM Panel Discussion
Moderator(s): Enrico Ascher, MD / Keith D. Calligaro, MD  
1:48 PM - 1:53 PM AAA Rupture After EVAR: Etiology, Best Treatment And Outcomes
  Presenter(s):Eric Ducasse, MD, PhD  
  View Slides in PDF      
1:54 PM - 1:59 PM Value Of 3D Contrast Enhanced Duplex Ultrasound (CEDU) In Evaluating AAAs: It Can Quantitate Thrombus Volume As A Biomarker And Follow AAA Volume To Monitor Growth More Accurately
  Presenter(s):Henrik Sillesen, MD, DMSc  
  View Slides in PDF      
2:00 PM - 2:05 PM DEBATE: Patient Compliance After EVAR: Can Poor Compliance Be Predicted: Is It Bad And Should Non-Compliant Patients Have Open Surgery
  Presenter(s):Ali F. AbuRahma, MD  
  View Slides in PDF      
2:06 PM - 2:11 PM DEBATE: Non-Compliance After EVAR Is No Big Deal: It Does Not Increase Aneurysm Related Or All Cause Mortality
  Presenter(s):Pete Holt, MD, PhD / Matthew Joe Grima, MD, MRCSEd, MSc, ChM / Ian Loftus, MD  
  View Slides in PDF      
2:12 PM - 2:17 PM Update On Predicting AAA Growth Rates And Rupture Risk From Smooth Muscle Behavior (Grown From Skin Biopsies): This Correlates With AAA Wall Strength
  Presenter(s):Kak Khee Yeung, MD, PhD  
  View Slides in PDF      
2:18 PM - 2:23 PM Intrasac Thrombus In AAAs May Lower Wall Strength And Increases Rupture Risk: What Is The Mechanism
  Presenter(s):Gregory L. Moneta, MD / Gregory J. Landry, MD  
  View Slides in PDF      
2:24 PM - 2:29 PM How Is MR Evaluated Mural Thrombus In AAAs Associated With Predicting Their Growth Rates
  Presenter(s):Jes S. Lindholt, MD  
  View Slides in PDF      
2:30 PM - 2:36 PM Panel Discussion
END OF SESSION 5
 
SESSION 6 SCHEDULE
Tuesday
SESSION 6: NEW DEVELOPMENTS IN THE MANAGEMENT OF SHORT-NECKED (JUXTARENAL) AAAs AND PARARENAL AAAs
x
2:36 PM - 2:41 PM DEBATE: With Short-Necked AAAs Or Those With Undesirable Necks Outside IFUs, Poor EVAR Outcomes Can Be Expected With All Endograft Devices
  Presenter(s):Andres Schanzer, MD  
  View Slides in PDF      
2:42 PM - 2:47 PM DEBATE: Not So: Some Short Necked (4-8 mm) AAAs And Those With Other Undesirable Necks Outside IFUs Can Sometimes Be Well Treated With Standard EVAR Devices And Good 5-Year Results Can Be Obtained (From The ENGAGE Trial): When Is This So
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
  View Slides in PDF      
2:48 PM - 2:53 PM Why Chimney EVAR (Ch/EVAR) Is The Best Treatment For Juxtarenal And Pararenal Aneurysms
  Presenter(s):Konstantinos P. Donas, MD / Giovanni Torsello, MD  
  View Slides in PDF      
2:54 PM - 2:59 PM Why Fenestrated EVAR (F/EVAR) Is The Best Treatment For Juxtarenal And Pararenal AAAs - Although There Are Limitations
  Presenter(s):Thomas L. Forbes, MD  
  View Slides in PDF      
3:00 PM - 3:05 PM F/EVAR With The Cook ZFEN Device Plus 2 Chimney Grafts Is A Good Option For Some Pararenal AAAs: Which Ones
  Presenter(s):Ravi K. Veeraswamy, MD  
  View Slides in PDF      
3:06 PM - 3:11 PM Does F/EVAR Solve The Durability Problem Of Using Standard EVAR Devices To Treat AAAs With Short Or Difficult Necks: The GLOBALSTAR Registry Says YES
  Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS  
  View Slides in PDF      
3:12 PM - 3:17 PM Endoanchors As Adjuncts To EVAR With Standard Endograft Devices In Patients With Short Or Poor AAA Necks Can Provide Effective And Durable Results: What Are The Limitations: From The ANCHOR Registry
  Presenter(s):William D. Jordan Jr., MD  
  View Slides in PDF      
3:18 PM - 3:23 PM Open Surgery Is The Best Treatment For Juxtarenal And Pararenal AAAs In Good Risk Patients
  Presenter(s):Kimihiro Komori, MD, PhD  
  View Slides in PDF      
3:24 PM - 3:29 PM Ch/EVAR, F/EVAR, Combinations And Open Repair All Have A Role In Treating Short And No Necked AAAs: When Is Each The Best
  Presenter(s):Jason T. Lee, MD  
  View Slides in PDF      
3:30 PM - 3:37 PM Panel Discussion
3:37 PM - 3:48 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 6
 
SESSION 7 SCHEDULE
Tuesday
SESSION 7: MORE NEW DEVELOPMENTS IN TBADs, TEVAR, THORACIC AND THORACOABDOMINAL AORTIC ANEURYSMS (TAAAs)
x
3:48 PM - 3:53 PM When Is Open Repair Of TAAAs The Only Solution: When Is It The Best Solution: When Is No Repair The Best Solution
  Presenter(s):Hazim J. Safi, MD  
  View Slides in PDF      
3:54 PM - 3:59 PM With Acute Or Ruptured TAAAs An Off-The-Shelf (OTS) Endograft Is A Solution For One-Third Of Patients – But For Two-Thirds Of Patients Open Repair Is The Best Treatment
  Presenter(s):Roberto Chiesa, MD / Germano Melissano, MD / Chiara Mascoli, MD  
  View Slides in PDF      
4:00 PM - 4:05 PM For Acute Or Ruptured TAAAs Parallel Endografts (Ch/EVAR) Are The Best Solution And Can Provide Durable Repairs If Done Right
  Presenter(s):Mario L. Lachat, MD / Nicola Mangialardi, MD  
  View Slides in PDF      
4:06 PM - 4:11 PM What Is New With Cerebral Embolic Protection Devices For TEVAR And TAVI Procedures: Which Device Is Best And When Should They Be Used: What Are The Limitations
  Presenter(s):Jeffrey P. Carpenter, MD  
  View Slides in PDF      
4:12 PM - 4:17 PM How To Prevent Particulate Embolic Strokes During TEVAR: How Do The Protection Devices Work And When Should They Be Used
  Presenter(s):Richard G.J. Gibbs, FRCS  
  View Slides in PDF      
4:18 PM - 4:23 PM Why Analyzing The Nature Of The False Lumen And The Origins Of Visceral (And Renal) Arteries Is Critical To The Treatment Of Acute TBADs: How To Do It And What To Do About It
  Presenter(s):Herve Rousseau, MD, PhD  
  View Slides in PDF      
4:24 PM - 4:29 PM Fenestrated And Branched EVAR (F/B/EVAR) Is The Best Way To Treat TAAAs After TEVAR For TBADs: Value Of Inner Branched Grafts And The BeGraft Plus For Bridging Endografts
  Presenter(s):Eric L.G. Verhoeven, MD, PhD / Athanasios Katsargyris, MD  
  View Slides in PDF      
4:30 PM - 4:35 PM Role Of Branched EVAR (B/EVAR) To Treat Visceral Segment TAAAs With Chronic TBADs: Challenges And How To Overcome Them
  Presenter(s):Marcelo Ferreira, MD  
  View Slides in PDF      
4:36 PM - 4:41 PM The Initial False Lumen To True Lumen (FL/TL) Ratio On CTs Is A Most Accurate Predictor Of The Need For Interventions With Acute TBADs
  Presenter(s):Jean M. Panneton, MD  
  View Slides in PDF      
4:42 PM - 4:48 PM Panel Discussion
END OF SESSION 7
 
SESSION 8 SCHEDULE
Tuesday
SESSION 8: CONTROVERSIES AND NEW DEVELOPMENTS IN THE MANAGEMENT OF UNCOMPLICATED TBADs
x
4:48 PM - 4:53 PM New Developments In The Endovascular Treatment Of Uncomplicated TBAD Patients: The FLIRT Concept: What Has Changed: TEVAR Is Indicated In Most At 2-8 Weeks After Onset: Who Are They And What Else Is Needed
  Presenter(s):Christoph A. Nienaber, MD, PhD  
  View Slides in PDF      
4:54 PM - 4:59 PM Trends In US National Treatment For Asymptomatic Uncomplicated TBADs: From The National Inpatient Sample Through 2015
  Presenter(s):Raghuveer Vallabhaneni, MD  
  View Slides in PDF      
5:00 PM - 5:05 PM When Should Acute Uncomplicated TBADs Be Treated By TEVAR: How Can Imaging Help
  Presenter(s):Rachel E. Clough, MD, PhD, FRCS  
  View Slides in PDF      
5:06 PM - 5:11 PM Outcomes Of Endovascular Repair Of Multi-Channeled Aortic Dissection With And Without Full True Lumen Collapse
  Presenter(s):Weiguo Fu, MD  
  View Slides in PDF      
5:12 PM - 5:17 PM DEBATE: The Case For Treating All Uncomplicated Acute TBAD Patients With TEVAR
  Presenter(s):Ross Milner, MD  
  View Slides in PDF      
5:18 PM - 5:23 PM DEBATE: The Case Against TEVAR For All Uncomplicated Acute TBAD Patients And For Good Medical Treatment Alone For Most: What Constitutes Good Medical Treatment
  Presenter(s):Ali Azizzadeh, MD  
  View Slides in PDF      
5:24 PM - 5:29 PM Patient Compliance With Good Medical Therapy For TBADs Is Poor: How Can This Be Improved And What Is Its Impact On The Debate Over Optimal Treatment For These Patients
  Presenter(s):Colin D. Bicknell, MD FRCS  
  View Slides in PDF      
5:30 PM - 5:35 PM Another Controversial Opinion: Why TEVAR Should Be Performed On All Acute TBAD Patients
  Presenter(s):Mark Conrad, MD, MMSc  
  View Slides in PDF      
5:36 PM - 5:41 PM A Different Controversial Opinion: Not So: Why TEVAR Should Only Be Performed Selectively On Patients With Uncomplicated Acute TBADs
  Presenter(s):Michel Makaroun, MD  
  View Slides in PDF      
5:42 PM - 5:47 PM DEBATE: Why A Randomized Controlled Trial (RCT) Of TEVAR And Medical Treatment vs. Medical Treatment Alone Is Needed For Acute Uncomplicated TBADs: Such A Trial (INTACT-AD) Has Been Designed With The Following Features . . .
  Presenter(s):Firas F. Mussa, MD  
  View Slides in PDF      
5:48 PM - 5:53 PM DEBATE: We Don’t Need Such A RCT: Data From The SVS Registry And Other Sources Will Suffice
  Presenter(s):Richard P. Cambria, MD  
  View Slides in PDF      
5:54 PM - 6:02 PM Panel Discussion
End of Program A
END OF SESSION 8
 
SESSION 9 SCHEDULE
Tuesday
SESSION 9: PROGRESS IN VASCULAR ROBOTICS, LAPAROSCOPY, SIMULATION AND IMPROVED GUIDANCE SYSTEMS IN VASCULAR SURGERY
x
6:40 AM - 6:44 AM Opening Remarks
  Presenter(s):Enrico Ascher, MD  
  View Slides in PDF      
6:45 AM - 6:50 AM How A Robotic Program With The DaVinci Robot For Aortic Surgery Can Be Safe, Clinically Valuable, And Cost Effective
  Presenter(s):Jean-Marc Alsac, MD, PhD  
  View Slides in PDF      
6:51 AM - 6:56 AM Update On The Value Of Laparoscopy And Robotic Techniques In Vascular Surgery: Will They Be Widely Applicable And Beneficial
  Presenter(s):Willem Wisselink, MD  
  View Slides in PDF      
6:57 AM - 7:02 AM Laparoscopic Techniques For Aortic Procedures (AAA Repair) Has No Future And Is Not Worth Training For
  Presenter(s):Jean-Baptiste Ricco, MD, PhD  
  View Slides in PDF      
7:03 AM - 7:08 AM Value Of Robotics For Endovascular Procedures: What Does The Future Hold
  Presenter(s):Celia Riga, BSc, MBBS, MD, FRCS / Nicholas J.W. Cheshire, MD  
  View Slides in PDF      
SIMULATION FOR VASCULAR PROCEDURES
7:09 AM - 7:14 AM How To Use Virtual Reality Simulation To Train More Interventional Doctors To Safely And Effectively Perform Intracranial Thrombectomy For Acute Strokes
  Presenter(s):Lars B. Lonn, MD, PhD  
  View Slides in PDF      
7:15 AM - 7:21 AM Use Of Simulation To Improve Ultrasound Guided Arterial And Venous Access Of Difficult Vessels
  Presenter(s):Afshin Assadian, MD  
  View Slides in PDF      
7:22 AM - 7:27 AM Whole Task Simulator For Improved Training In Carotid Procedures: Carotid Endarterectomy (CEA) Or TransCarotid Artery Revascularization (TCAR)
  Presenter(s):Michael C. Stoner, MD  
  View Slides in PDF      
IMPROVED GUIDANCE
7:28 AM - 7:33 AM Advances In Imaging And Robotic Guidance For Treating Complex AAAs And TBADs
  Presenter(s):Alan B. Lumsden, MD, FACS  
  View Slides in PDF      
7:34 AM - 7:39 AM Intraoperative Positioning System (IOPS - From Centerline Biomedical): A Non-X-ray 3D Imaging And Navigation System For Guiding Endovascular Procedures: How It Works And Future Potential
  Presenter(s):Mark A. Farber, MD / Matthew J. Eagleton, MD  
  View Slides in PDF      
7:40 AM - 7:46 AM Panel Discussion
END OF SESSION 9
 
SESSION 10 SCHEDULE
Tuesday
SESSION 10: NEW DEVELOPMENTS IN THE MANAGEMENT OF CAROTID DISEASE AND ASYMPTOMATIC CAROTID STENOSIS (ACS)
x
7:46 AM - 7:51 AM Risk Of Stroke In Patients With High Grade Asymptomatic Re-Stenoses After Carotid Endarterectomy (CEA) Is Low And Even Lower After Carotid Stenting (CAS): Invasive Treatment Is Rarely Justified
  Presenter(s):Ross Naylor, MD, FRCS  
  View Slides in PDF      
7:52 AM - 7:57 AM New Findings From The SAMMPRIS RCT Comparing Intracranial Stenting To Best Medical Treatment (BMT): BMT Is Feasible And There Is A High Incidence Of In Stent Restenosis (ISR) Causing Strokes
  Presenter(s):Colin P. Derdeyn, MD  
  View Slides in PDF      
7:58 AM - 8:03 AM What Is The Significance Of Subclinical DW MRI Brain Lesions After CAS And CEA: Do They Impair Brain Function
  Presenter(s):Laura Capoccia, MD, PhD  
  View Slides in PDF      
8:04 AM - 8:09 AM Minor Strokes Are Not Benign – Whether From Carotid Disease Or Other Causes
  Presenter(s):Emmanuel M. Houdart, MD  
  View Slides in PDF      
8:10 AM - 8:15 AM What Other Than Emboli From Carotid Lesions Can Cause Strokes: What Percentage Of Strokes Are Caused By Carotid Bifurcation Disease
  Presenter(s):Thomas G. Brott, MD  
  View Slides in PDF      
8:16 AM - 8:21 AM What Is The Value Of The CREST-2 Registry And What Will It Tell Us
  Presenter(s):Kenneth Rosenfield, MD  
  View Slides in PDF      
8:22 AM - 8:28 AM Panel Discussion
Moderator(s): Ross Naylor, MD, FRCS / Sumaira Macdonald, MD, PhD  
8:28 AM - 8:33 AM DEBATE: Near Total Occlusion Of The Internal Carotid Artery (ICA) – A “String Sign” Should Not Be Treated Invasively Even If Symptomatic: Medical Treatment Is Best
  Presenter(s):George Geroulakos, MD, PhD  
  View Slides in PDF      
8:34 AM - 8:39 AM DEBATE: Not So: Some Symptomatic Patients With An ICA String Sign Need Urgent Invasive Treatment: Which Ones; What Treatment: What Outcome Can Be Expected
  Presenter(s):Hans-Henning Eckstein, MD, PhD  
  View Slides in PDF      
ACS MEGA DEBATE
8:40 AM - 8:45 AM In Patients With Asymptomatic Carotid Stenosis (ACS) Risks Of Invasive Treatment (CEA/CAS) Outweigh Any Potential Benefit: None Should Undergo CEA Or CAS
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
  View Slides in PDF      
8:46 AM - 8:51 AM Patients With High Risk ACS – Even If Elderly – Should Undergo Invasive Treatment, Usually CEA: What Percentage Of ACS Patients Should Get CEA: It Is At Least 20%
  Presenter(s):Bruce A. Perler, MD, MBA  
  View Slides in PDF      
8:52 AM - 8:57 AM That Percentage Is Too High: Approximately 10% of ACS Patients Should Undergo Invasive Treatment: How Can They Reliably Be Selected
  Presenter(s):Kosmas I. Paraskevas, MD / Jean-Baptiste Ricco, MD, PhD  
  View Slides in PDF      
8:58 AM - 9:03 AM Invasive Treatment Of ACS Is Rarely Indicated: ACS Patients Need Good Medical Treatment And A Low LDL Cholesterol (LDL-C): How Low: Less Than 3% Of ACS Patients Should Have Invasive Treatment And These Are Hard To Select
  Presenter(s):Henrik Sillesen, MD, DMSc  
  View Slides in PDF      
9:04 AM - 9:09 AM Statins And Omega 3 Can Stabilize Carotid Plaques And Render Them Less Harmful and Embologenic: How Often And How Low Does The LDL-C Have To Go For This To Occur
  Presenter(s):Andrew N. Nicolaides, MS, FRCS  
  View Slides in PDF      
9:10 AM - 9:16 AM Panel Discussion
9:16 AM - 9:28 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 10
 
SESSION 11 SCHEDULE
Tuesday
SESSION 11: PROGRESS IN THE INTERVENTIONAL MANAGEMENT OF ACUTE STROKES – A NEW HORIZON
x
9:28 AM - 9:33 AM Acute Stroke Treatment In 2018: Highlights Of Progress And How Best To Treat Strokes From Acute ICA Occlusion
  Presenter(s):Klaus D. Mathias, MD  
  View Slides in PDF      
9:34 AM - 9:39 AM Treating Strokes From Acute ICA Occlusion Is Not Simple And Requires A Multidisciplinary Approach With Removal Of Clot In The Neck And Intracranial Arteries And Fixing The Causative Lesion: Technical Plan And Results
  Presenter(s):Timothy M. Sullivan, MD  
  View Slides in PDF      
9:40 AM - 9:45 AM Tips And Tricks For Acute Stroke Interventions
  Presenter(s):Horst Sievert, MD  
  View Slides in PDF      
9:46 AM - 9:51 AM The COMPASS RCT Shows That New Aspiration Systems Are Equal To Stentrievers For Removing Intracranial Clot To Treat Acute Strokes: When Are They Better
  Presenter(s):Alejandro M. Spiotta, MD  
  View Slides in PDF      
9:52 AM - 9:57 AM Optimal Current Strategies And Techniques For Treating An Acute Stroke After CEA: The Treatment Paradigm Has Changed
  Presenter(s):Colin P. Derdeyn, MD  
  View Slides in PDF      
9:58 AM - 10:03 AM Update On Value Of Intracranial Clot Removal For Acute Strokes: When Is A Longer Window After Symptom Onset (Up to 24 Hours) Acceptable: From The DAWN, DIFFUSE And EXTEND-IA TNK Randomized Controlled Trials
  Presenter(s):L. Nelson Hopkins, MD  
  View Slides in PDF      
10:04 AM - 10:09 AM Interventional Treatment Of Acute Strokes: Stroke Patients Should Be Admitted Directly To Neuro-EndoCompetent Centers: What Tests Can Predict When Clot Removal May Be Helpful And When Not
  Presenter(s):Emmanuel M. Houdart, MD  
  View Slides in PDF      
10:10 AM - 10:15 AM What Training Is Needed For A Vascular Surgeon Or Specialist To Be Qualified To Perform Intracranial Interventions For Acute Strokes: Such Training Is Mandatory
  Presenter(s):Thomas Haldis, DO  
  View Slides in PDF      
10:16 AM - 10:21 AM How Does Targeted Temperature Management And Induced Hypothermia Help In The Treatment Of Acute Strokes
  Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC  
  View Slides in PDF      
10:22 AM - 10:28 AM Panel Discussion
END OF SESSION 11
 
SESSION 12 SCHEDULE
Tuesday
SESSION 12: PROGRESS IN THE TREATMENT OF AORTO-ILIAC OCCLUSIVE DISEASE
x
10:28 AM - 10:33 AM When Is Open Aorto-Bifemoral Bypass The Procedure Of Choice For Aorto-Iliac Occlusive Disease
  Presenter(s):Domenico Valenti, DMChir, PhD, FRCS, FRCS(Ed), FEBVS  
  View Slides in PDF      
10:34 AM - 10:39 AM Can Duplex Ultrasonography Evaluate Unsuspected Subclinical Axillary/Subclavian Stenosis Before Axillo-Bifemoral Bypasses Or Is Angiography Always Mandatory
  Presenter(s):Keith D. Calligaro, MD / Matthew J. Dougherty, MD  
  View Slides in PDF      
10:40 AM - 10:45 AM When Endovascular Treatments Are Not Feasible For Aorto-Iliac Occlusive Disease, Axillofemoral Bypass Should Be The Procedure Of Choice
  Presenter(s):Russell H. Samson, MD, RVT, FACS  
  View Slides in PDF      
10:46 AM - 10:51 AM Thoracic Aorto-Bifemoral Bypasses Are Useful When Other Revascularizations Have Failed: Tips And Tricks To Make The Procedure Simple
  Presenter(s):Manju Kalra, MBBS  
  View Slides in PDF      
10:52 AM - 10:57 AM None Of These Open Operations Should Ever Be Necessary: Endovascular Treatments Should Suffice For All Aorto-Iliac Occlusive Lesions Needing Treatment: Tips And Tricks
  Presenter(s):Sonia Ronchey, MD, PhD / Nicola Mangialardi, MD  
  View Slides in PDF      
10:58 AM - 11:03 AM Advances In Stent Treatment For Aorto-Iliac Occlusive Disease
  Presenter(s):Jos C. van den Berg, MD, PhD  
  View Slides in PDF      
11:04 AM - 11:09 AM Tips And Tricks For Optimal Iliac Stenting: How To Maximize Patency And Avoid Rupture: Image Fusion Can Help
  Presenter(s):Klaus M. Overbeck, MD, MPhil  
  View Slides in PDF      
11:10 AM - 11:17 AM Panel Discussion
Moderator(s): Sean P. Lyden, MD / Daniel G. Clair, MD  
11:17 AM - 11:22 AM Isolated Aortic Stenosis/Occlusion: A Disease Of Women Best Treated With A Balloon Expandable Stent-Graft
  Presenter(s):Sigrid Nikol, MD  
  View Slides in PDF      
11:23 AM - 11:28 AM Incidence And Treatment Techniques For Iliac Artery Rupture And Acute Limb Ischemia During Endovascular Treatment Of Aorto-Iliac Occlusive Disease
  Presenter(s):Francesco Setacci, MD  
  View Slides in PDF      
11:29 AM - 11:34 AM Challenges Of Treating Heavily Calcified Aorto-Iliac Occlusive Lesions: How Can Intravascular Lithotripsy (Shockwave Medical) Be Helpful
  Presenter(s):Fabrizio Fanelli, MD, EBIR  
  View Slides in PDF      
11:35 AM - 11:40 AM Importance Of Hip Flexion And Extension In External Iliac Stenting: How To Minimize Its Detrimental Effects: Are Covered Stents Advantageous
  Presenter(s):Franco Grego, MD  
  View Slides in PDF      
11:41 AM - 11:46 AM Hybrid Approach To Treat Severe And Extensive External Iliac Artery Occlusive Disease Using Viabahn Stent-Grafts And Femoral Endarterectomy: Technique And Advantages
  Presenter(s):Frederic Cochennec, PhD  
  View Slides in PDF      
11:47 AM - 11:52 AM Reconstruction Of The Aortic Bifurcation For Occlusive Disease: The CERAB Procedure: 3-Year Good Results; Advantages; Best Available Stent Grafts
  Presenter(s):Michel M.P. Reijnen, MD, PhD / Peter C.J. Goverde, MD  
  View Slides in PDF      
11:53 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break - 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 12
 
SESSION 13 SCHEDULE
Tuesday
SESSION 13: NEW IMPROVED OR CONTROVERSIAL CONCEPTS OR TECHNIQUES
x
1:00 PM - 1:05 PM Radial Artery Access: First And Best Option For Intra-Abdominal And Lower Extremity Interventions: Tips, Tricks, Equipment Needed And Pitfalls: How To Make It Safe
  Presenter(s):Marcelo Guimaraes, MD, FSIR  
  View Slides in PDF      
1:06 PM - 1:11 PM Minimizing Risks When Using Upper Extremity Access For Treating Abdominal And Lower Extremity Lesions
  Presenter(s):Matthew W. Mell, MD, MS  
  View Slides in PDF      
1:12 PM - 1:17 PM All CTOs In Iliac And Lower Extremity Arteries Can Be Crossed With Catheters And Guidewires: How To Do It And How To Deal Simply With Failed Re-Entry
  Presenter(s):Ali Amin, MD, RVT, FACS, FACC  
  View Slides in PDF      
1:18 PM - 1:23 PM DEBATE: Triple Screening For AAAs, PVD, And Hypertension Saves Lives: From The VIVA Danish Trial
  Presenter(s):Jes S. Lindholt, MD  
  View Slides in PDF      
1:24 PM - 1:29 PM DEBATE: Value Of The Quick Carotid Scan For Screening: Is It Ready For Widespread Use To Detect Asymptomatic Carotid Stenosis (ACS) If Most Patients With It Are Best Treated Medically
  Presenter(s):George S. Lavenson, MD  
  View Slides in PDF      
1:30 PM - 1:35 PM DEBATE: Widely Advertised Non-Invasive Vascular Screening Seems Like A Good Idea But Causes More Harm Than Benefit
  Presenter(s):Frank J. Criado, MD, FACS, FSVM  
  View Slides in PDF      
1:36 PM - 1:41 PM Use Of 2D Vector Velocity And 3D Ultrasound Can Non-Invasively Measure Intravascular Pressure Changes, Gradients And Flow Abnormalities
  Presenter(s):Lars B. Lonn, MD, PhD  
  View Slides in PDF      
1:42 PM - 1:47 PM Bariatric Gastric Artery Embolization For Weight Management: How Is It Done: How Effective Is It (The LOSE-IT RCT) And Will It Replace Bariatric Surgery
  Presenter(s):Nickolas Kipshidze, MD, PhD  
  View Slides in PDF      
1:48 PM - 1:53 PM The Post-Implantation Syndrome After EVAR: What Is It And How Should It Be Diagnosed And Treated
  Presenter(s):Erik E. Debing, MD, PhD  
  View Slides in PDF      
1:54 PM - 2:00 PM Panel Discussion
END OF SESSION 13
 
SESSION 14 SCHEDULE
Tuesday
SESSION 14: VASCULAR SURGERY’S GOVERNING BODIES, BOARDS, RESIDENCY REVIEW COMMITTEES, TRAINING, THE NEED FOR INDEPENDENCE AND BRANDING OF THE SPECIALTY
x
2:00 PM - 2:05 PM Vascular Surgery Is A Separate Independent Specialty In The UK And Most Of Europe: How Has The European Vascular Surgery Board Benefitted Patients And Vascular Surgeons
  Presenter(s):David McLain, FEBVS  
  View Slides in PDF      
2:06 PM - 2:11 PM Integrated Vascular Surgery Residencies (0+5 Programs): How Many Exist; How Are They Working; Why More Would Help: Should Vascular Surgery Be An Independent Specialty
  Presenter(s):Murray L. Shames, MD  
  View Slides in PDF      
2:12 PM - 2:17 PM How To Remedy The Projected Shortage Of Vascular Surgeons In The US By Increasing The Number Of 0+5 Training Programs: Would An Independent Board Help
  Presenter(s):Andres Schanzer, MD  
  View Slides in PDF      
2:18 PM - 2:23 PM Training The Vascular Surgery Workforce Of The Future: How Is It Changing: What Are The Challenges In Recruiting And Training So Vascular Surgery Can Thrive: Would Independent Specialty Status Help
  Presenter(s):William D. Jordan Jr., MD  
  View Slides in PDF      
2:24 PM - 2:29 PM Why An Independent Board And Residency Review Committee In Vascular Surgery (RRC-VS) Would Help The Specialty And Patients: What Is Wrong With The Status Quo
  Presenter(s):John F. Eidt, MD  
  View Slides in PDF      
2:30 PM - 2:36 PM Panel Discussion
2:36 PM - 2:41 PM What Vascular Surgery Needs To Do To Thrive: We Need Better Branding: Being An Independent Specialty Would Help In Many Ways
  Presenter(s):Alan M. Dietzek, MD, RPVI, FACS  
  View Slides in PDF      
2:42 PM - 2:47 PM Why Vascular Surgery Needs An Independent ABMS Approved Board Now: How Can We Get There
  Presenter(s):Timur P. Sarac, MD  
  View Slides in PDF      
2:48 PM - 2:53 PM Why Vascular Surgery Needs Separate Governing Bodies: A Group Practice Leader’s Perspective
  Presenter(s):Jeffrey H. Hsu, MD  
  View Slides in PDF      
2:54 PM - 2:59 PM On The Path To Vascular Surgery Independence: The Role Of Independent Fellowships And The Urgent Need For An RRC-VS And An Independent Approved Board (ABVS): A Program Director And Division Chief's Perspective
  Presenter(s):Timothy M. Sullivan, MD  
  View Slides in PDF      
3:00 PM - 3:05 PM The Need For Autonomy In Vascular Surgical Training: We Need An Autonomous Board And RRC: A Younger Vascular Surgery Program Director’s Perspective
  Presenter(s):Jean E. Starr, MD  
  View Slides in PDF      
3:06 PM - 3:11 PM Why An Independent ABMS Approved Specialty Board Is Critically Important For The Branding Of Vascular Surgery And The Well Being Of Its Patients
  Presenter(s):Scott L. Stevens, MD  
  View Slides in PDF      
3:12 PM - 3:17 PM Vascular Surgery Has Evolved Into A Specialty Separate And Distinct From General Surgery: It Should Now Have Its Own Separate Governing Bodies: Many Benefits Will Accrue
  Presenter(s):O. William Brown, MD, JD  
  View Slides in PDF      
3:18 PM - 3:23 PM Dramatic Evolutionary Changes In Vascular Surgery Include: An Endovascular Focus In Most Treatments And Widespread Integrated Training Programs: Do These Changes Require That Governing And Credentialing Bodies Take A New Look At Independence For The Specialty
  Presenter(s):Bruce A. Perler, MD, MBA  
  View Slides in PDF      
3:24 PM - 3:38 PM Panel Discussion And Break
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 14
 
SESSION 15 SCHEDULE
Tuesday
SESSION 15: PROGRESS IN THE TREATMENT OF RENAL AND VISCERAL ARTERY DISEASE
x
3:38 PM - 3:43 PM When Is Renal Artery Stenting A Worthwhile Procedure – Despite The RCTs Showing It Has No Value
  Presenter(s):Thomas A. Sos, MD  
  View Slides in PDF      
3:44 PM - 3:49 PM New Developments In The Treatment Of The Nutcracker Syndromes – Arterial (Duodenal Compression) And Venous (Renal Vein Compression)
  Presenter(s):Irwin V. Mohan, MBBS, MD, FRCS, FEBVS, FRACS  
  View Slides in PDF      
3:50 PM - 3:55 PM Endovascular vs. Open Treatment Of Renal And Visceral Artery Aneurysms: When Is Each Needed And When Is Observation Best
  Presenter(s):Timur P. Sarac, MD  
  View Slides in PDF      
3:56 PM - 4:01 PM New Detachable Coils Facilitate The Treatment Of Renal And Visceral Artery Aneurysms: Technical Tips
  Presenter(s):Michele Rossi, MD  
  View Slides in PDF      
4:02 PM - 4:07 PM Current Optimal Treatment Of Visceral And Renal Artery Aneurysms: Lessons Learned And Pitfalls
  Presenter(s):Jean-Pierre Becquemin, MD, FRCS  
  View Slides in PDF      
4:08 PM - 4:13 PM Isolated Spontaneous Mesenteric Artery Dissections (Of SMA And Celiac Axis): Etiology, Natural History, Diagnosis And Treatment: Most Are Benign
  Presenter(s):Heron E. Rodriguez, MD  
  View Slides in PDF      
4:14 PM - 4:20 PM Panel Discussion
4:20 PM - 4:25 PM Open Retrograde SMA Stenting: When Is It Indicated And How To Do It
  Presenter(s):Richard J. Powell, MD  
  View Slides in PDF      
4:26 PM - 4:31 PM Value Of Penumbra Indigo Suction Thrombectomy Device In Treating Acute Bowel Ischemia: Advantages And Precautions
  Presenter(s):Claudio J. Schonholz, MD  
  View Slides in PDF      
4:32 PM - 4:37 PM Median Arcuate Ligament Syndrome: Is It Real And How Best To Diagnose And Treat It
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh  
  View Slides in PDF      
4:38 PM - 4:43 PM Endovascular vs. Open Treatment Of Acute And Chronic Mesenteric Ischemia: When Is Each Best
  Presenter(s):Timur P. Sarac, MD  
  View Slides in PDF      
4:44 PM - 4:49 PM Prevention And Endovascular Treatment Of Hepatic Artery Stenoses After Liver Transplantation: Tips And Precautions: How To Manage Complications
  Presenter(s):W. Charles Sternbergh III, MD  
  View Slides in PDF      
4:50 PM - 4:56 PM Panel Discussion
END OF SESSION 15
 
SESSION 16 SCHEDULE
Tuesday
SESSION 16: OPEN AND HYBRID SURGICAL PROCEDURES
x
4:56 PM - 5:01 PM Distal Vertebral Bypass: It Can Be Easier Than You Think: Indications And How To Do It
  Presenter(s):Enrique Criado, MD, FACS  
  View Slides in PDF      
5:02 PM - 5:07 PM When Should Open Surgery Be The First Option For Popliteal Aneurysm Repair: What Approach Is Best – Medial Or Posterior
  Presenter(s):Jose Fernandes e Fernandes, MD, PhD, FRCS (Eng), FACS, FESC, FEBVS  
  View Slides in PDF      
5:08 PM - 5:13 PM Open Surgical Treatment Of Splenic Artery Aneurysms In The Endo Era: Indications And Technical Tips
  Presenter(s):Armando Mansilha, MD, PhD, FEBVS  
  View Slides in PDF      
5:14 PM - 5:19 PM Tips And Tricks For Open Surgical Treatment Of Vascular Emergencies In The Porta Hepatis With Whipple And Other Procedures
  Presenter(s):James H. Black III, MD  
  View Slides in PDF      
5:20 PM - 5:25 PM Techniques For Controlling Intraoperative Bleeding During Aortic Operations: Surviving Nightmares
  Presenter(s):Kenneth J. Cherry, MD  
  View Slides in PDF      
5:26 PM - 5:31 PM Acute Abdominal Aortic Occlusions: A Misleading Catastrophe: When Should Treatment Be Open, Endo Or Hybrid
  Presenter(s):Gabriel Szendro, MD  
  View Slides in PDF      
5:32 PM - 5:37 PM Tips And Tricks For Vascular Control And Reconstructions (Arteries And Veins) During Big Cancer Operations
  Presenter(s):Ashraf Mansour, MD  
  View Slides in PDF      
5:38 PM - 5:43 PM Why The Role Of Open Surgery For AAAs Is Increasingly Important: What Are The Current Indications And How Will Vascular Trainees Learn To Do It
  Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS  
  View Slides in PDF      
5:44 PM - 5:49 PM How To Prevent And Treat Graft Related Complications During And After Aortic Surgery
  Presenter(s):James H. Black III, MD  
  View Slides in PDF      
5:50 PM - 5:57 PM Panel Discussion
End of Program B
END OF SESSION 16
 
SESSION 17 SCHEDULE
Tuesday
SESSION 17: MANAGEMENT OF PULMONARY EMBOLISM: A COMPLEX TEAM SPORT – PART 1
Moderators:Michael R. Jaff, DO  
x
7:00 AM - 7:05 AM Introduction To The Symposium
  Presenter(s):Frank J. Veith, MD  
  View Slides in PDF      
7:05 AM - 7:15 AM Welcome And Introduction
  Presenter(s):Michael R. Jaff, DO  
  View Slides in PDF      
7:15 AM - 7:25 AM The Basics Of Pulmonary Embolism: What Is The Role Of The History, Exam, Biomarkers
  Presenter(s):Raghu Kolluri, MD  
  View Slides in PDF      
7:25 AM - 7:35 AM CT For PE: What Does This Actually Tell Us: Is There Any Role For MR In Acute Or Chronic PE
  Presenter(s):Brian B. Ghoshhajra, MD, MBA  
  View Slides in PDF      
7:35 AM - 7:50 AM Medical Treatment Of PE: When, Why, For How Long, And How Can I Remember How Long
  Presenter(s):Geno J. Merli, MD, MACP, FHM, FSVM  
  View Slides in PDF      
7:50 AM - 8:00 AM Testing For Cancer And Other Hypercoagulable States In PE
  Presenter(s):Rachel Rosovsky, MD, MPH  
  View Slides in PDF      
8:00 AM - 8:10 AM Setting The Stage – The Emergency Physician Algorithm For Acute PE Management
  Presenter(s):D. Mark Courtney, MD  
  View Slides in PDF      
8:10 AM - 8:25 AM Intravenous Thrombolytic Therapy For PE: No Need For Catheter-Based Intervention
  Presenter(s):Jeffrey W. Olin, DO  
  View Slides in PDF      
8:25 AM - 8:35 AM Advancing The Science In PE Treatment – What Do We Need To Know, And How Will We Learn
  Presenter(s):Akhilesh K. Sista, MD  
  View Slides in PDF      
8:35 AM - 8:45 AM Percutaneous Pharmaco-Mechanical Intervention For PE: Is There A Rationale
  Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA  
  View Slides in PDF      
8:45 AM - 8:55 AM Step-By-Step Technical Tips For Pharmaco-Mechanical Intervention For PE
  Presenter(s):Gary M. Ansel, MD  
  View Slides in PDF      
8:55 AM - 9:05 AM Percutaneous Mechanical Thrombectomy Without Lytics: The Results Of The FLARE Study
  Presenter(s):Thomas M. Tu, MD  
  View Slides in PDF      
Moderator(s): Michael R. Jaff, DO  
9:05 AM - 9:15 AM Panel Discussion
  Panelist(s): Gary M. Ansel, MD / D. Mark Courtney, MD / Brian B. Ghoshhajra, MD, MBA / Raghu Kolluri, MD / Robert A. Lookstein, MD, MHCDL, FSIR, FAHA / Geno J. Merli, MD, MACP, FHM, FSVM / Jeffrey W. Olin, DO / Rachel Rosovsky, MD, MPH / Akhilesh K. Sista, MD / Thomas M. Tu, MD  
  View Slides in PDF      
9:15 AM - 9:45 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 17
 
SESSION 18 SCHEDULE
Tuesday
SESSION 18: MANAGEMENT OF PULMONARY EMBOLISM: A COMPLEX TEAM SPORT – PART 2
Moderators:Michael R. Jaff, DO  
x
9:45 AM - 9:55 AM Pulmonary Embolism Intervention With Angiojet Thrombectomy
  Presenter(s):Jeffrey Y. Wang, MD  
  View Slides in PDF      
9:55 AM - 10:05 AM Vortex Strategy For Massive PE
  Presenter(s):Christopher J. Kwolek, MD  
  View Slides in PDF      
10:05 AM - 10:20 AM ECMO And Surgical Thromboembolectomy For Massive PE: When, How And Why
  Presenter(s):Mark G. Davies, MD  
  View Slides in PDF      
10:20 AM - 10:35 AM Putting It All Together: What Is The Modern Algorithm For Management Of Massive And Submassive PE
  Presenter(s):Ido Weinberg, MD, MSc  
  View Slides in PDF      
10:35 AM - 10:50 AM Vena Cava Filters In PE Treatment: Do We Need Them, And If So, When
  Presenter(s):Sanjay Misra, MD  
  View Slides in PDF      
10:50 AM - 11:05 AM Balloon Angioplasty For Chronic Thromboembolic Pulmonary Hypertension - Does This Really Work
  Presenter(s):Kenneth Rosenfield, MD  
  View Slides in PDF      
11:05 AM - 11:20 AM The Team Approach To PE Management: The National PERT Consortium
  Presenter(s):Victor F. Tapson, MD  
  View Slides in PDF      
11:20 AM - 11:35 AM Is There A Role For Vascular Surgery On PERTs
  Presenter(s):Rabih A. Chaer, MD  
  View Slides in PDF      
Moderator(s): Michael R. Jaff, DO  
11:35 AM - 12:00 PM Challenging Cases And “PERT” Decisions
  Panelist(s): Rabih A. Chaer, MD / Mark G. Davies, MD / Christopher J. Kwolek, MD / Sanjay Misra, MD / Victor F. Tapson, MD / Kenneth Rosenfield, MD / Jeffrey Y. Wang, MD / Ido Weinberg, MD, MSc  
  View Slides in PDF      
12:00 PM - 1:00 PM Lunch Break - 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

End of Program C
END OF SESSION 18
 
SESSION 19 SCHEDULE
Tuesday
SESSION 19: HOT NEW TOPICS RELATED TO THE AORTA AND ITS BRANCHES AND AORTIC COARCTATIONS (4 ½ MINUTE FAST PACED TALKS)
x
THORACIC AORTIC TOPICS
1:00 PM - 1:05 PM Natural History Of Patients With Aortic Intramural Hematoma (IMH) With And Without Treatment: Aortic Mortality Is Low; All Cause Mortality Is Substantial: When Should TEVAR Be Done
  Presenter(s):Jürg Schmidli, MD / Martin Czerny, MD  
  View Slides in PDF      
1:05 PM - 1:10 PM A Phase 1 Human Trial Of Catheter Septotomy In Acute Type B Aortic Dissection: How Is It Done
  Presenter(s):Ramon Berguer, MD, PhD / Juan C. Parodi, MD  
  View Slides in PDF      
1:10 PM - 1:15 PM Why Bovine Aortic Arches Are Predictive Of A Bad Outcome With TBADs
  Presenter(s):Jan S. Brunkwall, MD, PhD  
  View Slides in PDF      
1:15 PM - 1:20 PM Ascending Aortic TEVAR: Where Is It And What Is Its Future Potential
  Presenter(s):Tilo Koelbel, MD, PhD  
  View Slides in PDF      
1:20 PM - 1:25 PM Importance, Prevention And Treatment Of Vascular Complications Of TAVI
  Presenter(s):Ali Khoynezhad, MD, PhD  
  View Slides in PDF      
1:25 PM - 1:30 PM Panel Discussion
MANAGEMENT OF AORTIC COARCTATION
1:30 PM - 1:35 PM Current Optimal Treatment Of Aortic Coarctation: When Endo, When Open: Bare vs. Covered Stents: Which Covered Stent Is Best: Precautions And Long-Term Results
  Presenter(s):Elchanan Bruckheimer, MBBS  
  View Slides in PDF      
1:35 PM - 1:40 PM Aortic Coarctations And Related Aneurysms: When Is Endovascular Treatment Best: Bare Stent vs. Covered Stent: When Is Open Operation Required
  Presenter(s):Christoph A. Nienaber, MD, PhD  
  View Slides in PDF      
ABDOMINAL AORTIC AND BRANCH TOPICS
1:40 PM - 1:45 PM Trans Endograft Approach To Treat Type 2 Endoleaks: Technique, Precautions And Results
  Presenter(s):Mazin Foteh, MD  
  View Slides in PDF      
1:45 PM - 1:50 PM DEBATE: With Ectatic Common Iliac Arteries (18-25 mm) During EVAR, Bell Bottom Techniques Are A Good Treatment In What Circumstances: It Is Simpler And Cheaper
  Presenter(s):Kim J. Hodgson, MD  
  View Slides in PDF      
1:50 PM - 1:55 PM DEBATE: Not So: In Most Patients With Ectatic Iliac Arteries Iliac Branched Devices (IBDs) Should Be Used To Prevent Failure From Common Iliac Dilatation
  Presenter(s):Fabio Verzini, MD, PhD  
  View Slides in PDF      
1:55 PM - 2:00 PM EVAR With Flared Limbs >20 mm Or Bell Bottom Grafts Have A High Rate Of Failure And Type 1b Endoleaks
  Presenter(s):Jan S. Brunkwall, MD, PhD  
  View Slides in PDF      
2:00 PM - 2:05 PM Panel Discussion
END OF SESSION 19
 
SESSION 20 SCHEDULE
Tuesday
SESSION 20: HOT NEW TOPICS RELATED TO THE AORTA AND ILIAC ARTERIES (4 ½ MINUTE FAST PACED TALKS)
x
2:05 PM - 2:10 PM Some Patients With Large AAAs And Complex Anatomy Are Sometimes Best Not Treated Invasively Or Best Treated By Open Repair
  Presenter(s):Frank J. Criado, MD, FACS, FSVM  
  View Slides in PDF      
2:10 PM - 2:15 PM How To Manage A Dissection Flap In The AAA Neck When Treating An Infrarenal AAA
  Presenter(s):Ronald L. Dalman, MD  
  View Slides in PDF      
2:15 PM - 2:20 PM Why Does EVAR For AAA Patients Increase Their Cancer Risk: Is It From The Radiation During The Primary Procedure, Surveillance Or Both
  Presenter(s):Matt M. Thompson, MD  
  View Slides in PDF      
2:20 PM - 2:25 PM When Renal Arteries Are Covered During EVAR Or F/EVAR, Delayed Kidney Salvage Is Possible Due To Collaterals Keeping The Kidney Viable
  Presenter(s):James F. McKinsey, MD  
  View Slides in PDF      
2:25 PM - 2:30 PM AAA Polymer Sac Filling To Treat Recalcitrant Endoleaks: How Does It Work, Technique And Results
  Presenter(s):Michael J. Jacobs, MD  
  View Slides in PDF      
2:30 PM - 2:35 PM Panel Discussion
2:35 PM - 2:40 PM At What Diameter Do Internal Iliac (Hypogastric) Aneurysms Rupture: It Is Larger Than Commonly Thought: Inflow Occlusion Into The Hypogastric Aneurysm Alone Is Inadequate Treatment
  Presenter(s):Maarit Venermo, MD, PhD  
  View Slides in PDF      
2:40 PM - 2:45 PM Technical Tips For Placement Of An IBD After Prior EVAR: Why Is It Difficult And How To Overcome The Difficulty
  Presenter(s):Gustavo S. Oderich, MD, FACS  
  View Slides in PDF      
2:45 PM - 2:50 PM When Are Parallel Grafts The Best Way To Preserve Hypogastric Flow With Common Iliac Aneurysms
  Presenter(s):Vicente Riambau, MD, PhD  
  View Slides in PDF      
2:50 PM - 2:55 PM What Branch Stent-Grafts And Techniques Should Be Used For Parallel (Sandwich) Grafts To Revascularize Hypogastric Arteries: When Are Such Grafts The Only Way To Do So Because IBDs Won’t Work
  Presenter(s):Claude Mialhe, MD  
  View Slides in PDF      
2:55 PM - 3:00 PM With IBDs, Are Self-Expanding Or Balloon Expanding Covered Stents Best For The Hypogastric Branch: Based On Results Of 900 Patients In The ELVIS Registry
  Presenter(s):Fabio Verzini, MD, PhD  
  View Slides in PDF      
3:00 PM - 3:05 PM How To Prevent And Treat Spinal Cord Ischemia (SCI) With Endovascular TAAA Repairs
  Presenter(s):Salvatore T. Scali, MD  
  View Slides in PDF      
3:05 PM - 3:10 PM Kissing Covered Stents To Facilitate EVAR In AAA And Other Aortic Disease Patients With Small Necks And Small Iliac Access Arteries: Technique And Results
  Presenter(s):Guangqi Chang, MD  
  View Slides in PDF      
3:10 PM - 3:15 PM Panel Discussion
3:15 PM - 3:25 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 20
 
SESSION 21 SCHEDULE
Tuesday
SESSION 21: HOT NEW TOPICS RELATED TO LOWER EXTREMITY OR CAROTID TREATMENTS (4½ MINUTE FAST PACED TALKS)
x
3:25 PM - 3:30 PM Advantages Of Fusion Imaging Techniques For Iliac And Extremity Interventions: The Philips Vessel Navigator Can Reduce Operator And Patient Radiation Exposure And Contrast Dose And Improve Guidance
  Presenter(s):Yann Gouëffic, MD, PhD  
  View Slides in PDF      
3:30 PM - 3:35 PM 10-Year Experience With 4 French Systems For SFA Stenting: Tips, Tricks, Advantages And Durability
  Presenter(s):Jos C. van den Berg, MD, PhD  
  View Slides in PDF      
3:35 PM - 3:40 PM Propensity Matched Comparison Of Endo And Open Bypasses In 3800 Critical Limb Threatening Ischemia (CLTI) Patients: Bypasses Yield Superior Limb Outcomes With Equal Morbidity
  Presenter(s):William P. Robinson, MD  
  View Slides in PDF      
3:40 PM - 3:45 PM Single vs. Multiple Artery Revascularization For Infrapopliteal Interventional Treatments: Is There Proof Fixing Multiple Vessels Is Better
  Presenter(s):James F. McKinsey, MD  
  View Slides in PDF      
3:45 PM - 3:50 PM Delay In Treatment With Diabetic Foot Ulcers With Ischemia Has A Big Negative Impact On Outcomes: What To do About It
  Presenter(s):Katariina M. Noronen, MD, PhD  
  View Slides in PDF      
3:50 PM - 3:55 PM Panel Discussion
3:55 PM - 4:00 PM Value Of Antegrade Femoral Artery Access And How To Perform It Safely
  Presenter(s):Todd Berland, MD  
  View Slides in PDF      
4:00 PM - 4:05 PM Extended Value Of The Zilver PTX Drug Eluting Stent In Treating Femoro-Popliteal (Fempop) Occlusive Lesions: New Findings From The Chinese Post-Market Registry
  Presenter(s):Wei Guo, MD  
  View Slides in PDF      
4:05 PM - 4:10 PM Unique Assets Of The Zilver PTX Drug Eluting Stent For Treating Long Complex Fempop Disease: Based On 5-Year Results Of The Japanese Post-Market Surveillance Study
  Presenter(s):Hiroyoshi Yokoi, MD  
  View Slides in PDF      
4:10 PM - 4:15 PM Additional Lessons Learned About The Value Of The Zilver PTX Drug Eluting Stent For Fempop Disease With Calcified Lesions, Poor Runoff And In Patients With Diabetes And Renal Failure: From The 5-Year Results Of The Japanese Post -Market Registry
  Presenter(s):Kimihiro Komori, MD, PhD  
  View Slides in PDF      
CAROTID TOPICS
4:15 PM - 4:20 PM Outcomes Of TCAR (TransCarotid Artery Revascularization) Compare Favorably With Those Of CEA In Symptomatic And Asymptomatic Patients Despite The Higher Medical Risk Of The TAR Patients: From The SVS/VQI Registry
  Presenter(s):Marc L. Schermerhorn, MD  
  View Slides in PDF      
4:20 PM - 4:25 PM A New Implantable Carotid Intraluminal Coil Device (Javelin Vine) To Prevent Embolic Strokes In High Risk Atrial Fibrillation Patients: Device Description And Scientific Rationale
  Presenter(s):Vivek Reddy, MD  
  View Slides in PDF      
4:25 PM - 4:30 PM Is Redo CEA More Risky For Stroke And Cranial Nerve Injury Than Primary CEA In Asymptomatic Patients; In Symptomatic Patients: Should This Influence The Choice Of Treatment - Medical Alone Or CAS
  Presenter(s):Mahmoud B. Malas, MD, MHS / Christopher J. Abularrage, MD  
  View Slides in PDF      
4:30 PM - 4:35 PM The Natural History Of Patients With Bilateral Internal Carotid Artery (ICA) Occlusion Is Bad: How Can It Be Treated
  Presenter(s):Ali F. AbuRahma, MD  
  View Slides in PDF      
4:35 PM - 4:40 PM Panel Discussion
END OF SESSION 21
 
SESSION 22 SCHEDULE
Tuesday
SESSION 22: HOT NEW TOPICS RELATED TO LOWER EXTREMITY TREATMENTS OR MEDICAL ISSUES (4 ½ MINUTE FAST PACED TALKS)
x
4:40 PM - 4:45 PM Next Version Of The Supera Interwoven Vascular Mimetic Nitinol Stent (Supera Pro From Abbott): Why It Might Be A Game Changer
  Presenter(s):Brian G. DeRubertis, MD  
  View Slides in PDF      
4:45 PM - 4:50 PM Value Of The Supera Interwoven Stent (Abbott) For Common Femoral Artery (CFA) Lesions: 1-Year Results
  Presenter(s):Koen R. Deloose, MD  
  View Slides in PDF      
4:50 PM - 4:55 PM Meta-Analysis Comparing Results Of Supera Interwoven Stents vs. Drug Eluting Stents For Treatment Of SFA Lesions: Which Is Best And When
  Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR  
  View Slides in PDF      
4:55 PM - 5:00 PM Optimal Technique (PRESTO) For Deploying Supera Stents To Maximize Their Value And Give The Best Outcomes
  Presenter(s):Marco G. Manzi, MD  
  View Slides in PDF      
5:00 PM - 5:05 PM Drug Eluting Stents (DESs - Zilver PTX And Eluvia) Are Changing The Paradigm For Treating Long Complex SFA/Pop Lesions: The Trials And Registries Show Why
  Presenter(s):Iris Baumgartner, MD  
  View Slides in PDF      
5:05 PM - 5:10 PM Panel Discussion
5:10 PM - 5:15 PM New Improved Image Guided (OCT) Directional Atherectomy System (Pantharis Lumivascular From Avinger): Advantages And Limitations: A Possible Game Changer
  Presenter(s):Konstantinos P. Donas, MD / Arne G. Schwindt, MD  
  View Slides in PDF      
5:15 PM - 5:20 PM 1-Year Results Of The BATTLE Multicenter RCT Comparing Zilver PTX (Cook) DESs vs. Misago (Terumo) Bare Metal Stents (BMSs) For SFA Lesions
  Presenter(s):Yann Gouëffic, MD, PhD / William A. Gray, MD  
  View Slides in PDF      
5:20 PM - 5:25 PM Patterns Of Calcification In Below The Knee (BTK) Arteries: Implications For Atherectomy And Vessel Prep
  Presenter(s):Jos C. van den Berg, MD, PhD / 
  View Slides in PDF      
5:25 PM - 5:30 PM Optimal Endovascular Technique For Extremely Calcified Femoropopliteal Lesions: Advantages And Precautions: From The CRACK And PAVE Registry
  Presenter(s):Andrej Schmidt, MD  
  View Slides in PDF      
MEDICAL ISSUES
5:30 PM - 5:35 PM Sarcopenia (Loss Of Muscle): A Biomarker Of Frailty: How To Measure It With CT: How Is It Helpful In The Treatment Of Thoracic Aortic Patients
  Presenter(s):Jon S. Matsumura, MD  
  View Slides in PDF      
5:35 PM - 5:40 PM Why We Should Switch From ASA To Plavix For Postoperative And Post-Procedure Care Of Patients Having Lower Extremity Treatments
  Presenter(s):Iris Baumgartner, MD  
  View Slides in PDF      
5:40 PM - 5:45 PM Panel Discussion
End of Program D
END OF SESSION 22
 
SESSION 23 SCHEDULE
Wednesday
SESSION 23: TOPICS RELATED TO GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE LESIONS
x
6:40 AM - 6:45 AM Status Of The Global Vascular Guideline For The Treatment Of CLTI And The Global Limb Anatomic Staging System: How Will They Help
  Presenter(s):Michael S. Conte, MD  
  View Slides in PDF      
6:46 AM - 6:51 AM How Have Drug Delivery (Coating) And Retrograde Access Changed The Paradigm For SFA/Pop Treatment: The Game Has Changed
  Presenter(s):Peter A. Schneider, MD  
  View Slides in PDF      
6:52 AM - 6:57 AM The Class Effect vs. The Specific Device Effect Of Drug Eluting Devices And Other Treatments For Arterial Occlusive Lesions: Why Is The Difference Important
  Presenter(s):Thomas Zeller, MD  
  View Slides in PDF      
6:58 AM - 7:03 AM DEBATE: In The Near Future Almost All Lower Extremity Treatment For Occlusive Lesions Will Be Endovascular And Endo-First Will Be The Rule
  Presenter(s):Craig M. Walker, MD  
  View Slides in PDF      
7:04 AM - 7:09 AM DEBATE: Not So: Many Patients Will Be Better Served By A Bypass At Some Point In Their Course, And Some With A Bypass As Their Primary Procedure
  Presenter(s):Joseph L. Mills, MD  
  View Slides in PDF      
7:10 AM - 7:15 AM Overuse Of Endo-First Treatment For CLTI With Tissue Necrosis Jeopardizes Last Chance Bypasses And Limb Salvage
  Presenter(s):Jean-Baptiste Ricco, MD, PhD  
  View Slides in PDF      
7:16 AM - 7:21 AM Importance Of Adequate Vessel Prep Before Stenting And DCBs: How Best To Do It And Proof Of Its Value
  Presenter(s):D. Christopher Metzger, MD   
  View Slides in PDF      
7:22 AM - 7:27 AM Value Of Local Anesthesia In The Adventia Of Arteries During Interventions: How To Do It: For SFA/Pop Lesions
  Presenter(s):Andrej Schmidt, MD  
  View Slides in PDF      
7:28 AM - 7:33 AM Optimal Current Treatment For SFA/Pop Occlusive Lesions: What Technology Is Best And When
  Presenter(s):Gary M. Ansel, MD  
  View Slides in PDF      
7:34 AM - 7:39 AM Below The Ankle (BTA) PTA: When Is It Helpful: When Harmful: Should 1 Or More Arteries Be Treated; Other Pearls
  Presenter(s):Roberto Ferraresi, MD  
  View Slides in PDF      
7:40 AM - 7:46 AM Panel Discussion
END OF SESSION 23
 
SESSION 24 SCHEDULE
Wednesday
SESSION 24: PROGRESS IN LOWER EXTREMITY STENT BASED TREATMENTS FOR OCCLUSIVE LESIONS
x
7:46 AM - 7:51 AM Optimal Treatment For Crural Artery Lesions In 2018 In The US And Elsewhere: Value Of Coronary Drug Eluting Stents (DESs): When And How To Use Them
  Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA  
  View Slides in PDF      
7:52 AM - 7:57 AM Endovascular Stent Treatment Of Common Femoral Artery (CFA) Is Best For All Lesions: Based On The TECCO RCT (Stent vs. Open Endarterectomy): Classification Of Lesions And Subsequent Access Through Stents Is OK
  Presenter(s):Yann Gouëffic, MD, PhD  
  View Slides in PDF      
7:58 AM - 8:03 AM Value Of Multiple Short Stents For Treating Fempop Long Lesions: Better Than A Full Metal Jacket: The LOCOMOTIVE Trial Of Vascuflex System (From B. Braun)
  Presenter(s):Thomas Zeller, MD / Peter C.J. Goverde, MD  
  View Slides in PDF      
8:04 AM - 8:09 AM New Findings From The Zilver PTX DES 5-Year RCT And Other Studies Show The Advantages Of This Stent For Fempop Lesions
  Presenter(s):Michael D. Dake, MD  
  View Slides in PDF      
8:10 AM - 8:15 AM Value And Limitations Of Zilver PTX DESs: How Do They Change The Pattern And Volume Of In-Stent Restenosis (ISR) Compared To Other Stents
  Presenter(s):Gary M. Ansel, MD  
  View Slides in PDF      
8:16 AM - 8:21 AM ZILVER PASS RCT Comparing ZILVER PTX DES To PTFE Fempop Bypasses: For TASC C And D Lesions: Zilver PTX Is As Good Or Better At 2 Years
  Presenter(s):Marc Bosiers, MD / Koen R. Deloose, MD  
  View Slides in PDF      
8:22 AM - 8:27 AM 2-Year Results Of The RAPID RCT Comparing Supera Stent Treatment For SFA Lesions With And Without A DCB
  Presenter(s):Jean-Paul de Vries, MD, PhD  
  View Slides in PDF      
8:28 AM - 8:33 AM MAJESTIC DES Trial: 3-Year Results For Treatment In Superficial Femoral And Proximal Popliteal Lesions: How Does Eluvia Differ From Other DES
  Presenter(s):Stefan Mueller-Huelsbeck, MD / Thomas Zeller, MD / Dierk Scheinert, MD  
  View Slides in PDF      
8:33 AM - 8:38 AM IMPERIAL Head To Head RCT: 1 Year Results Of The Eluvia DES vs. ZilverPTX For Fempop Lesions
  Presenter(s):William A. Gray, MD / Andrew Holden, MBChB  
  View Slides in PDF      
8:39 AM - 8:44 AM Status Of Bioresorbable DESs For Treating BTK Arteries: Though They Failed In The Coronary Arteries They Show Promise In The Leg: The ABSORB BTK Trial 4-Year Results Show Why
  Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD  
  View Slides in PDF      
8:45 AM - 8:58 AM Panel Discussion
END OF SESSION 24
 
SESSION 25 SCHEDULE
Wednesday
SESSION 25: MORE TOPICS RELATED TO COMPLEX LOWER EXTREMITY DISEASE AND ITS TREATMENT: ATHERECTOMY, LITHOPLASTY, OVERCOMING CALCIFICATION BELOW THE KNEE (BTK), TIBIAL ARTERY TREATMENTS, AND COMBINATIONS OF TREATMENTS
x
8:58 AM - 9:03 AM Atherectomy 2018: When Indicated; Which Device(s) Are Best; Downsides; Precautions; Are Complementary DCBs Necessary
  Presenter(s):Lawrence A. Garcia, MD  
  View Slides in PDF      
9:04 AM - 9:09 AM Histological Evaluation Of Adventitial Injury From Directional Atherectomy: Value Of OCT Guidance
  Presenter(s):Theodosios Bisdas, MD  
  View Slides in PDF      
9:10 AM - 9:15 AM Debulking Atherectomy: Is There Proof It Has Value: In What Circumstances: Which Device Is Best And Why
  Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR  
  View Slides in PDF      
9:16 AM - 9:21 AM Importance Of Debulking And Other Lesion Preparation Strategies With All Drug Eluting Treatments: Why It Is Critical
  Presenter(s):Erwin Blessing, MD  
  View Slides in PDF      
9:22 AM - 9:27 AM Value Of Intravascular Lithotripsy (Shockwave Medical) With And Without DCBs For Treatment Of Calcified Lesions: Single Center Studies And The DISRUPT I, II And III Trial Results
  Presenter(s):Gunnar Tepe, MD / Andrew Holden, MBChB / Thomas Zeller, MD  
  View Slides in PDF      
BTK TREATMENTS
9:28 AM - 9:33 AM Present And Future Status Of DCBs: Successes, Failures, Adjuncts Needed, Problems And Solutions: They Will Have A Role In All Vascular Beds Including BTK Arteries
  Presenter(s):Brian G. DeRubertis, MD / Krishna J. Rocha-Singh, MD  
  View Slides in PDF      
9:34 AM - 9:39 AM Shockwave Intravascular Lithotripsy In Calcified Tibial Artery Lesions: How Well Does It Work
  Presenter(s):Andrew Holden, MBChB / Thomas Zeller, MD  
  View Slides in PDF      
9:40 AM - 9:45 AM DCBs vs. DESs For SFA/Pop Lesions: Which Is Best And When With Midterm Follow-Up: From The DRASTICO Trial
  Presenter(s):Francesco Liistro, MD  
  View Slides in PDF      
9:46 AM - 9:51 AM Combination Lesion Treatment With Passeo-18 Lux DCB And Pulsar-18 Uncoated Stent: Advantages And Good Results
  Presenter(s):Koen R. Deloose, MD  
  View Slides in PDF      
9:52 AM - 9:58 AM When Is Distal Embolic Protection Needed During Lower Extremity Interventions: How Should It Be Performed
  Presenter(s):Peter A. Schneider, MD  
  View Slides in PDF      
9:58 AM - 10:04 AM Panel Discussion
10:04 AM - 10:16 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 25
 
SESSION 26 SCHEDULE
Wednesday
SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs), OTHER DEVICES FOR TREATMENT OF LOWER EXTREMITY OCCLUSIVE LESIONS, RANDOMIZED TRIALS (RCTs) AND BTK TREATMENTS
x
10:16 AM - 10:21 AM Impact And Significance Of Downstream Embolization And Restenosis With Different DCBs
  Presenter(s):Aloke Finn, MD / Renu Virmani, MD  
  View Slides in PDF      
10:22 AM - 10:27 AM DCBs Are Changing The Landscape And Algorithm For Treating Long Complex SFA/Pop Lesions And Minimizing The Need For Stents: Advantages Of Sirolimus vs. Paclitaxel Coatings
  Presenter(s):Thomas Zeller, MD  
  View Slides in PDF      
10:28 AM - 10:33 AM Update On In.Pact SFA I And II RCTs Show Benefit Of In.Pact (Medtronic) DCBs Persisting And Increasing Over POBA At 4 years With Fem/Pop Lesions
  Presenter(s):John R. Laird, MD / Peter A. Schneider, MD / Gunnar Tepe, MD  
  View Slides in PDF      
10:34 AM - 10:39 AM Update On Persistent Benefit Of Lutonix DCB (Bard/BD) For Fempop Lesions As Shown By A RCT vs. Plain Balloon Angioplasty (POBA): Long Lesions (>14 cm) Were Included
  Presenter(s):Kenneth Rosenfield, MD / Dierk Scheinert, MD  
  View Slides in PDF      
10:40 AM - 10:45 AM COMPARE Pilot RCT: 1 Year Results Of A Randomized Comparison Of RANGER DCB vs. IN.PACT DCB In Complex SFA Lesions
  Presenter(s):Dierk Scheinert, MD  
  View Slides in PDF      
10:46 AM - 10:51 AM Update On ILLUMINATE RCTs With Stellarex DCBs (Spectranetics/Philips): 2- And 3-Year Results For SFA/Pop Lesions And ISR Are Equal To Other DCBs: Advantages Over Other DCBs
  Presenter(s):Sean P. Lyden, MD / Timothy M. Sullivan, MD / Thomas Zeller, MD / Stefan Mueller-Huelsbeck, MD  
  View Slides in PDF      
10:52 AM - 10:57 AM Lessons Learned From The In.Pact DCB GLOBAL Registry - Chronic Total Occlusion (CTO) Cohort: How To Make DCBs Work Best With CTOs
  Presenter(s):Marianne Brodmann, MD / Gunnar Tepe, MD  
  View Slides in PDF      
10:58 AM - 11:03 AM In.Pact DCBs Have Equal Benefits When Treating Long SFA/Pop Lesions As When Treating Shorter Lesions
  Presenter(s):Antonio Micari, MD, PhD  
  View Slides in PDF      
11:04 AM - 11:11 AM Panel Discussion
Moderator(s): Sean P. Lyden, MD / Giancarlo Biamino, MD, PhD  
11:11 AM - 11:16 AM What Is The Long-Term Durability Of The Benefits Of The Different DCBs: What Is The Value Of Spot Stenting Of Residual Stenoses With DCBs
  Presenter(s):Gunnar Tepe, MD  
  View Slides in PDF      
11:17 AM - 11:22 AM Present Role For DCBs And DESs For SFA Lesions: Updated Treatment Algorithm And How To Deal With Severe Calcification
  Presenter(s):Fabrizio Fanelli, MD, EBIR  
  View Slides in PDF      
11:23 AM - 11:28 AM Update On Evaluation Of DCBs: When Are They Worthwhile And Advantages Of Different DCBs
  Presenter(s):Gary M. Ansel, MD  
  View Slides in PDF      
DCBS FOR BTK LESIONS
11:29 AM - 11:34 AM Value Of DCBs In BTK And Crural Arteries: Reasons For Past Failures: New Technology, New Results And Promising Future Prospects
  Presenter(s):Francesco Liistro, MD  
  View Slides in PDF      
11:35 AM - 11:40 AM Value Of Stellarex DCBs (Spectranetics/Philips) In BTK And Infrapopliteal Artery Lesions
  Presenter(s):Gunnar Tepe, MD  
  View Slides in PDF      
11:41 AM - 11:46 AM > 1-Year Safety And Effectiveness Results Of Lutonix DCBs (Bard/BD) For Treating BTK And Crural Artery Lesions: Late Breaking Update And 6-Month Results Of Lutonix Below-The-Knee Global DCB IDE RCT Study
  Presenter(s):Patrick J. Geraghty, MD / Michael K.W. Lichtenberg, MD  
  View Slides in PDF      
11:47 AM - 11:52 AM Update On Value Of The Chocolate Touch (Restrained) DCB (QT Vascular And TriReme Medical): What Makes It Different And 2-Year Results From The ENDURE Trial
  Presenter(s):Gunnar Tepe, MD / D. Christopher Metzger, MD  / Andrew Holden, MBChB / Wei Guo, MD  
  View Slides in PDF      
11:53 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break - 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 26
 
SESSION 27 SCHEDULE
Wednesday
SESSION 27: EXOTIC AND EXTREME NEW TREATMENTS AND TECHNIQUES FOR SEVERE LOWER EXTREMITY OCCLUSIVE DISEASE AND CHRONIC LIMB THREATENING ISCHEMIA (CLTI): DEALING WITH THE “NO OPTION” FOR TREATMENT OR “UNSALVAGEABLE” LIMB AND THE “DESERT FOOT”
x
1:00 PM - 1:05 PM Is No Option CLTI Ever Real: Yes, But Rarely: How To Decrease The Major Amputation Rate: Open Bypasses Have A Role
  Presenter(s):Hisham Rashid, FRCS, FRCS(Gen)  
  View Slides in PDF      
1:06 PM - 1:11 PM Primary Open Bypass Is Better Than Endo-First Approach For CLTI Patients With Extensive Gangrene And Advanced WIfI Lesions
  Presenter(s):Francesco Spinelli, MD  
  View Slides in PDF      
1:12 PM - 1:17 PM Latest Techniques And New Developments In Treating Leg And Foot Artery Lesions Causing CLTI With Extensive Ischemic Gangrene And Ulceration
  Presenter(s):Marco G. Manzi, MD  
  View Slides in PDF      
1:18 PM - 1:23 PM Interventional Strategies For Treating So-Called No Option CLTI Patients: Such Patients Are Becoming Very Rare
  Presenter(s):Erwin Blessing, MD  
  View Slides in PDF      
1:24 PM - 1:29 PM PQ (Percutaneous) Transvenous Arterial Fempop Bypass Procedure: Concept And Technique For Performing (Video)
  Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD / James D. Joye, DO  
  View Slides in PDF      
1:30 PM - 1:35 PM Percutaneous (PQ) Transvenous Fempop Arterial Bypass For Long (> 15 cm) SFA Occlusions: The DETOUR I And II Trial 2-Year Results: When Can It Work And When Can It Not
  Presenter(s):Sean P. Lyden, MD / 
  View Slides in PDF      
ARTERIALIZATION OF FOOT VEINS
1:36 PM - 1:41 PM Open Surgical Arterial Bypasses To Deep Ankle Veins With Distal Vein Valve Disruption For CLTI With No Distal Target Arteries: Technique And Long-Term Results: It Works
  Presenter(s):Pramook Mutirangura, FRCS (Edinburgh)  
  View Slides in PDF      
1:42 PM - 1:47 PM Percutaneous Deep Vein Arterialization (pDVA) With The LimFlow Device For The No Option Patient With A “Desert” Foot: Technique, Results And Limitations
  Presenter(s):Steven Kum, MD / Daniel G. Clair, MD  
  View Slides in PDF      
1:48 PM - 1:53 PM Pros And Cons Of Hybrid Deep Vein Arterialization Of Foot Veins For No Option CLTI Patients: It Can Work But . . .
  Presenter(s):Roberto Ferraresi, MD  
  View Slides in PDF      
1:54 PM - 1:59 PM Hybrid Venous Arterialization: What Is It: How To Do It And When To Use It For No Option CLTI Patients
  Presenter(s):Miguel F. Montero-Baker, MD  
  View Slides in PDF      
2:00 PM - 2:06 PM Panel Discussion
END OF SESSION 27
 
SESSION 28 SCHEDULE
Wednesday
SESSION 28: NEW DEVELOPMENTS IN LOWER EXTREMITY TREATMENTS WITH STENT-GRAFTS AND PROSTHETIC BYPASS GRAFTS; PROGRESS IN TREATING IN STENT RESTENOSIS (ISR)
x
2:06 PM - 2:11 PM 8-Year Results Of Heparin Bonded PTFE Viabahn Stent Grafts For The Treatment Of Long TASC C And D Fempop Lesions: Advantages And Limitations
  Presenter(s):Maria Antonella Ruffino, MD, EBIR  
  View Slides in PDF      
2:12 PM - 2:17 PM DEBATE: PTFE Grafts With Bonded Heparin (Propaten) Have Patencies Approaching Those Of Saphenous Vein Grafts For Lower Extremity Bypasses: The Bonded Heparin Makes A Difference
  Presenter(s):Russell H. Samson, MD, RVT, FACS  
  View Slides in PDF      
2:18 PM - 2:23 PM DEBATE: Not So: The Heparin Bonding Is Not The Reason For The Good Results: Other Factors Are More Important
  Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS  
  View Slides in PDF      
2:24 PM - 2:29 PM The SUPER B RCT Shows Viabahn Endografts Perform As Well As Open Surgical Fempop Bypass Grafts For 2 Years: Will DCBs To Prevent Edge Stenosis Improve The Viabahn Results
  Presenter(s):Michel M.P. Reijnen, MD, PhD  
  View Slides in PDF      
2:30 PM - 2:35 PM What Is The Best Current Treatment For ISR: DCBs Delay Re-Restenosis But There Is Catch-Up (From The COPA CABANA Trial): So What Is The Solution
  Presenter(s):Gunnar Tepe, MD  
  View Slides in PDF      
2:36 PM - 2:41 PM Value Of Gore Viabahn Endografts To Treat ISR: Tips And Tricks For Successful Durable Use In This Setting
  Presenter(s):Marc Bosiers, MD / Koen R. Deloose, MD  
  View Slides in PDF      
2:42 PM - 2:47 PM New Covered Balloon Expandable Stents: Which Ones Are Available (VBX-Gore; Lifestream-Bard/BD; BeGraft – Bentley): Advantages And Limitations Of Each: Tips For Use
  Presenter(s):Claudio J. Schonholz, MD  
  View Slides in PDF      
2:48 PM - 2:53 PM Comparison Of 4 Balloon Expandable Covered Stents For Treatment Of Aorto- Iliac Occlusive Lesions: iCAST Or Advanta V12 Atrium (Maquet/Getinge); VBX (Gore); Lifestream (Bard/BD); BeGraft (Bentley); Which, Where And When
  Presenter(s):Andrew Holden, MBChB  
  View Slides in PDF      
2:54 PM - 3:00 PM Panel Discussion
3:00 PM - 3:10 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 28
 
SESSION 29 SCHEDULE
Wednesday
SESSION 29: LOWER EXTREMITY CLTI AND ITS TREATMENT: WHAT IS ITS BEST TREATMENT; RCTs; METHODS TO ASSESS FOOT PERFUSION AND TREATMENT SUCCESS; VALUE OF ANGIOSOME CONCEPT
x
RCTS AND REGISTRIES OF CLTI TREATMENT
3:10 PM - 3:15 PM Update On The BEST-CLI RCT Comparing Open And Endo Treatments Of CLTI: Recruitment To Date: Successes And Problems To Date: What Will It Tell Us And When
  Presenter(s):Matthew T. Menard, MD / Alik Farber, MD / Kenneth Rosenfield, MD  
  View Slides in PDF      
3:16 PM - 3:21 PM Status Of The BASIL 2 And 3 RCTs: 2 Compares Crural Vein Bypasses With Endo Treatments; 3 Compares DCBs/DESs With PTA And Uncoated Stents: What Will They Tell Us And When
  Presenter(s):Robert J. Hinchliffe, MD / Andrew W. Bradbury, MD, FRCSEd  
  View Slides in PDF      
3:22 PM - 3:27 PM These Trials Will Have Big Problems And May Tell Us Little About Their Primary End Points, But Will Provide Other Valuable Information
  Presenter(s):Mehdi H. Shishehbor, DO, MPH, PhD  
  View Slides in PDF      
3:28 PM - 3:33 PM New Findings From The SPINACH Study Of CLTI Treatments Show Bypass First Is Better With Extensive Gangrene And Infection: Otherwise Endo First Is Justified
  Presenter(s):Nobuyoshi Azuma, MD / Osamu Iida, MD  
  View Slides in PDF      
3:34 PM - 3:39 PM Open Bypass Improves Perfusion More Than Endovascular Treatments: The Angiosome Concept Usually Does Not Matter: When Does It
  Presenter(s):Maarit Venermo, MD, PhD  
  View Slides in PDF      
3:40 PM - 3:45 PM Duplex Ultrasound Is The Best Technique For Following BTK Interventions: Why It Improves Outcomes Big Time
  Presenter(s):Francesco Liistro, MD  
  View Slides in PDF      
3:46 PM - 3:52 PM Panel Discussion
ASSESSING FOOT PERFUSION
3:52 PM - 3:57 PM Value Of Lumee Implantable Micro Oxygen Sensors In The Treatment Of CLTI Patients
  Presenter(s):Miguel F. Montero-Baker, MD  
  View Slides in PDF      
3:58 PM - 4:03 PM Can Perfusion Angiography Judge Foot Perfusion And Predict Wound Healing In Patients With CLTI: From The REPEAT Trial
  Presenter(s):Jean-Paul de Vries, MD, PhD  
  View Slides in PDF      
4:04 PM - 4:09 PM Perfusion Angiography (From Philips Health Care) To Assess The Functionality Of Sympathetic Activity And Foot Perfusion: It Is A Strong Predictor For Early Amputation In Ischemic Diabetic Foot Disease And A Way To Assess The Effects Of Revascularization Treatments
  Presenter(s):Jim Reekers, MD, PhD  
  View Slides in PDF      
4:10 PM - 4:15 PM How To Measure Foot Perfusion After Tibial Interventions: These Measurements Are More Important Than Angiosomes
  Presenter(s):Werner Lang, MD  
  View Slides in PDF      
4:16 PM - 4:21 PM Near Infrared Spectroscopy (NIRS) Is A Novel Non-Invasive Way To Measure Foot Perfusion When Other Methods Fail: How Does It Work And How Does It Help
  Presenter(s):Paolo Zamboni, MD  
  View Slides in PDF      
4:22 PM - 4:27 PM DEBATE: Angiosome Directed Revascularization Improves Wound Healing With CLTI: When Does It Matter
  Presenter(s):Richard F. Neville, MD  
  View Slides in PDF      
4:28 PM - 4:33 PM DEBATE: Why The Angiosome Concept Is Irrelevant In Most CLTI Patients With Tissue Necrosis
  Presenter(s):Jean-Baptiste Ricco, MD, PhD  
  View Slides in PDF      
4:34 PM - 4:39 PM Pros And Cons About The Angiosome Concept: What Is Its Real Value And How Can It Improve Limb Salvage
  Presenter(s):Kenneth R. Ziegler, MD / Fred A. Weaver, MD  
  View Slides in PDF      
4:40 PM - 4:45 PM Angiosomes Have Little Value In Diabetic Limb Salvage: WIfI Staging Is A Better Predictor Of Wound Healing Than “Direct” Revascularization
  Presenter(s):Christopher J. Abularrage, MD  
  View Slides in PDF      
4:46 PM - 4:52 PM Panel Discussion
END OF SESSION 29
 
SESSION 30 SCHEDULE
Wednesday
SESSION 30: NEW DEVELOPMENTS IN THE TREATMENT OF LOWER EXTREMITY INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI)
x
4:52 PM - 4:57 PM How To Get Patients To Recognize That Exercise And Neuromuscular Stimulation (NMES) Are Good Treatments For IC And To Comply With Them
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh  
  View Slides in PDF      
INTERMITTENT CLAUDICATION
4:58 PM - 5:03 PM Update On Value And Logistics Of Exercise Treatment For Intermittent Claudication (IC): Things Are Getting Better And Why
  Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS  
  View Slides in PDF      
5:04 PM - 5:09 PM A Recently Completed RCT Of Endovascular Revascularization vs. Supervised Exercise For IC: The SUPER Trial Results: Outcomes, QOL And Cost Effectiveness; How Does It Compare With The Other IC RCTs
  Presenter(s):Mark J.W. Koelemay, MD, PhD  
  View Slides in PDF      
5:10 PM - 5:15 PM Exercise TcPO2 Can Distinguish Buttock IC From The Symptoms Of Spinal Stenosis: How Should Buttock IC Be Treated
  Presenter(s):Manju Kalra, MBBS  
  View Slides in PDF      
5:16 PM - 5:21 PM New And Current Data On All Cause And Cardiovascular Mortality In Patients With IC And CLTI: Have Recent Improvement In Medical Treatment And Statins Made A Difference
  Presenter(s):Gert J. de Borst, MD, PhD  
  View Slides in PDF      
5:22 PM - 5:27 PM Differences In Decision Making For The Treatment Of IC In Europe And The US: Based On Data From The PORTRAIT Registry
  Presenter(s):Jan M.M. Heyligers, MD, PhD, FEBVS  
  View Slides in PDF      
5:28 PM - 5:33 PM Panel Discussion
ACUTE LIMB ISCHEMIA (ALI)
5:33 PM - 5:38 PM DEBATE: All ALI Patients Should Be Treated With An Endo First Policy And Over 90% Can Be Treated Entirely Endovascularly
  Presenter(s):Ali Amin, MD, RVT, FACS, FACC  
  View Slides in PDF      
5:39 PM - 5:44 PM DEBATE: Not So: Some Patients With ALI Should Have An Open Procedure First And Over 10% Will Require Some Open Component: Which Ones
  Presenter(s):Joseph L. Mills, MD  
  View Slides in PDF      
5:45 PM - 5:50 PM More Effective Treatment Of ALI By Thrombolysis With Microbubbles And Ultrasound
  Presenter(s):Kak Khee Yeung, MD, PhD  
  View Slides in PDF      
5:51 PM - 5:56 PM Current And New Data On Morbidity And Mortality Risks After Lower Extremity Embolectomy/Thrombectomy For ALI Open And Endo: Is It Less Than In The Past And Why
  Presenter(s):Alik Farber, MD  
  View Slides in PDF      
5:57 PM - 6:02 PM Advances In The Endovascular Treatment Of ALI: Equipment, Techniques And Results
  Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD  
  View Slides in PDF      
6:03 PM - 6:09 PM Panel Discussion
End of Program E
END OF SESSION 30
 
SESSION 31 SCHEDULE
Wednesday
SESSION 31: NEW DEVELOPMENTS AND ADVANCES IN MEDICAL AND ANTI-ATHEROGENIC TREATMENTS FOR PATIENTS WITH ARTERIAL DISEASE
x
6:40 AM - 6:45 AM How Long Should Patients With DVT Be Kept On Anticoagulants: A Review Of The Data
  Presenter(s):Geoffrey Barnes, MD, MSc  
  View Slides in PDF      
6:46 AM - 6:51 AM What Are The New AHA Hypertension Guidelines And Why All PAD Patients Should Be Treated According To These Guidelines
  Presenter(s):Jeffrey W. Olin, DO  
  View Slides in PDF      
6:52 AM - 6:57 AM Benefits Of Cilostazol Before And After Peripheral Endovascular Procedures: What Regimen And Dosage Should Be Given Routinely
  Presenter(s):Gary M. Ansel, MD  
  View Slides in PDF      
6:58 AM - 7:03 AM What Is Anacetrapib: Do CETP Inhibitors To Reduce LDL Cholesterol (LDL-C) More Than Statins Have A Role In PAD Patients: What About Ezetemibe (Zetia): How Low An LDL-C Should We Try To Get
  Presenter(s):Kavita Sharma, MD  
  View Slides in PDF      
7:04 AM - 7:09 AM PCSK-9 Inhibitors: Highlights For The Vascular Specialist In 2018
  Presenter(s):Pradeep Natarajan, MD, MMSc  
  View Slides in PDF      
7:10 AM - 7:15 AM DEBATE: Statins Are Dangerous Drugs: Lowering LDL-C Does No Good And Is Harmful In Most Patients
  Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC  
  View Slides in PDF      
7:16 AM - 7:21 AM DEBATE: Not So: Lowering LDL-C Levels With Statins And PCSK-9 Inhibitors In At Risk Patients With PAD Prevents Cardiovascular Events And Deaths; It Is Safe And Prolongs Life
  Presenter(s):Ron Waksman, MD  
  View Slides in PDF      
7:22 AM - 7:27 AM How Important Is It To Give High Intensity Statins To PAD Patients: How Low Should We Push Their LDL-C, To <50 mg/dL; What About Adding Other Drugs: What About Statins In Older (>80) PAD Patients
  Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC  / Caron B. Rockman, MD  
  View Slides in PDF      
7:28 AM - 7:33 AM DEBATE: What Did The COMPASS RCT Show: After This Trial, Rivaroxaban Plus Aspirin Should Be Given To All PAD Patients To Lower Their Risk Of Stroke, MI And Death: What Doses
  Presenter(s):Jay Giri, MD, MPH  
  View Slides in PDF      
7:34 AM - 7:39 AM DEBATE: Not So Fast: We Still Need To Know More Before Adding Rivaroxaban For PAD Patients
  Presenter(s):Brian H. Annex, MD  
  View Slides in PDF      
7:40 AM - 7:46 AM Panel Discussion
END OF SESSION 31
 
SESSION 32 SCHEDULE
Wednesday
SESSION 32: MORE ON MEDICAL TREATMENTS AND NEW TECHNIQUES FOR TREATING RESISTANT HYPERTENSION; PREDICTIONS FOR THE FUTURE
x
7:46 AM - 7:51 AM Can Renal Denervation Still Be An Effective Treatment For Resistant Hypertension: Results With The Spyral-HTN Device (Medtronic) In A Sham Controlled RCT Suggest It Can: What About Other Endovascular Treatments
  Presenter(s):Horst Sievert, MD  
  View Slides in PDF      
7:52 AM - 7:57 AM The Mobius HD Intra-Arterial Implant (From Vascular Dynamics) To Stimulate Baroreceptor Activity And Lower BP (The CALM-2 Trial): How Does It Work And Results To Date
  Presenter(s):Kim J. Hodgson, MD  
  View Slides in PDF      
7:58 AM - 8:03 AM The ROX Coupler To Create An Iliac A-V Fistula And Control Resistant Hypertension: Positive Results Of The CONTROL HTN-2 Sham Controlled RCT: Will Blood Pressure Measurement With Light-Sensitive Finger Photoplethysmography Become A Reality
  Presenter(s):David H. Deaton, MD, FACS / Krishna J. Rocha-Singh, MD  
  View Slides in PDF      
8:04 AM - 8:09 AM DEBATE: Beta Blockers Lower The Postoperative Mortality Of Patients Undergoing Open Repair Of AAAs: What Drug Dose And Timing Should Be Used
  Presenter(s):Mahmoud B. Malas, MD, MHS  
  View Slides in PDF      
8:10 AM - 8:15 AM DEBATE: The Evidence Supporting The Value Of Peri-Operative Beta Blockers In Lowering Morbidity Of Vascular Procedures Is Weak And They May Be Harmful: What Should We Do: Is It Just A Dosage Problem
  Presenter(s):Peter Henke, MD  
  View Slides in PDF      
8:16 AM - 8:21 AM What Is The Optimal Medical Treatment For Patients With CLTI; With PAD: How Much Will Medical Treatment Replace Invasive Interventions By 2028
  Presenter(s):Ido Weinberg, MD, MSc / Michael R. Jaff, DO  
  View Slides in PDF      
8:22 AM - 8:28 AM Panel Discussion
8:28 AM - 8:33 AM Adherence To Lipid Guidelines (Which Ones) In CLTI Patients Undergoing Open And Endo Revascularization Leads To A Decrease In Mortality And Major Adverse Limb Events (MALEs): How Low Should The LDL-C Be Pushed
  Presenter(s):Marc L. Schermerhorn, MD  
  View Slides in PDF      
8:34 AM - 8:39 AM Implications Of The CANTOS Trial Showing That An Anti-Inflammatory Drug (Canakinumab From Novartis) Reduces Strokes, MIs And Deaths Without Changing LDL-C Levels
  Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC  / Caron B. Rockman, MD  
  View Slides in PDF      
8:40 AM - 8:45 AM PCSK-9 Inhibitor (Evolocumab) Plus Statins Decreases MI, Stroke, MALE And Death More In PAD And Recent MI Patients Than Others: From A FOURIER RCT Trial Subanalysis: What LDL-C Level Should We Aim For
  Presenter(s):Caron B. Rockman, MD / Jeffrey S. Berger, MD, MS, FAHA, FACC   
  View Slides in PDF      
8:46 AM - 8:51 AM The Best Antiplatelet And Anticoagulant Medications For Patients With Aggressive PAD: How Important Are LDL-C Levels: When Should Ezetemibe (Zetia) And PCSK-9 Inhibitors Be Added To Statins
  Presenter(s):Peter Henke, MD  
  View Slides in PDF      
8:52 AM - 8:57 AM Is There A Future For Bioresorbable Stents In The Coronary Arteries Or Elsewhere
  Presenter(s):Ron Waksman, MD  
  View Slides in PDF      
8:58 AM - 9:04 AM Panel Discussion
END OF SESSION 32
 
SESSION 33 SCHEDULE
Wednesday
SESSION 33: PROGRESS IN THE MANAGEMENT OF COMPLICATIONS AND ENDOLEAKS
x
9:04 AM - 9:09 AM Retroperitoneal Hemorrhage Is Life-Threatening: Vascular Specialists Should Never Cause It: How To Prevent It: How To Diagnose And Treat It
  Presenter(s):Russell H. Samson, MD, RVT, FACS  
  View Slides in PDF      
9:10 AM - 9:15 AM Lower Extremity Ischemic Complications With EVAR And F/EVAR: Causes And Treatment
  Presenter(s):Thomas S. Maldonado, MD  
  View Slides in PDF      
ENDOLEAKS AFTER EVAR
9:16 AM - 9:21 AM Management Strategies For Type 1a Endoleaks After EVAR: When Can They Be Ignored And When Must They Be Treated: What Treatment Is Best And When
  Presenter(s):Murray L. Shames, MD  
  View Slides in PDF      
9:22 AM - 9:27 AM When Can Embolization Techniques Fix Type 1 Endoleaks After EVAR: Which Agents Are Best And Technical Tips
  Presenter(s):Robert A. Morgan, MD  
  View Slides in PDF      
9:28 AM - 9:33 AM DEBATE: Type 2 Endoleaks With Increasing AAA Sac Size Are Dangerous And Usually Must Be Treated: Here Is The Evidence
  Presenter(s):Jean-Pierre Becquemin, MD, FRCS  
  View Slides in PDF      
9:34 AM - 9:39 AM DEBATE: There Is No Evidence That Treating Type 2 Endoleaks Is Beneficial And Such Treatment May Be Harmful
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
  View Slides in PDF      
9:40 AM - 9:45 AM Transcaval Embolization Of Type 2 Endoleaks After EVAR: Indications, Technique, Precautions And Results
  Presenter(s):Clifford M. Sales, MD, MBA, FACS  
  View Slides in PDF      
9:46 AM - 9:51 AM Contrast Enhanced Ultrasound (CEUS) To Facilitate Effective Treatment Of Type 2 Endoleaks
  Presenter(s):Thanila A. Macedo, MD / Gustavo S. Oderich, MD, FACS  
  View Slides in PDF      
9:52 AM - 9:57 AM When And How To Treat Type 2 Endoleaks: How Often Is Treatment Effective; How Often Is It Not
  Presenter(s):Marc L. Schermerhorn, MD  
  View Slides in PDF      
9:58 AM - 10:03 AM Onyx To Treat Type 2 Endoleaks: Technique And Precautions To Do It Safely And Effectively And Be Sure It Gets Into The Nidus
  Presenter(s):Mark W. Mewissen, MD, RVT  
  View Slides in PDF      
10:04 AM - 10:12 AM Panel Discussion
10:12 AM - 10:28 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 33
 
SESSION 34 SCHEDULE
Wednesday
SESSION 34: TRIBUTES TO VASCULAR GREATS; ISSUES RELATED TO A VASCULAR PRACTICE – PROBLEMS TO BE FACED AND HOW TO DEAL WITH THEM AND SUCCEED: ARTIFICIAL INTELLIGENCE AND HISTORY
x
A BIT OF HISTORY
10:28 AM - 10:33 AM My Diversion To Gander, Newfoundland On 9/11/2001 And What It Taught Me: The Play “Come From Away” Brought Back Memories
  Presenter(s):Klaus D. Mathias, MD  
  View Slides in PDF      
TRIBUTES TO GIANTS
10:34 AM - 10:39 AM A Tribute To Frank A. Lederle, MD (1952-2018)
  Presenter(s):Jerry Goldstone, MD, FACS, FRCSEd  
  View Slides in PDF      
10:40 AM - 10:45 AM A Tribute To Anthony (Tony) M. Imparato (1922-2018)
  Presenter(s):Mark A. Adelman, MD  
  View Slides in PDF      
ISSUES FOR VASCULAR SURGEONS
10:46 AM - 10:51 AM Is The Double Booked Vascular Surgeon A Thing Of The Past: Not Totally: What Are The Limitations
  Presenter(s):Vincent J. Santo III, MD  
  View Slides in PDF      
10:52 AM - 10:57 AM White Coat Crime In Vascular Surgery: What Is It And How Can It Be Stopped
  Presenter(s):Russell H. Samson, MD, RVT, FACS  
  View Slides in PDF      
10:58 AM - 11:03 AM Physical Ailments That Accrue To Vascular Surgeons From Their Work: What Are The Causes: How To Measure And Prevent Them
  Presenter(s):Samuel R. Money, MD, MBA  
  View Slides in PDF      
11:04 AM - 11:11 AM Panel Discussion
11:11 AM - 11:16 AM Life After Being A Busy Successful Surgeon: When And How To Stop Operating And Still Have A Useful Enjoyable Life
  Presenter(s):Simran B. Singh, MD, MBA  
  View Slides in PDF      
11:17 AM - 11:22 AM How Can Vascular Surgeon-Scientists Survive In Today’s Unfriendly DRG/RVU Climate
  Presenter(s):Peter Henke, MD  
  View Slides in PDF      
11:23 AM - 11:28 AM Key Personal Qualities That Help One To Achieve Success In Vascular Surgery And Other Vascular Specialties
  Presenter(s):Tej M. Singh, MD, MBA  
  View Slides in PDF      
11:29 AM - 11:34 AM Challenges And Keys To Success For Women In Vascular Surgery
  Presenter(s):Rebeca Reachi Lugo, MD  
  View Slides in PDF      
11:35 AM - 11:40 AM What Measures Need To Be Taken To Promote The Well-Being Of Vascular Surgeons In Today’s Medical Climate
  Presenter(s):Cynthia K. Shortell, MD  
  View Slides in PDF      
ARTIFICIAL INTELLIGENCE IN MEDICINE
11:41 AM - 11:46 AM Role Of Artificial Intelligence And Big Data In Health Care: Are Doctors’ Jobs In Danger
  Presenter(s):Ido Weinberg, MD, MSc  
  View Slides in PDF      
11:47 AM - 11:52 AM How Innovation Is Changing Health Care: Artificial Intelligence, Amazon, Google, Etc. Will Revolutionize Things In the Future
  Presenter(s):Eugene M. Langan III, MD  
  View Slides in PDF      
11:53 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break - 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 34
 
SESSION 35 SCHEDULE
Wednesday
SESSION 35: ISSUES RELATED TO OUTPATIENT CENTERS, PODIATRY, REIMBURSEMENTS, PERFORMANCE AND COST CONTROL
x
1:00 PM - 1:05 PM Office Or Outpatient Centers Are The Best Place To Perform Most Arterial And Venous Interventional Treatments: Precautions And Current Status Of Their Accreditation And Reimbursement
  Presenter(s):Krishna Jain, MD  
  View Slides in PDF      
1:06 PM - 1:11 PM What Is The OEIS (Outpatient Endovascular And Interventional Society); How Can It Help Vascular Surgeons And Specialists And Their Patients
  Presenter(s):Jeff G. Carr, MD  
  View Slides in PDF      
1:12 PM - 1:17 PM DEBATE: Outpatient Atherectomy For IC (Claudication) Leads To Worse Outcomes And More Amputations Than The Natural History Of The Disease: From Medicare Billing Data
  Presenter(s):Dipankar Mukherjee, MD  
  View Slides in PDF      
1:18 PM - 1:23 PM DEBATE: Not So: Why Outpatient Atherectomy Should Not Increase Amputation Rates But Should Decrease Them: Why The Medicare Data Is Misleading
  Presenter(s):Lawrence A. Garcia, MD  
  View Slides in PDF      
1:24 PM - 1:29 PM New Concepts In Podiatry Important To Vascular Surgeons/Specialists: Game Changing Single Dose Antibiotic (Dalbavancin) For Foot Infections And How To Avoid Opiods For Pain
  Presenter(s):Wayne J. Caputo, DPM  
  View Slides in PDF      
1:30 PM - 1:35 PM Panel Discussion
REIMBURSEMENT AND COST ISSUES
1:35 PM - 1:40 PM What Is Happening With MACRA And The Other Alphabet Soup Entities Impacting On Reimbursement
  Presenter(s):Timothy F. Kresowik, MD  
  View Slides in PDF      
1:41 PM - 1:46 PM Why Endovascular Treatments For CLTI Are More Cost Effective Than Open Surgery Or Amputation In The Drug Eluting Era
  Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD  
  View Slides in PDF      
1:47 PM - 1:52 PM Strategies For Decreasing Costs Without Decreasing Success In A PVD Practice
  Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA  
  View Slides in PDF      
1:53 PM - 1:58 PM What Are The Latest Objective SFA-Pop Performance Goals: How Do They Influence Patient Care And Costs
  Presenter(s):Jack L. Cronenwett, MD  
  View Slides in PDF      
1:59 PM - 2:04 PM V-HEALTHY: A Program To Increase Vascular Disease Awareness And The Role And Importance Of Vascular Surgeons: How Does It Work
  Presenter(s):Manish Mehta, MD, MPH  
  View Slides in PDF      
2:05 PM - 2:11 PM Innovation In Vascular Surgery: What Does It Take To Develop A New Treatment And Change The Standard Of Care
  Presenter(s):Frank J. Criado, MD, FACS, FSVM  
  View Slides in PDF      
2:11 PM - 2:16 PM Panel Discussion
END OF SESSION 35
 
SESSION 36 SCHEDULE
Wednesday
SESSION 36: MORE ISSUES RELATED TO QUALIFICATIONS, GOVERNMENT, COMPENSATION OR INCOMES, INCENTIVES, PUBLIC REPORTING OF OUTCOMES, PROCEDURAL USAGE AND VALUE OF VASCULAR SURGEONS
x
2:16 PM - 2:21 PM Why European Qualifications In Vascular Surgery Will Have Increasing Importance: How Will It Help Vascular Surgeons And Patients
  Presenter(s):Armando Mansilha, MD, PhD, FEBVS  
  View Slides in PDF      
2:22 PM - 2:27 PM What Is Happening With Vascular Device Evaluation And Approval At The FDA: How Is It Helping Vascular Surgeons Develop And Get To Use New Devices
  Presenter(s):Dorothy B. Abel, BSBME  
  View Slides in PDF      
2:28 PM - 2:33 PM How Is The SVS Coding And Government Relations Committees And The SVS PAC Helping Vascular Surgeons’ Incomes
  Presenter(s):Sean P. Roddy, MD  
  View Slides in PDF      
2:34 PM - 2:39 PM How To Design A Fair Compensation Package For Academic Vascular Surgeons: It Should Not Just Be About RVUs And DRGs
  Presenter(s):Mark G. Davies, MD  
  View Slides in PDF      
2:40 PM - 2:45 PM Pay For Performance (P4P) Incentive Systems Are Flawed: What Frustrations Do They Cause For Vascular Surgeons/Specialists Dealing With High Risk Patients And How Can These Be Overcome
  Presenter(s):James W. Jones, MD, PhD, MHA  
  View Slides in PDF      
2:46 PM - 2:52 PM Panel Discussion
2:52 PM - 2:57 PM DEBATE: Public Reporting Of Individual Vascular Surgeons And Other Vascular Specialists Is A Good Thing For Patients
  Presenter(s):Bruce A. Perler, MD, MBA  
  View Slides in PDF      
2:58 PM - 3:03 PM DEBATE: No: Such Reporting Is Bad For Patients, Society And Specialists: Here Is Why
  Presenter(s):Ian Loftus, MD  
  View Slides in PDF      
3:04 PM - 3:09 PM Factors Influencing Usage Of Procedures (Like Carotid Revascularizations) By Doctors: Maintenance Of Incomes Is A Major Factor And Could Be Detrimental To Patients
  Presenter(s):Philip P. Goodney, MD, MS  
  View Slides in PDF      
3:10 PM - 3:15 PM Why Do Some Alleged Vascular Surgeons Perform 1 Or 2 AAA Repairs Per Year: What Is The Result And How Can The Problem Be Fixed
  Presenter(s):Jack L. Cronenwett, MD  
  View Slides in PDF      
3:16 PM - 3:21 PM Urgent Operative Consultations Provided By Vascular Surgeons - Usually To Stop Bleeding: Skills We Have That Others Need: Can Our Value Be Compensated And Is It
  Presenter(s):Michael Belkin, MD  
  View Slides in PDF      
3:22 PM - 3:27 PM Panel Discussion
3:27 PM - 3:36 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 36
 
SESSION 37 SCHEDULE
Wednesday
SESSION 37: ISSUES RELATED TO MALPRACTICE, VASCULAR CARE AND THE VALUE AND WELL-BEING OF VASCULAR SURGEONS
x
3:36 PM - 3:41 PM How To Neutralize And Unmask Hostile Medical Expert Witnesses And Their Testimony
  Presenter(s):O. William Brown, MD, JD  
  View Slides in PDF      
3:42 PM - 3:47 PM Why Is The EPIC EHR System Currently Such A Problem For Vascular Surgeons/Specialists: Can It Be Improved: Are There Better Systems
  Presenter(s):Timothy F. Kresowik, MD  
  View Slides in PDF      
3:48 PM - 3:53 PM How To Decrease The Cost Of Vascular Care Delivery For Lower Extremity And EVAR Procedures Without Impairing Quality
  Presenter(s):Richard J. Powell, MD  
  View Slides in PDF      
3:54 PM - 3:59 PM How To Let Vascular Patients Share More In Their Treatment Decisions: What Tools Are Available: The OVIDIUS Trial
  Presenter(s):Dirk T. Ubbink, MD, PhD  
  View Slides in PDF      
4:00 PM - 4:05 PM EVAR And Carotid Interventions Can Have Durable Good Results In Patients Over 80: How Can Results Be Improved In Elderly Patients
  Presenter(s):B. Patrice Mwipatayi, MMed, MClinEd  
  View Slides in PDF      
4:06 PM - 4:11 PM Eliminating Avoidable Disasters In The OR And Managing Them When They Occur
  Presenter(s):Robert B. McLafferty, MD  
  View Slides in PDF      
4:12 PM - 4:17 PM Panel Discussion
4:17 PM - 4:22 PM Why We Need To Centralize Vascular Care For AAAs And CLTI: Will It Happen
  Presenter(s):Michael C. Stoner, MD  
  View Slides in PDF      
4:23 PM - 4:28 PM How A Certification Plan For Vascular Centers Will Be Structured: Will It Happen And How Will It Help Vascular Surgery
  Presenter(s):Anton N. Sidawy, MD, MPH  
  View Slides in PDF      
4:29 PM - 4:34 PM Recognition Of Burnout In Vascular Surgeons: Strategies To Prevent And Overcome It
  Presenter(s):John (Jeb) W. Hallett, MD  
  View Slides in PDF      
4:35 PM - 4:40 PM How To Optimize And Reward The Value Of A Vascular Surgeon In A Large Health Care System
  Presenter(s):Ronald M. Fairman, MD  
  View Slides in PDF      
4:41 PM - 4:46 PM Panel Discussion
END OF SESSION 37
 
SESSION 38 SCHEDULE
Wednesday
SESSION 38: ISSUES RELATED TO THE SVS, VQIs, GUIDELINES, TRIALS, ETHICS AND THE JVS
x
4:46 PM - 4:51 PM Current Status, Advantages And Limitations Of The SVS VQI
  Presenter(s):Larry W. Kraiss, MD  
  View Slides in PDF      
4:52 PM - 4:57 PM How VQIs Can Be Used To Help Set Ethical Standards
  Presenter(s):Thomas W. Wakefield, MD  
  View Slides in PDF      
4:58 PM - 5:03 PM How VQIs Can Help To Develop Good RCTs
  Presenter(s):Mohammad H. Eslami, MD, MPH  
  View Slides in PDF      
5:04 PM - 5:09 PM Highlights And Key Messages From The New SVS Practice Guidelines For Care Of AAA Patients
  Presenter(s):Elliot L. Chaikof, MD, PhD  
  View Slides in PDF      
5:10 PM - 5:15 PM Highlights And Key Messages From The UK Guidance Document On AAA Treatment
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh  
  View Slides in PDF      
5:16 PM - 5:21 PM SVS Guidelines For Hospital Privileges For Vascular Surgeons In The US
  Presenter(s):Keith D. Calligaro, MD  
  View Slides in PDF      
5:22 PM - 5:27 PM Panel Discussion
5:27 PM - 5:32 PM Why Registries Can Be Better Than RCTs For Evaluating Vascular Devices
  Presenter(s):Jean-Baptiste Ricco, MD, PhD  
  View Slides in PDF      
5:33 PM - 5:38 PM Traditional Clinical Trials In Vascular Disease Have Problems: How Can We Fix This With Bayesian Trial Designs
  Presenter(s):Charles C. Miller, PhD  
  View Slides in PDF      
5:39 PM - 5:44 PM Why Do So Many Trials Of Treatments For CLTI Fail: What Is The Best Design To Prevent Failure In This Setting
  Presenter(s):Mahmood Razavi, MD  
  View Slides in PDF      
5:45 PM - 5:50 PM Update On Status Of And Improvements In The JVS: How To Review A Paper For The JVS
  Presenter(s):Peter F. Lawrence, MD / Peter Gloviczki, MD  
  View Slides in PDF      
5:51 PM - 5:56 PM How To Make A Paper Have The Best Chance Of Getting Published In The JVS Despite A High Rejection Rate
  Presenter(s):Peter Gloviczki, MD / Peter F. Lawrence, MD  
  View Slides in PDF      
5:57 PM - 6:03 PM Panel Discussion
End of Program F
END OF SESSION 38
 
SESSION 39 SCHEDULE
Wednesday
SESSION 39: MORE TOPICS RELATED TO THE THORACIC AORTA, TEVAR, AORTIC DISSECTIONS AND THEIR TREATMENT
x
6:45 AM - 6:50 AM Why Left Subclavian Artery (LSA) Revascularization With TEVAR Is Best Accomplished With A Carotid-To-Axillary Bypass Rather Than By A Carotid-To-LSA Bypass Or Transposition: Technical Tips
  Presenter(s):Frank J. Criado, MD, FACS, FSVM  
  View Slides in PDF      
6:51 AM - 6:56 AM System For Preoperative Risk Assessment For TEVAR Outcomes
  Presenter(s):Richard G.J. Gibbs, FRCS  
  View Slides in PDF      
6:57 AM - 7:02 AM How Best To Size (Diameter) Endografts For TEVAR: For Treatment Of Aneurysms, TBADs And Traumatic Aortic Injuries
  Presenter(s):Thomas S. Maldonado, MD  
  View Slides in PDF      
7:03 AM - 7:08 AM At What Size (Diameter) Should Asymptomatic Thoracic Aortic Aneurysms (TAAs) Undergo Treatment By TEVAR
  Presenter(s):Robert J. Hinchliffe, MD  
  View Slides in PDF      
7:09 AM - 7:14 AM Impact Of TEVAR On Pulsatile Aortic Strain In Acute TBAD: What Is Its Clinical Significance
  Presenter(s):Frans L. Moll, MD, PhD  
  View Slides in PDF      
7:15 AM - 7:20 AM Panel Discussion
TBAD RELATED TOPICS
7:20 AM - 7:25 AM 4-Year Outcomes Of TBAD Treatment With The Valiant Device (From Medtronic) For TEVAR
  Presenter(s):Ali Azizzadeh, MD  
  View Slides in PDF      
7:26 AM - 7:31 AM Invasive Treatment In Patients With Genetically Triggered Aortopathy (Like Marfan’s): When Is Endovascular Treatment Acceptable And When Not
  Presenter(s):Cherrie Z. Abraham, MD  
  View Slides in PDF      
7:32 AM - 7:37 AM Risk Factors For New Distal Endovascular Graft Induced Re-Entry Tears After TEVAR For TBADs: How To Avoid Them
  Presenter(s):Ludovic Canaud, MD, PhD  
  View Slides in PDF      
7:38 AM - 7:43 AM Importance Of The Primary Tear Distance From The LSA In Predicting Aortic Growth With TBADs
  Presenter(s):William D. Jordan Jr., MD  
  View Slides in PDF      
7:44 AM - 7:49 AM When And How To Intervene For Endoleaks And False Lumen Perfusion After TEVAR For TBADs
  Presenter(s):Manish Mehta, MD, MPH  
  View Slides in PDF      
7:50 AM - 7:55 AM How Can False Lumen Intentional Placement (FLIP) Of An Endograft Facilitate Repair Of A Chronic TBAD With TAAA Formation: Techniques And Results
  Presenter(s):William J. Quinones-Baldrich, MD  
  View Slides in PDF      
7:56 AM - 8:01 AM Panel Discussion
END OF SESSION 39
 
SESSION 40 SCHEDULE
Wednesday
SESSION 40: MORE NEW DEVELOPMENTS IN THE TREATMENT OF LESIONS OF THE ASCENDING AORTA AND THE AORTIC ARCH
x
8:01 AM - 8:06 AM Risk Factors For Retrograde Type A Dissections After TEVAR Procedures And How To Avoid Them And Treat Them
  Presenter(s):Frank R. Arko, MD  
  View Slides in PDF      
8:07 AM - 8:12 AM Ascending Aortic Aneurysms Are Over-Diagnosed Using Cardiology Guidelines: When Is The Ascending Aorta Really Aneurysmal
  Presenter(s):Jes S. Lindholt, MD  
  View Slides in PDF      
8:13 AM - 8:18 AM Early Multicenter Experience With The Gore Ascending Aortic Off-The-Shelf (OTS) Endograft: Indications, Contraindications, Advantages And Results
  Presenter(s):Jean Bismuth, MD  
  View Slides in PDF      
8:19 AM - 8:24 AM Technical Tips For Open Arch Replacement In Type A Aortic Dissections (TAADs) To Facilitate Subsequent TAAA Repair
  Presenter(s):Christian D. Etz, MD, PhD  
  View Slides in PDF      
8:25 AM - 8:30 AM Chimney TEVAR (Ch/TEVAR) To Treat Aortic Arch Lesions: Long-Term Good Outcomes And How To Achieve Them
  Presenter(s):Martin R. Back, MD  
  View Slides in PDF      
8:31 AM - 8:36 AM How To Prevent Gutter Endoleaks With Arch Chimney Grafts (Ch/TEVAR)
  Presenter(s):Jan S. Brunkwall, MD, PhD  
  View Slides in PDF      
8:37 AM - 8:43 AM Panel Discussion
8:43 AM - 8:48 AM New Concepts For Better Understanding Aortic Arch Pathology, Its Progression And Treatment
  Presenter(s):Santi Trimarchi, MD, PhD  
  View Slides in PDF      
8:49 AM - 8:54 AM Retrograde Type A Aortic Dissections After TEVAR: Etiologic Factors Can Be Operator Dependent; Device Dependent And/Or Disease Dependent: How To Prevent And Treat Them
  Presenter(s):Ourania Preventza, MD / Joseph S. Coselli, MD  
  View Slides in PDF      
8:55 AM - 9:00 AM Open vs. Endo Arch Reconstructions In 2018: What Is Evidence-Based And What Is Anecdote-Based
  Presenter(s):Christoph A. Nienaber, MD, PhD / Nicholas J.W. Cheshire, MD  
  View Slides in PDF      
9:01 AM - 9:06 AM Update On The Gore Retrograde Single Branched Endograft Device For Treating Aortic Arch Lesions: Advantages, Precautions And Results
  Presenter(s):Michael D. Dake, MD / Michel Makaroun, MD  
  View Slides in PDF      
9:07 AM - 9:12 AM Percutaneous Transapical Approach For Placing Arch And Other Devices: How Is It Possible
  Presenter(s):Ross Milner, MD  
  View Slides in PDF      
9:13 AM - 9:18 AM How To Manage A Chronically Diseased Aorta Distal To A Previous Surgical Or Endograft Treated TAAD
  Presenter(s):Jean-Marc Alsac, MD, PhD  
  View Slides in PDF      
9:19 AM - 9:25 AM Panel Discussion
9:25 AM - 9:40 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 40
 
SESSION 41 SCHEDULE
Wednesday
SESSION 41: MORE ABOUT JUXTA- AND PARARENAL AAAs, F/B/EVAR, TAAAs, NEW ENDOGRAFTS, SANDWICH GRAFTS AND HYBRID GRAFTS
x
9:40 AM - 9:45 AM New Advances In Open TAAA Repair Especially After Endovascular Treatment Failures: Technical Tips And Results
  Presenter(s):Roberto Chiesa, MD  
  View Slides in PDF      
9:46 AM - 9:51 AM DEBATE: Endovascular Repair Is The Best Treatment For Most TAAAs – Especially With The Availability Of Some Newer Endograft Systems
  Presenter(s):Mark A. Farber, MD  
  View Slides in PDF      
9:52 AM - 9:57 AM DEBATE: Not So: Many TAAAs Are Best Treated By Open Surgery: Technical Pearls To Improve Results
  Presenter(s):Virendra I. Patel, MD, MPH  
  View Slides in PDF      
9:58 AM - 10:03 AM Why Open Surgery Is Still The Best Treatment For Juxta- And Pararenal AAAs In Good Risk Patients: Technical Tips
  Presenter(s):Kimihiro Komori, MD, PhD  
  View Slides in PDF      
10:04 AM - 10:09 AM Update On The Sandwich Technique For Treating Complex TAAAs: Technical Tips, Precautions And Results
  Presenter(s):Armando C. Lobato, MD, PhD  
  View Slides in PDF      
10:10 AM - 10:15 AM Endovascular Options For Treating TAAAs: What Off-Label Options Are Safe And Effective
  Presenter(s):Murray L. Shames, MD  
  View Slides in PDF      
10:16 AM - 10:21 AM Propensity Matched Comparison Of F/B/EVAR And Open Repair For TAAAs Shows That Endovascular Treatment Is Best
  Presenter(s):Piergiorgio Cao, MD, FRCS  
  View Slides in PDF      
10:22 AM - 10:27 AM Tips And Tricks For Performing B/EVAR Without Axillary Access
  Presenter(s):Stephan Haulon, MD  
  View Slides in PDF      
10:28 AM - 10:34 AM Panel Discussion
Moderator(s): Stephan Haulon, MD / Ali F. AbuRahma, MD  
10:34 AM - 10:39 AM Visceral Manifold Endograft System From Medtronic For Treating Complex AAAs And TAAAs: Advantages, Precautions And Midterm Results: When Will It Be Available Commercially
  Presenter(s):Patrick W. Kelly, MD  
  View Slides in PDF      
10:40 AM - 10:45 AM Update On A New Manifold Multibranched Endo Device (Colt Device) For Improving TAAA Treatment: Concept, Advantages And Results
  Presenter(s):Piotr Szopinski, MD, PhD  
  View Slides in PDF      
10:46 AM - 10:51 AM Update On The Spider Hybrid Graft For Partially Open TAAA Repair Without A Thoracotomy: How It Works, Clinical Experience, Advantages And Limitations
  Presenter(s):Sebastian E. Debus, MD, PhD  
  View Slides in PDF      
10:52 AM - 10:57 AM Open Repair For Visceral Segment TAAAs After TEVAR: The Reverse Cactus Operation: A Good Option When Endo Treatment Is Not Possible: Technique And 1-Year Results
  Presenter(s):Francesco Spinelli, MD  
  View Slides in PDF      
10:58 AM - 11:03 AM Chimney EVAS (Ch/EVAS) With The Nellix Device For Juxta- And Pararenal AAAs: Tips And Tricks For Performing And Results Of The ASCEND Trials 1 And 2 (IDE)
  Presenter(s):Ian Loftus, MD / Pete Holt, MD, PhD  
  View Slides in PDF      
11:04 AM - 11:09 AM Branched EVAR (B/EVAR) Through The False Lumen For Chronic TBADs With TAAAs: Why Is It Necessary: How To Do It And Results
  Presenter(s):Piotr M. Kasprzak, MD  
  View Slides in PDF      
11:10 AM - 11:15 AM Adjuncts To Achieve Better Sealing And AAA Exclusion With F/EVAR And Ch/EVAR: Value Of Viabahn BX (Balloon Expandable) Branch Grafts As Shown In An In Vitro Model
  Presenter(s):Jan D. Blankensteijn, MD  
  View Slides in PDF      
11:16 AM - 11:22 AM Panel Discussion
END OF SESSION 41
 
SESSION 42 SCHEDULE
Wednesday
SESSION 42: UPDATE ON MULTILAYER FLOW MODULATING BARE STENTS FOR THE TREATMENT OF PERIPHERAL AND VISCERAL ANEURYSMS, COMPLEX AORTIC ANEURYSMS AND DISSECTIONS
x
11:22 AM - 11:27 AM Why Multilayer Flow Modulating Bare Stents (From Cardiatis) Are The Treatment Of Choice For Peripheral And Visceral Aneurysms: What Is The Evidence: These Are The Results
  Presenter(s):Michel Henry, MD  
  View Slides in PDF      
11:28 AM - 11:33 AM Update On The Value Of Treating Aortic Aneurysms And Dissections With A Combination Of Multilayered Uncovered Stents Together With Covered Stents: Indications, Techniques And Results
  Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD  
  View Slides in PDF      
11:34 AM - 11:39 AM When Is The Multilayered Flow Modulating Bare Stent A Good Treatment For TBADs And The Treatment Of Choice For Penetrating Aortic Ulcers (PAUs): Indications, Precautions And Results
  Presenter(s):Ralf R. Kolvenbach, MD  
  View Slides in PDF      
11:40 AM - 11:45 AM Multilayer Flow Modulating Bare Stents: Long-Term Results In Aortic Dissections And Complex AAAs And TAAAs: When Do They Work And When Don’t They: From The DRAGON Multicenter Trial
  Presenter(s):Claude D. Vaislic, MD  
  View Slides in PDF      
11:46 AM - 11:51 AM Value Of Multilayer Flow Modulating Stents In Treating Complex Aortic Pathology: They Are Effective In Aortic Dissections: What About With Complex AAAs
  Presenter(s):Ivo Petrov, MD, PhD  
  View Slides in PDF      
11:52 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 42
 
SESSION 43 SCHEDULE
Wednesday
SESSION 43: MORE INTERESTING TOPICS RELATED TO INFRARENAL AAAs AND STANDARD EVAR AND TBADs
x
1:00 PM - 1:05 PM Off-Label Use Of EVAR Devices For Treating AAAs With Challenging Neck Anatomy Is Safe And Effective Under Certain Conditions: What Are They
  Presenter(s):Martin Malina, MD, PhD  
  View Slides in PDF      
1:06 PM - 1:11 PM Should Mesh Reinforcement Of Abdominal Incisions Be The Standard Of Care For Open AAA Surgery To Prevent Wound Complications: Based On RCTs
  Presenter(s):Mark J.W. Koelemay, MD, PhD  
  View Slides in PDF      
1:12 PM - 1:17 PM Multilayer Flow Modulating (MFM) Stents Are A Safe And Effective Option For Treating Complex Type B Aortic Dissections (TBADs): Based On A 4-Year Experience
  Presenter(s):Victor S. Costache, MD, PhD  
  View Slides in PDF      
1:18 PM - 1:23 PM EVAR 2’s Level 1 Evidence No Longer Applies For Many Reasons: Why EVAR Is Currently Indicated In Many Patients Unfit For Open Repair: Which Ones
  Presenter(s):Frank E.G. Vermassen, MD, PhD  
  View Slides in PDF      
1:24 PM - 1:29 PM Of Course EVAR Is Indicated In Many Patients Who Could Not Undergo An Open Repair: This Is An Example Of RCT Level 1 Evidence Being Outdated And No Longer Applicable To Current Practice
  Presenter(s):Edward Y. Woo, MD  
  View Slides in PDF      
1:30 PM - 1:35 PM How To Treat Patients With Large AAAs Who Are Unfit For Open Repair In 2018: When Should They Undergo EVAR
  Presenter(s):Katariina M. Noronen, MD, PhD  
  View Slides in PDF      
1:36 PM - 1:41 PM Why EVAR 2 Level 1 Evidence May Not Apply In 2018 And Why Patients Unfit For Open Repair May Now Benefit From EVAR
  Presenter(s):Cynthia K. Shortell, MD / Leila Mureebe, MD  
  View Slides in PDF      
1:42 PM - 1:47 PM New Insights Into Long-Term Reintervention And AAA Rupture Rates After EVAR And Open Repair: From The SVS VQI
  Presenter(s):Philip P. Goodney, MD, MS  
  View Slides in PDF      
1:48 PM - 1:54 PM Panel Discussion
END OF SESSION 43
 
SESSION 44 SCHEDULE
Wednesday
SESSION 44: MORE NEW DEVELOPMENTS RELATING TO AAAs AND EVAR
x
1:54 PM - 1:59 PM The Gamesmanship And Subjectivity Involved In Measuring AAA Diameter: You Can Make It What You Want
  Presenter(s):Janet T. Powell, MD, PhD  
  View Slides in PDF      
2:00 PM - 2:05 PM Significance Of Infrarenal Aortas Measuring 25-29 mm In Diameter: They Will Likely Become Aneurysmal And They Require Follow-Up: At What Intervals
  Presenter(s):Martin Bjorck, MD, PhD  
  View Slides in PDF      
2:06 PM - 2:11 PM DEBATE: EVAR With Large Diameter Devices (Up To 36 mm) Can Be Effective And Are Associated With Acceptable Risks: Special Tips For Treatment
  Presenter(s):Michael J. Singh, MD  
  View Slides in PDF      
2:12 PM - 2:17 PM DEBATE: Not So. Large Diameter AAA Necks And Devices Over 28 mm Have Higher EVAR Failure Rates: How Should They Be Treated
  Presenter(s):Ali F. AbuRahma, MD  
  View Slides in PDF      
2:18 PM - 2:23 PM EVAR With Large Diameter Devices Have Increased Risks Of Failure: When Should Ch/EVAR Or F/EVAR Be Used Instead Of Standard EVAR With Large Diameter Devices
  Presenter(s):Jason T. Lee, MD  
  View Slides in PDF      
2:24 PM - 2:29 PM How And When To Treat Thrombus Within Endografts And The Native Aorta
  Presenter(s):Barend M.E. Mees, MD, PhD / Geert Willem H. Schurink, MD, PhD  
  View Slides in PDF      
2:30 PM - 2:36 PM Panel Discussion
2:36 PM - 2:41 PM Value And Limitations Of EVAR For Inflammatory AAAs And Other AAAs Of Rare Etiologies
  Presenter(s):Furuzan Numan, MD  
  View Slides in PDF      
2:42 PM - 2:47 PM How Best To Treat Inflammatory AAAs: When Is EVAR Best And When Is It Not
  Presenter(s):Sonia Ronchey, MD, PhD  
  View Slides in PDF      
2:48 PM - 2:53 PM What Is The Association Between AAAs, TBADs And Cancer: What Is It Due To
  Presenter(s):Natzi Sakalihasan, MD, PhD  
  View Slides in PDF      
2:54 PM - 2:59 PM Bare Stent Suprarenal Fixation For EVAR: Is It Harmful Or Beneficial: What Are The Pros And Cons
  Presenter(s):Claude Mialhe, MD  
  View Slides in PDF      
3:00 PM - 3:05 PM Fenestrated Iliac Limbs To Preserve Hypogastric Flow When IBDs Won’t Work: How To Obtain Them Or Make Them
  Presenter(s):Afshin Assadian, MD  
  View Slides in PDF      
3:06 PM - 3:11 PM Do We Have The Right Endograft To Treat AAAs In Women: What Is The Best Device For EVAR In Women: Should Open Repair Be Used More
  Presenter(s):Sigrid Nikol, MD  
  View Slides in PDF      
3:12 PM - 3:17 PM EVAR Explantation And Revascularization For Failure And Infection: Technical Tips And Results
  Presenter(s):Thomas C. Bower, MD  
  View Slides in PDF      
3:18 PM - 3:23 PM Panel Discussion
3:24 PM - 3:30 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 44
 
SESSION 45 SCHEDULE
Wednesday
SESSION 45: CHALLENGING RECORDED LIVE CASES AND THOSE EMPLOYING INNOVATIVE TECHNIQUES
x
3:30 PM - 3:40 PM Internal Iliac Artery Preservation Using Parallel Grafts: Successes And Mistakes
  Presenter(s):Andrew Holden, MBChB  
  View Slides in PDF      
3:40 PM - 3:50 PM Hybrid Arterialization Of The Venous System Of The Foot In No Option CLI Patients
  Presenter(s):Roberto Ferraresi, MD  
  View Slides in PDF      
3:50 PM - 4:00 PM Complex TAAA Endovascular Repair
  Presenter(s):Stephan Haulon, MD  
  View Slides in PDF      
4:00 PM - 4:10 PM Retrograde BTK Micro-Stenting: Initial Experience
  Presenter(s):Marco G. Manzi, MD  
  View Slides in PDF      
4:10 PM - 4:20 PM TEVAR: Step-By-Step
  Presenter(s):Dittmar Boeckler, MD  
4:20 PM - 4:30 PM Treatment Of A Type 3B Endoleak With Off-Label Use Of A Device Used In Structural Heart Disease
  Presenter(s):Jos C. van den Berg, MD, PhD  
  View Slides in PDF      
4:30 PM - 4:40 PM What Kind Of Drug Do We Need To Treat BTK Arteries In CLI Patients
  Presenter(s):Marianne Brodmann, MD  
  View Slides in PDF      
END OF SESSION 45
 
SESSION 46 SCHEDULE
Wednesday
SESSION 46: RECORDED COMPLEX LIVE CASES FROM LEIPZIG AND LINC: PIONEERING TECHNIQUES FOR CHALLENGING VASCULAR PATHOLOGIES
x
4:40 PM - 5:00 PM Minimal Invasive Segmental Artery Coil Embolization (MISACE) For Prevention Of Spinal Cord Ischemia During EVAR Of Thoracoabdominal Aortic Pathologies: Initial Clinical Results
  Presenter(s):Daniela Branzan, MD  
  View Slides in PDF      
4:50 PM - 5:00 PM Minimal Invasive Segmental Artery Coil Embolization (MISACE) For Prevention Of Spinal Cord Ischemia During EVAR Of Thoracoabdominal Aortic Pathologies: Initial Clinical Results: Technical Aspects
  Presenter(s):Andrej Schmidt, MD  
  View Slides in PDF      
5:00 PM - 5:10 PM Experience With A New Nano-Coated DCB: 12-Month Results From The EFFPAC-RCT
  Presenter(s):Marcus Thieme, MD  
  View Slides in PDF      
5:10 PM - 5:20 PM Recorded Case: Transluminal Tumescent Anesthesia During Angioplasty Of Severely Calcified Vessels
  Presenter(s):Andrej Schmidt, MD  
  View Slides in PDF      
5:20 PM - 5:30 PM DCB + Focal scaffolding: The New Concept For Optimized BTK Angioplasty?
  Presenter(s):Marianne Brodmann, MD  
  View Slides in PDF      
5:30 PM - 5:40 PM Recorded Case: DCB + Tack Scaffolds BTK
  Presenter(s):Andrej Schmidt, MD  
5:40 PM - 5:50 PM Recorded Case: Prerecorded Percutaneous Deep Venous Arterialization: Procedure Using The LimFlow Technique
  Presenter(s):Steven Kum, MD  
  View Slides in PDF      
END OF SESSION 46
 
SESSION 47 SCHEDULE
Thursday
SESSION 47: EXCITING NEW OR UPDATED TECHNIQUES, CONCEPTS AND TECHNOLOGIES
x
6:45 AM - 6:50 AM New In Vitro System For Evaluating Optimal Techniques, Main And Branch Endografts, Sizing, Etc. For Ch/EVAR: How It Will Improve Results And Decrease Complications By Leading To Standardized Techniques And Endograft Components
  Presenter(s):Konstantinos P. Donas, MD / Taneva Gergana, MD / Martin J. Austermann, MD / Giovanni Torsello, MD  
  View Slides in PDF      
6:51 AM - 6:56 AM Pudendal Angioplasty (PTA) For Erectile Dysfunction: How To Diagnose It To Optimize Results Of Treatment
  Presenter(s):Frederic A. Baumann, MD  
  View Slides in PDF      
6:57 AM - 7:02 AM Non-Interventional Management Of CLTI: With Optimal Medical Treatment And Good Wound Care Many Amputations Can Be Prevented: When Is It The Best And Most Cost Effective Treatment
  Presenter(s):William A. Marston, MD  
  View Slides in PDF      
7:03 AM - 7:08 AM DEBATE: There Is A Future For Stem Cell Technology For Treating CLTI: What Does It Depend On
  Presenter(s):Dong-ik Kim, MD  
  View Slides in PDF      
7:09 AM - 7:14 AM DEBATE: There Is No Future For Stem Cell Technology To Treat CLTI: Sequential Compression Is Better And Cheaper And Beats Revascularization In Some Cases
  Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC  
  View Slides in PDF      
7:15 AM - 7:20 AM Update On Arterial Reconstructions With Bioengineered Vascular Grafts: How Well Are They Working
  Presenter(s):Jeffrey H. Lawson, MD, PhD  
  View Slides in PDF      
7:21 AM - 7:26 AM Why All DCBs Are Not The Same: Underlying Material Differences Are Important: Some Thoughts About Differences Between In.Pact, Lutonix, Stellarex, Ranger, Etc. And How They May Matter
  Presenter(s):Frank E.G. Vermassen, MD, PhD  
  View Slides in PDF      
7:27 AM - 7:32 AM Proper Hydration And Supplemental Oral Protein Administration Improves All Lower Extremity Ischemic Symptoms: It May Replace Stenting And Bypasses For Many Patients: The Evidence
  Presenter(s):Juan C. Parodi, MD  
  View Slides in PDF      
7:33 AM - 7:38 AM A New Computer Controlled Balloon Catheter To Improve Treatment For Cardiac Arrest And Massive Bleeding: How Does It Work And Results
  Presenter(s):Lars B. Lonn, MD, PhD  
  View Slides in PDF      
7:39 AM - 7:44 AM Update On GraftWorx Implantable Piezoelectric Sensors For Remotely Measuring Vascular Graft And Stent Flows And Other Parameters: When Will They Be Available
  Presenter(s):Richard F. Neville, MD  
  View Slides in PDF      
7:45 AM - 7:50 AM New Exciting Developments In Coronary Artery Evaluation By Non-Invasive FFRCT: Incidence Of Unexpected Lesions In Vascular Patients: Detection Lowers Myocardial Infarction And Mortality Rates: Who Should Get The Test
  Presenter(s):Christopher K. Zarins, MD  
  View Slides in PDF      
7:51 AM - 7:58 AM Panel Discussion
END OF SESSION 47
 
SESSION 48 SCHEDULE
Thursday
SESSION 48: ADVANCES IN FENESTRATED AND BRANCHED EVAR (F/B/EVAR) AND PARALLEL GRAFTS FOR COMPLEX AAAs
x
7:58 AM - 8:03 AM Long-Term Outcomes Of F/EVAR: Where Is The Technology Going
  Presenter(s):Matthew J. Eagleton, MD  
  View Slides in PDF      
8:04 AM - 8:09 AM Where Is F/EVAR Going: Custom-Made By Industry vs. Off-The-Shelf (OTS) Devices vs. Surgeon Modified
  Presenter(s):Andres Schanzer, MD  
  View Slides in PDF      
8:10 AM - 8:15 AM Techniques To Salvage F/EVAR Procedures When The Fenestrations Don’t Align With Branch Orifices
  Presenter(s):Gustavo S. Oderich, MD, FACS  
  View Slides in PDF      
8:16 AM - 8:21 AM Renal Fenestration Misalignment With F/EVAR Leads To Bad Outcomes: Prevention And Treatment
  Presenter(s):Thomas L. Forbes, MD  
  View Slides in PDF      
8:22 AM - 8:27 AM How To Make Endografts Fit And Align With Branch Orifices Perfectly Using Automated 3D Software From Aortica: It Will Improve Results And Increase F/EVAR Utilization
  Presenter(s):Benjamin W. Starnes, MD  
  View Slides in PDF      
8:28 AM - 8:33 AM Managing Branch Complications Of F/B/EVAR: Incidence And Outcomes
  Presenter(s):Burkhart Zipfel, MD, PhD  
  View Slides in PDF      
8:34 AM - 8:40 AM Panel Discussion
8:40 AM - 8:45 AM DEBATE: The Evidence For The Success And Durability Of Ch/EVAR Is Poor: F/EVAR Is Clearly The Gold Standard
  Presenter(s):Tara M. Mastracci, MD  
  View Slides in PDF      
8:46 AM - 8:51 AM DEBATE: Nonsense: The Evidence To Support The Success And Durability Of Ch/EVAR Is Solid – If The Procedure Is Done Right: Ch/EVAR Is Better Than F/EVAR In Some Circumstances
  Presenter(s):Konstantinos P. Donas, MD / Jason T. Lee, MD / Giovanni Torsello, MD  
  View Slides in PDF      
8:52 AM - 8:57 AM Parallel Grafts Work Well To Treat Aortic Lesions Involving The Visceral Segment And The Arch: The Mid- And Long-Term Results Demonstrate Durability Although Re-Interventions May Be Required
  Presenter(s):Mario L. Lachat, MD / Felice Pecoraro, MD / Nicola Mangialardi, MD  
  View Slides in PDF      
8:58 AM - 9:03 AM Conformable Sheaths And Other New Techniques To Simplify And Improve The Outcomes Of F/B/EVAR: Upper Extremity Access May Become Largely Unnecessary
  Presenter(s):Joshua D. Adams, MD  
  View Slides in PDF      
9:04 AM - 9:09 AM Comparative Renal Outcomes After F/EVAR, Ch/EVAR And Open Repair: What Is The Best Renal Protective Agent And Regimen
  Presenter(s):Mark A. Farber, MD  
  View Slides in PDF      
9:10 AM - 9:16 AM Panel Discussion
9:16 AM - 9:26 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 48
 
SESSION 49 SCHEDULE
Thursday
SESSION 49: MORE ABOUT F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs
x
9:26 AM - 9:31 AM When Are F/B/EVAR Procedures Better And More Cost Effective Than Open Repairs Of Complex AAAs And TAAAs: The French National Experience
  Presenter(s):Jean-Pierre Becquemin, MD, FRCS  
  View Slides in PDF      
9:32 AM - 9:37 AM 2-Year Comparison Of F/B/EVAR And Ch/EVAR For Complex Aneurysms In A Single Institution: Both Are Effective And Have A Role In Their Treatment: Advantages And Limitations Of Each
  Presenter(s):James F. McKinsey, MD  
  View Slides in PDF      
9:38 AM - 9:43 AM F/B/EVAR For Complex AAA Treatment In High Risk vs. Standard Risk Patients: These Procedures Should Be Used To Treat All Anatomically Suitable Patients
  Presenter(s):Carlos H. Timaran, MD  
  View Slides in PDF      
9:44 AM - 9:49 AM New Findings From The PERICLES Registry Shed Light On Ways To Improve Outcomes Of Parallel Grafts To Treat Complex Aneurysms
  Presenter(s):Konstantinos P. Donas, MD / Jason T. Lee, MD / Mario L. Lachat, MD / Giovanni Torsello, MD / David J. Minion, MD  
  View Slides in PDF      
9:50 AM - 9:55 AM Mid- And Long-Term Data From The PERICLES Registry Show Mortality, Branch Patency And Freedom From Endoleak For Ch/EVAR To Be Similar To Those Of F/EVAR
  Presenter(s):Jason T. Lee, MD / Konstantinos P. Donas, MD  
  View Slides in PDF      
9:56 AM - 10:01 AM Tips And Tricks To Facilitate F/EVAR In Challenging Circumstances
  Presenter(s):Cherrie Z. Abraham, MD  
  View Slides in PDF      
10:02 AM - 10:10 AM Panel Discussion
10:10 AM - 10:15 AM Advantages And Limitations Of Inner Branches In F/B/EVAR
  Presenter(s):Eric L.G. Verhoeven, MD, PhD  
  View Slides in PDF      
10:16 AM - 10:21 AM Preloaded Catheters And Guidewires To Facilitate Branch Access During F/B/EVAR: How Do They Work: Advantages And Disadvantages
  Presenter(s):Timothy A. Resch, MD, PhD  
  View Slides in PDF      
10:22 AM - 10:27 AM How To Overcome Difficult Branch Artery Access In Parallel Grafting Techniques: Tips And Tricks
  Presenter(s):Edward Y. Woo, MD  
  View Slides in PDF      
10:28 AM - 10:33 AM How To Obtain Percutaneous Axillary Access For F/B/EVAR: It Is Not Simple But It Can Be Safe: How To Prevent Bleeding And Nerve Injury
  Presenter(s):Luca Bertoglio, MD / Germano Melissano, MD / Roberto Chiesa, MD  
  View Slides in PDF      
10:34 AM - 10:39 AM Bilateral Common Iliac Aneurysms With Endo Repair Of Complex AAAs Are Troublesome And Associated With Higher Spinal Cord Ischemia And Reintervention Rates
  Presenter(s):Matthew J. Eagleton, MD  
  View Slides in PDF      
10:40 AM - 10:48 AM Panel Discussion
END OF SESSION 49
 
SESSION 50 SCHEDULE
Thursday
SESSION 50: A TRIBUTE TO OUR MILITARY AND SERVICE PHYSICIANS; TOPICS RELATED TO MILITARY HISTORY, A NATIONAL TRAUMA PLAN, VASCULAR TRAUMA, CONTROL OF HEMORRHAGE AND RESUSCITATIVE ENDOVASCULAR BALLOON OCCLUSION OF THE AORTA (REBOA)
x
10:48 AM - 11:00 AM The Battle Of Midway During WW II And The Impact It Had On Our Civilization (12-Minute Talk)
  Presenter(s):Wayne F. Yakes, MD  
  View Slides in PDF      
11:01 AM - 11:08 AM The US Military’s Role In The National Trauma Action Plan To Increase Homeland Security And Our Country’s Response To Mass Casualties (7-Minute Talk)
  Presenter(s):Todd E. Rasmussen, MD, FACS  
  View Slides in PDF      
11:09 AM - 11:16 AM Highlights From The 2018 International Resuscitation Trauma And Bleeding Management (EVTM) Meeting: What Is The EVTM And Why It Is Important (7-Minute Talk)
  Presenter(s):Tal M. Horer, MD, PhD  
  View Slides in PDF      
11:17 AM - 11:24 AM Highlights Of How The US Military Transformed And Improved Combat Casualty Care In Iraq And Afghanistan (7-Minute Talk)
  Presenter(s):Eric A. Elster, MD  
  View Slides in PDF      
11:25 AM - 11:31 AM Progress In Civilian And Military Vascular Trauma Care – Endovascular And Open (6-Minute Talk)
  Presenter(s):Joseph J. DuBose, MD  
  View Slides in PDF      
11:32 AM - 11:38 AM REBOA Is A New Tool For Resuscitation And Treatment For Medical As Well As Hemorrhagic Cardiac Arrest: Who Should Use It And Can It Help Outcomes (6-Minute Talk)
  Presenter(s):Tal M. Horer, MD, PhD  
  View Slides in PDF      
11:39 AM - 11:45 AM The Military’s Experience With Extending The Use Of REBOA To Forward Surgical Settings: How Well Is It Working: Who Is Performing It (6-Minute Talk)
  Presenter(s):Todd E. Rasmussen, MD, FACS  
  View Slides in PDF      
11:46 AM - 11:52 AM Emerging REBOA Technologies: Lower Profile And Improved Balloon Catheters; Simpler Insertion Methods Without Imaging (Fluoro) And Partial Balloon Occlusion Techniques (6-Minute Talk)
  Presenter(s):Joseph J. DuBose, MD  
  View Slides in PDF      
11:53 AM - 12:00 PM Panel Discussion (See Session 85 For More Talks On REBOA)
12:00 PM - 1:00 PM Lunch Break - 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 50
 
SESSION 51 SCHEDULE
Thursday
SESSION 51: RUPTURED AAAs AND TAAAs: RELATED ISSUES AND CONTROVERSIES
x
1:00 PM - 1:05 PM Quality Of Life In Survivors After Open And Endo Repair Of Ruptured AAAs (RAAAs): It Is Better After EVAR
  Presenter(s):Julien G. Sfeir, MD  
  View Slides in PDF      
1:06 PM - 1:11 PM Longer-Term Results Of The IMPROVE RCT (EVAR vs. Open Repair [OR]) Finally Shows EVAR Is Better Than OR For Ruptured RAAAs: In Terms Of Late Survival, Cost And Fewer Amputations
  Presenter(s):Janet T. Powell, MD, PhD / Roger M. Greenhalgh, MD  
1:12 PM - 1:17 PM Why Did It Take So Long To Show The Obvious: EVAR Is Superior To OR For The Treatment Of RAAAs If It Can Be Done
  Presenter(s):Martin Malina, MD, PhD  
  View Slides in PDF      
1:18 PM - 1:23 PM The IMPROVE RCT Shows EVAR Is Superior To OR For RAAA Treatment: What About The Dutch AJAX RCT Long-Term Results Of EVAR vs. OR
  Presenter(s):Willem Wisselink, MD  
  View Slides in PDF      
1:24 PM - 1:29 PM EVAR For RAAAs Is The Best Treatment: All Patients Should Be Treated By Some Endovascular Procedure: The Benefits Are Clear
  Presenter(s):Benjamin W. Starnes, MD  
  View Slides in PDF      
1:30 PM - 1:35 PM With Adjuncts (Chimney Grafts And Onyx) 100% Of RAAAs Can Be Treated By EVAR With Low 30-Day Mortality And Turn Down Rates: Technical Tips
  Presenter(s):Mario L. Lachat, MD / Thomas Larzon, MD, PhD / Dieter O. Mayer, MD  
  View Slides in PDF      
1:36 PM - 1:41 PM Long-Term Survival After EVAR For RAAAs Is Better Than After Open Repair: What Factors Are Predictive
  Presenter(s):Felice Pecoraro, MD / Mario L. Lachat, MD  
  View Slides in PDF      
1:42 PM - 1:47 PM Update On Abdominal Compartment Syndrome (ACS) After EVAR For RAAAs: Its Diagnosis And Treatment Should Be Better Than It Is In Most Centers
  Presenter(s):Martin Bjorck, MD, PhD  
  View Slides in PDF      
1:48 PM - 1:54 PM Panel Discussion
1:54 PM - 1:59 PM DEBATE: There Are Criteria Which Allow Preoperative Prediction Of Certain Non-Survival After EVAR Or OR In RAAA Patients: Invasive Treatment Should Be Denied For Such Patients
  Presenter(s):Benjamin W. Starnes, MD  
  View Slides in PDF      
2:00 PM - 2:05 PM DEBATE: Not So: Non-Survival After EVAR Or OR For RAAAs Cannot Be Predicted With Certainty: Turndown Rates Should Be Extremely Low - Especially If EVAR Is Used For Most Patients
  Presenter(s):Matthew W. Mell, MD, MS  
  View Slides in PDF      
2:06 PM - 2:11 PM What Re-Interventions Have Been Required After EVAR For RAAAs In The IMPROVE Trial: How Common Are Type 2 Endoleaks; How Often Are They Fatal
  Presenter(s):Janet T. Powell, MD, PhD  
  View Slides in PDF      
2:12 PM - 2:17 PM Predictors Of Bowel (Large And Small) Ischemia After EVAR For RAAAs: When Is Colonoscopy Indicated
  Presenter(s):Willem Wisselink, MD  
  View Slides in PDF      
2:18 PM - 2:23 PM Fully Percutaneous EVAR For RAAAs: Advantages, Contraindications And Technical Tips
  Presenter(s):Roy M. Fujitani, MD  
  View Slides in PDF      
2:24 PM - 2:29 PM New Developments In Radioactive Sodium Fluoride (18F-FBG) Imaging On PET CT To Predict AAA And TAAA Growth And Rupture
  Presenter(s):Natzi Sakalihasan, MD, PhD  
  View Slides in PDF      
2:30 PM - 2:35 PM Off-The-Shelf (OTS) Endografts To Treat Ruptured TAAAs: How Often Are They Applicable: Technical Tips And Results
  Presenter(s):Gianluca Faggioli, MD / Mauro Gargiulo, Professor / Andrea Stella, MD  
  View Slides in PDF      
2:36 PM - 2:42 PM Panel Discussion
END OF SESSION 51
 
SESSION 52 SCHEDULE
Thursday
SESSION 52: MORE INTERESTING HOT AORTIC TOPICS
x
2:42 PM - 2:47 PM Sandwich Graft Technique For Treating TAAAs: How To Make It Work Even In Urgent Or Ruptured Cases
  Presenter(s):James F. McKinsey, MD  
  View Slides in PDF      
2:48 PM - 2:53 PM The Best Branch Bridging Stent-Grafts For F/B/EVAR: What Is Available In The US And Elsewhere: Problems And Unmet Needs
  Presenter(s):Timothy A.M. Chuter, DM  
  View Slides in PDF      
2:54 PM - 2:59 PM Value Of Internal Branched Endografts For Treatment Of TAAAs And “Snare Ride” Technique For Difficult Sheath Advancement During F/B/EVAR
  Presenter(s):Marcelo Ferreira, MD  
  View Slides in PDF      
3:00 PM - 3:05 PM Decades Of EVAR RCTs And Registries: What Do They Tell Us Of Value; What Do They Tell Us That Is Wrong; And What Don’t They Tell Us
  Presenter(s):Frank J. Criado, MD, FACS, FSVM  
  View Slides in PDF      
3:06 PM - 3:11 PM Changes In AAA Neck Morphology After Standard EVAR, Ch/EVAR And F/EVAR: There Are Differences And Why
  Presenter(s):Jean-Paul de Vries, MD, PhD  
  View Slides in PDF      
3:12 PM - 3:17 PM Tips And Tricks To Perform Successful Standard EVAR In AAAs With Severely Angled Necks: Neck Length Is Key
  Presenter(s):Boonprasit Kritpracha, MD  
  View Slides in PDF      
3:18 PM - 3:23 PM Technical Tips For Open Retroperitoneal Exposure And Repair Of Complex AAAs: Maneuvers To Make It Relatively Simple
  Presenter(s):R. Clement Darling III, MD  
  View Slides in PDF      
3:24 PM - 3:32 PM Panel Discussion
3:33 PM - 3:46 PM Break - Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 52
 
SESSION 53 SCHEDULE
Thursday
SESSION 53: NEW TECHNIQUES, TREATMENTS, TECHNOLOGIES AND UPDATES IN TELEMEDICINE, RENAL PROTECTION, ROBOTICS, ETC.
x
3:46 PM - 3:51 PM Robotic Assisted Left Renal Vein Transposition For The Treatment Of Nutcracker Syndrome (Video)
  Presenter(s):Samuel R. Money, MD, MBA  
  View Slides in PDF      
3:52 PM - 3:57 PM Telehealth Methods To Improve The Care And Follow-Up Of Vascular Patients: Current Status And Future Potential
  Presenter(s):John (Jeb) W. Hallett, MD  
  View Slides in PDF      
3:58 PM - 4:03 PM Value Of Cloud Based Telemedicine To Treat Vascular Patients: Especially In Emergencies Like RAAAs Or Thoracic Aneurysms And Dissections
  Presenter(s):Nobuyoshi Azuma, MD  
  View Slides in PDF      
4:04 PM - 4:09 PM Wearable Technologies And Telemonitoring For Vascular Diseases: How To Keep Vascular Patients Out Of Hospitals
  Presenter(s):Celia Riga, BSc, MBBS, MD, FRCS  
  View Slides in PDF      
4:10 PM - 4:15 PM Why Is Genetic Susceptibility To Radiation Injury Important For Doctors, Staff And Patients: How Can It Be Assessed And What Can Be Done About It
  Presenter(s):Kieran Murphy, MD  
  View Slides in PDF      
4:16 PM - 4:21 PM NaHCO3 Plus Hydration Decreases Acute Kidney Failure After EVAR: Based On A Pilot RCT (The HYDRA Trial) Comparing It To Hydration Alone: Why Is It Different From Other Negative NaHCO3 RCTs
  Presenter(s):Asif Mahmood, MD, FRCS  
  View Slides in PDF      
4:22 PM - 4:27 PM Status Of Left Atrial Appendage Exclusion (Endo And Open) For Stroke Prevention With Atrial Fibrillation: Techniques And Results
  Presenter(s):Ali Khoynezhad, MD, PhD  
  View Slides in PDF      
4:28 PM - 4:33 PM Present Status Of The Use Of EVAR Devices For The Treatment Of Aorto-Iliac Occlusive Disease
  Presenter(s):Jonathan A. Cardella, MD  
  View Slides in PDF      
4:34 PM - 4:39 PM Why Iliac Branched Devices (IBDs) Do Not Decrease The Incidence Of Ischemic Colitis After Iliac Aneurysm Treatment: Micro-Emboli Not Ischemia Are A Major Cause Of Colon Necrosis In This Setting
  Presenter(s):Robyn A. Macsata, MD  
  View Slides in PDF      
4:40 PM - 4:45 PM Panel Discussion
END OF SESSION 53
 
SESSION 54 SCHEDULE
Thursday
SESSION 54: NEW CONDITIONS, IDEAS, UPDATED CONCEPTS AND RADIATION SAFETY (4 ½ MINUTE FAST PACED TALKS)
x
4:45 PM - 4:50 PM The Value Of Mesh Augmentation To Prevent Incisional Hernias After Open AAA Repair: The AIDA RCT Shows It Works
  Presenter(s):Sebastian E. Debus, MD, PhD  
  View Slides in PDF      
4:50 PM - 4:55 PM Radiation Induced Arterial Disease Causing CLTI: Endovascular Treatments Are Often Effective
  Presenter(s):Palma M. Shaw, MD  
  View Slides in PDF      
4:55 PM - 5:00 PM Operation “Grey Doc”: Using Retired Vascular Surgeons To Train Residents
  Presenter(s):Niten Singh, MD  
  View Slides in PDF      
5:00 PM - 5:05 PM Thin May Be In, But Fat Is Where It’s At: The Obesity Paradox With Vascular Surgical Procedures: Why Moderately Obese Patients Have Better Outcomes
  Presenter(s):Bruce A. Perler, MD, MBA  
  View Slides in PDF      
CCSVI-CURRENT STATUS
5:05 PM - 5:10 PM Update On Chronic Cerebrospinal Venous Insufficiency (CCSVI): Although The BRAVE DREAMS RCT Showed No Benefit For Balloon Venoplasty vs. Sham Control, The CCSVI Concept May Have Value In Multiple Sclerosis (MS) Treatment
  Presenter(s):Paolo Zamboni, MD  
  View Slides in PDF      
5:10 PM - 5:15 PM Why Venous Balloon Angioplasty Still Has A Role In The Treatment Of MS: Patient Selection
  Presenter(s):Donald B. Reid, MD  
  View Slides in PDF      
5:15 PM - 5:20 PM When Is MS Treatable By Venous Interventions: Why The BRAVE DREAMS RCT Is Misleading
  Presenter(s):Ivo Petrov, MD, PhD  
  View Slides in PDF      
5:20 PM - 5:25 PM How Does Relief Of Venous Congestion By Venous Angioplasty Relieve Intractable Headaches In Some Patients: How To Select Them
  Presenter(s):Sergio Gianesini, MD, PhD / Pierfrancesco Veroux, MD  
  View Slides in PDF      
5:25 PM - 5:30 PM Panel Discussion
PROGRESS IN RADIATION SAFETY (5-MINUTE TALKS)
5:30 PM - 5:35 PM New Developments In Radiation Safety: How Good Or Bad Is Radiation Protection Gear (Caps And Light-Weight Lead Gowns): Importance Of Gantry Angle In Radiation Exposure
  Presenter(s):Lindsay Machan, MD  
  View Slides in PDF      
5:36 PM - 5:41 PM Proper Use Of Shields Protects The Eyes From Radiation Damage Whereas Leaded Glasses Do So Poorly
  Presenter(s):Anders Wanhainen, MD, PhD  
  View Slides in PDF      
5:42 PM - 5:47 PM Radiation To Operators During Complex And Standard EVAR Can Cause Cellular DNA Damage: What Is The Significance And What Can Be Done To Lessen It
  Presenter(s):Bijan Modarai, PhD, FRCS  
  View Slides in PDF      
5:48 PM - 5:53 PM How To Decrease Radiation Exposure To Operators And Assistants During Standard And Complex EVARs
  Presenter(s):Gustavo S. Oderich, MD, FACS  
  View Slides in PDF      
5:54 PM - 5:59 PM New Techniques To Decrease Radiation Exposure To Surgeons And Staff During Complex Aortic Procedures
  Presenter(s):Mark A. Farber, MD  
  View Slides in PDF      
6:00 PM - 6:05 PM Panel Discussion
End of Program H
END OF SESSION 54
 
SESSION 55 SCHEDULE
Thursday
SESSION 55: NEW OR UPDATED DEVICES FOR STANDARD EVAR, F/EVAR AND ILIAC BRANCHED DEVICES (IBDs) (4 ½ MINUTE FAST PACED TALKS)
x
NEW OR UPDATED EVAR DEVICES
6:40 AM - 6:45 AM EVAR Device With More Cranial Sealing Rings And A New Polymer (From Endologix): Status Of The ALTO Device
  Presenter(s):Sean P. Lyden, MD  
  View Slides in PDF      
6:45 AM - 6:50 AM The Ovation Endograft Is An Effective Option For EVAR In Patients With Complex Neck Anatomy Unfit For FEVAR
  Presenter(s):Gianmarco de Donato, MD  
  View Slides in PDF      
6:50 AM - 6:55 AM Multicenter Italian Results With The Ovation Endograft For EVAR: Advantages And Limitations: From The EXTREME Trial
  Presenter(s):Laura Capoccia, MD, PhD / Francesco Speziale, MD  
  View Slides in PDF      
6:55 AM - 7:00 AM Value And 4-Year Results Of The Ovation Endograft For EVAR In Women: The Low Profile Makes A Difference
  Presenter(s):Martin Storck, MD, PhD  
  View Slides in PDF      
7:00 AM - 7:05 AM The Altura Double D Endograft Device For EVAR: Advantages, Limitations And 4-Year Results
  Presenter(s):Dainis K. Krievins, MD  
  View Slides in PDF      
7:05 AM - 7:10 AM Update On The Treovance Endograft (Terumo Aortic) For EVAR: Advantages And Results From The RATIONALE Registry
  Presenter(s):Vicente Riambau, MD, PhD  
  View Slides in PDF      
7:10 AM - 7:15 AM Panel Discussion
UPDATE ON ILIAC BRANCH DEVICES TO REVASCULARIZE HYPOGASTRIC ARTERIES
7:15 AM - 7:20 AM Propensity Matched Comparison Of 2 IBDs (1 From Cook And 1 From Gore): Advantages And Limitations Of Each
  Presenter(s):Carlo Pratesi, MD / Giovanni Pratesi, MD  
  View Slides in PDF      
7:20 AM - 7:25 AM New Information With Longer Follow-Up From The Multicenter Trial Of The Gore IBD For Iliac Aneurysms
  Presenter(s):Darren B. Schneider, MD  
  View Slides in PDF      
7:25 AM - 7:30 AM Technical Tips And Multicenter Results With The Use Of Bilateral Gore IBDs In Patients With Bilateral Common Iliac Aneurysms
  Presenter(s):Thomas S. Maldonado, MD  
  View Slides in PDF      
7:30 AM - 7:35 AM 12-Year Experience With The Cook IBD Show Its Effectiveness And Durability: How To Improve The Poor Results Of Others When There Are Associated Hypogastric Aneurysms: From The pELVIS Registry
  Presenter(s):Giovanni F. Torsello, MD / Giovanni Torsello, MD / Konstantinos P. Donas, MD  
  View Slides in PDF      
7:35 AM - 7:40 AM New Developments With The Cook IBD: Experience And Results In >900 Patients: Which Bridging Endograft To The Hypogastric Artery Is Best
  Presenter(s):Fabio Verzini, MD, PhD / Piergiorgio Cao, MD, FRCS  
  View Slides in PDF      
7:40 AM - 7:45 AM Results Of IBDs To Treat Isolated Iliac Artery Aneurysm: When Is It Possible And When Is It Not
  Presenter(s):Giovanni Pratesi, MD  
  View Slides in PDF      
7:45 AM - 7:50 AM Tips And Tricks To Treat With An IBD Common Iliac Aneurysms Developing After An EVAR Procedure: It Is Not Simple
  Presenter(s):James F. McKinsey, MD  
  View Slides in PDF      
7:50 AM - 7:55 AM Panel Discussion
7:55 AM - 8:00 AM 15-Year Outcomes With Zenith Endografts For Standard Infrarenal EVAR: The Grafts Are Durable
  Presenter(s):Jade S. Hiramoto, MD  
  View Slides in PDF      
8:00 AM - 8:05 AM Update On The Fenestrated Anaconda Endograft For F/EVAR: Worldwide Experience From The GLOBAL FACT Registry
  Presenter(s):Clark J. Zeebregts, MD, PhD  
  View Slides in PDF      
8:05 AM - 8:10 AM Advantages Of The Gore Excluder Conformable Device (CEXC Device) For EVAR With Unfavorable Neck Anatomy: The European Experience From The EXCEL Registry
  Presenter(s):Marc R.H.M. van Sambeek, MD, PhD  
  View Slides in PDF      
8:10 AM - 8:15 AM Early Experience With The New Gore Conformable Excluder With Active Neck Angulation Control: It Provides Better Treatments For AAAs With Severely Angled Necks: How It Works And IDE Trial Results
  Presenter(s):Robert Y. Rhee, MD  
  View Slides in PDF      
8:15 AM - 8:20 AM How To Treat Failed Open AAA Repairs And Failed EVARs With The Cook ZFEN Device: Indications, Contraindications And Technical Tips
  Presenter(s):Andres Fajardo, MD  
  View Slides in PDF      
8:20 AM - 8:25 AM Panel Discussion
END OF SESSION 55
 
SESSION 56 SCHEDULE
Thursday
SESSION 56: NEW AND UPDATED DEVICES FOR ENDOVASCULAR ANEURYSM SEALING (EVAS) AND EVAR FOR STANDARD AND COMPLEX AAAs (4 ½-MINUTE FAST PACED TALKS)
x
8:25 AM - 8:30 AM Downsides (Disadvantages) And Upsides (Advantages) Of Low Profile Devices For EVAR And TEVAR: There Are Tradeoffs
  Presenter(s):Michel Makaroun, MD  
  View Slides in PDF      
NEW DEVELOPMENTS IN EVAS
8:30 AM - 8:35 AM Update On The Nellix Endograft For EVAS: How Has Refinement Of The IFU Improved Outcomes: From The FORWARD IDE Trial
  Presenter(s):Jeffrey P. Carpenter, MD  
  View Slides in PDF      
8:35 AM - 8:40 AM Importance Of Good Seal Zones And Procedural Accuracy In Getting Good Results With Nellix Endografts And EVAS
  Presenter(s):Matt M. Thompson, MD  
  View Slides in PDF      
8:40 AM - 8:45 AM How Does EVAS With The Nellix Device Perform For Treating AAAs In Women: Data From The DEVASS Group
  Presenter(s):Jan M.M. Heyligers, MD, PhD, FEBVS  
  View Slides in PDF      
8:45 AM - 8:50 AM Worldwide Update On The Nellix Endograft For EVAS: From The GLOBAL 2 Registry And EVAS IDE 2 Trial: Both Assess New Improvements In The Device And Its IFU
  Presenter(s):Andrew Holden, MBChB  
  View Slides in PDF      
8:50 AM - 8:55 AM Value And Limitations Of Using The Nellix Endograft And EVAS To Treat Ruptured AAAs
  Presenter(s):Tal M. Horer, MD, PhD / Thomas Larzon, MD, PhD  
  View Slides in PDF      
8:55 AM - 9:00 AM Nellix-In-Nellix With Proximal Extension For Failed EVAS: Technique And Multicenter Results
  Presenter(s):Michel M.P. Reijnen, MD, PhD  
  View Slides in PDF      
9:00 AM - 9:05 AM How To Preserve Hypogastric Flow With Iliac Aneurysms When Using Nellix EVAS: Technique And Results
  Presenter(s):Dainis K. Krievins, MD  
  View Slides in PDF      
9:05 AM - 9:10 AM Panel Discussion
9:10 AM - 9:15 AM All-Cause Mortality Is Lower After EVAS Than Standard EVAR: Possible Mechanisms: Is It Because Of A Decreased Post-Implant Inflammatory Response
  Presenter(s):Marc L. Schermerhorn, MD  
  View Slides in PDF      
9:15 AM - 9:20 AM The ZFEN And ZFEN Plus Endografts From Cook For F/EVAR: Changes In The ZFEN Plus And Its Advantages, Limitations And Status In The US And Elsewhere
  Presenter(s):Jason T. Lee, MD  
  View Slides in PDF      
9:20 AM - 9:25 AM Long-Term Results With The Zenith Alpha AAA Endograft (From Cook): A Low Profile EVAR Device That Is Working
  Presenter(s):Thomas L. Forbes, MD  
  View Slides in PDF      
9:25 AM - 9:30 AM Latest 5-Year Results With The INCRAFT Device (From Cordis/Cardinal Health) For Standard EVAR: Advantages And Limitations
  Presenter(s):Andrej Schmidt, MD / Giovanni Torsello, MD  
  View Slides in PDF      
9:30 AM - 9:35 AM Update On The Cook P-Branch OTS Device For Treating Juxta- And Pararenal AAAs: Value, Limitations And Results
  Presenter(s):Mark A. Farber, MD  
  View Slides in PDF      
9:35 AM - 9:40 AM Panel Discussion
9:40 AM - 9:55 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 56
 
SESSION 57 SCHEDULE
Thursday
SESSION 57: NEW DEVICES FOR TREATMENT OF ASCENDING AORTIC AND ARCH LESIONS AND AORTIC DISSECTIONS; TEVAR AND Ch/TEVAR (4 ½ MINUTE FAST PACED TALKS)
x
9:55 AM - 10:00 AM Updated Experience With The Nexus Device For Treating Aortic Arch Lesions: How Does It Work And Midterm Results
  Presenter(s):Sonia Ronchey, MD, PhD / Nicola Mangialardi, MD / Matteo Orrico, MD / Mario L. Lachat, MD  
  View Slides in PDF      
10:00 AM - 10:05 AM Current Status Of Endovascular Treatment Of Ascending Aorta And Arch Lesions: Experience With The Cook And Terumo Aortic Arch Branch Devices And Parallel Grafts
  Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS  
  View Slides in PDF      
10:05 AM - 10:10 AM Update On The Advantages, Limitations And Midterm Results With The Terumo Aortic 3 Branch Arch Device: What Lesions Can It Treat
  Presenter(s):W. Anthony Lee, MD  
  View Slides in PDF      
10:10 AM - 10:15 AM Experience With The New Terumo Aortic Relay Plus DB (Double Branched) Device To Treat Arch Lesions: What Makes It Different And Early Results
  Presenter(s):Herve Rousseau, MD, PhD  
  View Slides in PDF      
10:15 AM - 10:20 AM Update On Experience With The Valiant MONA LSA Single Branched TEVAR Device (From Medtronic) To Treat Lesions Involving The Aortic Arch
  Presenter(s):Eric E. Roselli, MD / Frank R. Arko, MD  
  View Slides in PDF      
10:20 AM - 10:25 AM Panel Discussion
10:25 AM - 10:30 AM 4-Year Experience With The Zenith Alpha Low Profile Endograft For TEVAR: Advantages And Results
  Presenter(s):Germano Melissano, MD / Giovanni Torsello, MD / Eric L.G. Verhoeven, MD, PhD  
  View Slides in PDF      
10:30 AM - 10:35 AM New Medtronic Valiant™ Navion Low Profile Endograft For TEVAR: Advantages And Results
  Presenter(s):Fabio Verzini, MD, PhD  
  View Slides in PDF      
10:35 AM - 10:40 AM Terumo Aortic Relay Thoracic Endograft For TEVAR In Complex Aortic Pathology With Angles >90°: Advantages And Results
  Presenter(s):Patrick E. Muck, MD, FACS  
  View Slides in PDF      
10:40 AM - 10:45 AM Advances For Endograft Treatment Of Type A Aortic Dissections: Why And How Are The Next Generation Endografts Better
  Presenter(s):Naoki Fujimura, MD, PhD  
  View Slides in PDF      
10:45 AM - 10:50 AM Special Features Of The Cook Zenith Dissection Specific Endograft (TX2) For Treating TBADs: How Does It Decrease Retrograde Type A Dissections And Other Advantages
  Presenter(s):Bijan Modarai, PhD, FRCS  
  View Slides in PDF      
10:50 AM - 10:55 AM Stent-Graft Induced New Entry Tears (SINETs) Are Common Proximally And Distally After TEVAR For TBADs – Especially With Connective Tissue Disease: Cook Has A New Dissection Specific Endograft To Decrease These SINETs: How Does It Work
  Presenter(s):Anders Wanhainen, MD, PhD  
  View Slides in PDF      
10:55 AM - 11:00 AM Panel Discussion
END OF SESSION 57
 
SESSION 58 SCHEDULE
Thursday
SESSION 58: NEW DEVICES OR TECHNIQUES FOR THORACIC AORTIC LESIONS OR TAAAs (4 ½ MINUTE FAST PACED TALKS)
x
11:00 AM - 11:05 AM Update On The Terumo Aortic Relay Thoracic Stent-Graft System For TEVAR: How Important Is Stiffness Of The Device In Determining Ease Of Deployment And Outcomes: Why Relay Is Superior
  Presenter(s):Vicente Riambau, MD, PhD  
  View Slides in PDF      
11:05 AM - 11:10 AM Gore TAG Conformable Thoracic Aortic Endograft With Active Control Of Proximal Angulation: How It Works; Advantages And Results: From The SURPASS Trial
  Presenter(s):Giovanni Torsello, MD / Martin J. Austermann, MD  
  View Slides in PDF      
11:10 AM - 11:15 AM When Should The Left Subclavian Artery (LSA) Be Revascularized And When Can It Be Covered During TEVAR: Update From National Inpatient Sample
  Presenter(s):Wayne W. Zhang, MD  
  View Slides in PDF      
11:15 AM - 11:20 AM Why The “Stabilize Technique” With Overexpansion Of The Distal Uncovered Stent Component Of The Petticoat Endograft (Proximal Covered, Distal Uncovered) Is A Major Advance In Treating TBADs: When And How To Do It
  Presenter(s):Germano Melissano, MD  
  View Slides in PDF      
11:20 AM - 11:25 AM The “Turtle Heading Technique” For Improving Endograft Fixation And Sealing Of TEVARs In Patients With Lesions That Have Difficult Or Short Necks: How Does It Work And Results
  Presenter(s):Jerry Matteo, MD  
  View Slides in PDF      
11:25 AM - 11:30 AM Panel Discussion
NEW ENDOGRAFT DEVICES FOR TAAAS
11:30 AM - 11:35 AM Update On The Gore Excluder TAMBE Multibranched Endovascular Device For Treating TAAAs: Recent Technical Modifications And Clinical Experience
  Presenter(s):Mark A. Farber, MD / Gustavo S. Oderich, MD, FACS  
  View Slides in PDF      
11:35 AM - 11:40 AM Expanding The Role Of The OTS t-Branch Multibranched Device From Cook For Treating TAAAs Endovascularly
  Presenter(s):Marcelo Ferreira, MD  
  View Slides in PDF      
11:40 AM - 11:45 AM How To Perform Endograft Repair Of TAAAs Using Branched Endografts Entirely Via Femoral Access: The Secret Is The Use Of Steerable Sheaths
  Presenter(s):Tilo Koelbel, MD, PhD  
  View Slides in PDF      
11:45 AM - 11:50 AM Value Of An OTS t-Branched Graft To Treat TAAAs: How Often Is It Possible Based On Results From 3 Large Centers
  Presenter(s):Michel J. Bosiers, MD  
  View Slides in PDF      
11:50 AM - 11:55 AM Use Of A Power Wire To Create Fenestrations In A Dissection Flap To Access And Stent Branches Arising From The False Lumen: How To Do It And Equipment Required
  Presenter(s):Thomas F. Lindsay, MDCM, FRCS, FACS  
  View Slides in PDF      
11:55 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break - 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 58
 
SESSION 59 SCHEDULE
Thursday
SESSION 59: NEW OR IMPROVED DEVICES FOR TREATING LOWER EXTREMITY LESIONS: STENT-GRAFTS; OTHER ENDOVASCULAR TREATMENTS; PROSTHETIC ARTERIAL GRAFTS; HEPARIN COATED PROSTHETIC GRAFTS
x
NEW STENT-GRAFTS
1:00 PM - 1:05 PM Viabahn BX Balloon Expandable Stent-Graft (Gore) For SFA Lesions: Indications And 2-Year Results: Advantages And Limitations
  Presenter(s):D. Christopher Metzger, MD   
  View Slides in PDF      
1:06 PM - 1:11 PM Advantages Of Various Covered Stents In The CERAB Procedure For Aorto-Iliac Occlusive Lesions: What Stent-Grafts Work Best In Ch/CERAB Procedures
  Presenter(s):Peter C.J. Goverde, MD / Michel M.P. Reijnen, MD, PhD  
1:12 PM - 1:17 PM Advantages Of The Gore VBX Balloon Expandable Stent-Graft For F/EVAR, Ch/EVAR And Aorto-Iliac Occlusive Disease
  Presenter(s):James F. McKinsey, MD  
  View Slides in PDF      
1:18 PM - 1:23 PM Many New Balloon Expandable Stent-Grafts Are Now Available: Why Are They Different: Which Is Best For Various Uses: What About The BeGraft And BeGraft Plus From Bentley
  Presenter(s):Eric L.G. Verhoeven, MD, PhD  
  View Slides in PDF      
1:24 PM - 1:29 PM Panel Discussion
1:29 PM - 1:34 PM The Phoenix Hybrid Atherectomy System: How It Works And Why It Is Different And Possibly Better Than Older Atherectomy Systems: Indications And Initial Results
  Presenter(s):George L. Adams, MD  
  View Slides in PDF      
1:35 PM - 1:40 PM Endovascular Treatment Of Chronically Occluded Saphenous Vein Grafts: A New Treatment Horizon That Can Be Effective: Techniques And Results
  Presenter(s):Claudio Rabbia, MD  
  View Slides in PDF      
1:41 PM - 1:46 PM Value Of Drug Eluting Stents (DESs) To Salvage Failed Or Failing Vein Grafts
  Presenter(s):Benjamin M. Jackson, MD  
  View Slides in PDF      
1:47 PM - 1:52 PM Comparable Long-Term (4-Year) Outcomes Of Grafts Of Greater Saphenous Vein And PTFE With Bonded Heparin (Propaten) For Tibial Artery Bypasses: Does A Distal Vein Patch Make A Difference
  Presenter(s):Peter H. Lin, MD  
  View Slides in PDF      
1:53 PM - 1:58 PM Are Fempop Bypasses With Heparin Bonded PTFE (Propaten) Durable Treatment For Long SFA-Pop Occlusions: When Are They The Best Treatment And Why
  Presenter(s):Walter Dorigo, MD / Carlo Pratesi, MD / Raffaele Pulli, MD  
  View Slides in PDF      
1:59 PM - 2:04 PM Panel Discussion
END OF SESSION 59
 
SESSION 60 SCHEDULE
Thursday
SESSION 60: NEW OR IMPROVED DEVICES AND DEVELOPMENTS FOR LOWER EXTREMITY ENDOVASCULAR TREATMENT: STENTS, BALLOONS, DCBs, DESs AND TACKS
x
2:04 PM - 2:09 PM The Flex Scoring Catheter (From Ventura Med): A Simple Cost-Effective Method For Lesion Preparation Prior To DCB Use: How It Works, Advantages And Early Results
  Presenter(s):Thomas Zeller, MD  
  View Slides in PDF      
2:10 PM - 2:15 PM The Serranator Balloon Catheter (From Cagent Vascular) To Score Lesions, Facilitate Their Dilatation Without Dissection And Possibly Improve Drug Delivery: How It Works And Results Of The PRELUDE Trial
  Presenter(s):William A. Gray, MD / Krishna J. Rocha-Singh, MD / Andrew Holden, MBChB / Thomas Zeller, MD  
  View Slides in PDF      
2:16 PM - 2:21 PM The Vanguard IEP Balloon PTA System With An Integrated Embolic Protection Filter: How It Works And When It Should Be Used
  Presenter(s):Thomas Zeller, MD  
  View Slides in PDF      
2:22 PM - 2:27 PM The Tigris Dual Component Stent (From Gore): Advantages And 1-Year Results In Treating SFA-Pop Occlusive Lesions: From The Austrian Registry
  Presenter(s):Martin Werner, MD  
  View Slides in PDF      
2:28 PM - 2:33 PM More About The Value And Limitations Of The Tigris Dual Component Stent For SFA-Pop Lesion Treatment: What Makes It Different
  Presenter(s):Maria Antonella Ruffino, MD, EBIR  
  View Slides in PDF      
2:34 PM - 2:39 PM Update On The Value Of The Bullfrog Catheter (From Mercator Medical Systems) To Infuse Dexamethasone Into The Adventitia Of Lesions: Status And Results Of The DANCE Trial And The LIMBO-ATX RCT In Patients With CLTI Due To BTK Lesions
  Presenter(s):George L. Adams, MD  
  View Slides in PDF      
2:40 PM - 2:45 PM Update On The Value Of Tack Assisted Balloon Angioplasty (TOBA) (From Intact Vascular): Results Of The TOBA II Study: Do The Tacks Improve PTA Patency In The Femoropopliteal Segment
  Presenter(s):Marianne Brodmann, MD / Christian Wissgott, MD / William A. Gray, MD  
  View Slides in PDF      
2:46 PM - 2:52 PM Panel Discussion
MORE ABOUT NEW OR IMPROVED STENTS AND DCBS
2:52 PM - 2:57 PM The Advantages Of The BioMimics 3D Helical Swirling Flow Stent (Veryan Medical): How It Works And Why It Is Better Than Straight Stents
  Presenter(s):Peter Gaines, MD  
  View Slides in PDF      
2:58 PM - 3:03 PM Update On The BioMimics 3D Helical Swirling Flow Stent: The MIMICS-2 Trial Results Show It Works Well With Complex Lesions (CTOs, Heavy Calcification And Long Lesions)
  Presenter(s):Timothy M. Sullivan, MD  
  View Slides in PDF      
3:04 PM - 3:09 PM Based On 3-Year Results, Supera Interwoven Biomimetic Stents (From Abbott) Are Superior For Treating Lesions In Angulated Arteries And Those In The CFA
  Presenter(s):Rajiv Parakh, MBBS, MS, FRCS  
  View Slides in PDF      
3:10 PM - 3:15 PM Value And Limitations Of The New Smart Flex Stent (From Cordis/Cardinal Health) In Treating Lower Extremity And Iliac Artery Occlusive Lesions
  Presenter(s):Peter C.J. Goverde, MD  
3:16 PM - 3:21 PM Progress In Developing A Site Specific Self-Expanding DES For Use In The Crural Arteries: The SAVAL Trial
  Presenter(s):Miguel F. Montero-Baker, MD / 
  View Slides in PDF      
3:22 PM - 3:27 PM Experimental And Preclinical Advantages Of A New DCB (From Abbott): The Surmodics DCB
  Presenter(s):Renu Virmani, MD / Aloke Finn, MD  
  View Slides in PDF      
3:28 PM - 3:33 PM 1-Year Results With The New Kanshas DCB (From Terumo): What Makes It Different And Potentially Better
  Presenter(s):Michael K.W. Lichtenberg, MD  
  View Slides in PDF      
3:34 PM - 3:40 PM Panel Discussion
3:40 PM - 3:54 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 60
 
SESSION 61 SCHEDULE
Thursday
SESSION 61: NEW OR IMPROVED DEVICES AND DEVELOPMENTS TO TREAT ENDOLEAKS AND PREVENT MIGRATION: ENDOANCHORS
x
3:54 PM - 3:59 PM 2-Year Results From The ANCHOR Registry Show When Endoanchors (Medtronic) Should Be Used: How They Improve EVAR Results And When They Can Salvage Failed EVARs
  Presenter(s):William D. Jordan Jr., MD / Jean-Paul de Vries, MD, PhD  
  View Slides in PDF      
4:00 PM - 4:05 PM Which Ugly AAA Necks Can Be Treated By Standard EVAR Devices Plus Endoanchors And Which Cannot: What Are The Failure Modes Of Endoanchors And How To Avoid Them
  Presenter(s):Jean-Paul de Vries, MD, PhD  
  View Slides in PDF      
4:06 PM - 4:11 PM 2-Year ANCHOR Registry Data Show That Endoanchors Can Prevent Neck Dilatation After EVAR With Self-Expanding Devices
  Presenter(s):Apostolos K. Tassiopoulos, MD  
  View Slides in PDF      
4:12 PM - 4:17 PM Tips And Tricks To Use Endoanchors Optimally And Avoid Failures
  Presenter(s):Giovanni Pratesi, MD  
  View Slides in PDF      
4:18 PM - 4:23 PM Why Does Cranial Migration Occur With Thoracic Endografts: How Can Endoanchors Prevent It If Used Appropriately
  Presenter(s):Vicente Riambau, MD, PhD  
  View Slides in PDF      
4:24 PM - 4:29 PM Endoanchors Can Improve The Outcomes Of Difficult TEVARs: What Is The Proof They Really Help And How To Use Them
  Presenter(s):Jean M. Panneton, MD  
  View Slides in PDF      
4:30 PM - 4:35 PM How To Use Endoanchors To Treat Type 1 Endoleaks After TEVAR And EVAR
  Presenter(s):Colin D. Bicknell, MD FRCS  
  View Slides in PDF      
4:36 PM - 4:42 PM Panel Discussion
END OF SESSION 61
 
SESSION 62 SCHEDULE
Thursday
SESSION 62: NEW OR UPDATED DEVICES OR TECHNIQUES FOR REMOVING IATROGENIC OR DISEASE GENERATED CLOT
x
4:42 PM - 4:47 PM More Effective Techniques Of Thrombolysis With Microbubbles And Ultrasound: Feasibility, Safety And Effectiveness In A Clinical Study (The MUST Trial)
  Presenter(s):Kak Khee Yeung, MD, PhD  
  View Slides in PDF      
4:48 PM - 4:53 PM Advantages And Limitations Of The Various Pharmaco-Mechanical Thrombectomy Devices: When And Why Is Each Device The Best One To Use
  Presenter(s):Guillermo A. Escobar, MD  
  View Slides in PDF      
4:54 PM - 4:59 PM Improved Endovascular Mechanical Vacuum Assisted Indigo Clot Extraction System From Penumbra: When Is It The Treatment Of Choice For Arterial Thrombo-Embolectomy: From The PRISM Trial
  Presenter(s):James F. Benenati, MD  
  View Slides in PDF      
5:00 PM - 5:05 PM Vacuum Assisted Thrombectomy With The Penumbra Indigo System For Visceral And Lower Limb Artery Occlusions
  Presenter(s):Michele Rossi, MD  
  View Slides in PDF      
5:06 PM - 5:11 PM Single Session Continuous Aspiration Thrombectomy With The Penumbra Indigo System For Occluded Aortic Stent Grafts And Limbs: Technical Tips, Precautions And Results
  Presenter(s):Patrick E. Muck, MD, FACS  
  View Slides in PDF      
5:12 PM - 5:17 PM Vacuum Assisted Catheter Based Thrombo-Embolectomy For Acute Limb Ischemia (ALI): How Does It Work And Results: From The INDIAN Registry
  Presenter(s):Gianmarco de Donato, MD  
  View Slides in PDF      
5:18 PM - 5:23 PM New Techniques In Endovascular Aspiration Thrombectomy: The World Has Changed For Treatment And Rescue Clot Extraction With Penumbra Indigo Suction Devices In Various Vascular Beds
  Presenter(s):Claudio J. Schonholz, MD  
  View Slides in PDF      
5:24 PM - 5:29 PM Tips And Tricks For Thrombo-Embolectomy For Clot Removal From All Arteries Using The Indigo System: How To Measure Success
  Presenter(s):Scott L. Stevens, MD  
  View Slides in PDF      
5:30 PM - 5:35 PM Simplifying Treatment Of ALI With The Use Of The Indigo Thrombectomy System: When Is Open Surgery Required
  Presenter(s):Mazin Foteh, MD  
  View Slides in PDF      
5:36 PM - 5:44 PM Panel Discussion
End of Program I
END OF SESSION 62
 
SESSION 63 SCHEDULE
Thursday
SESSION 63: VENOUS CLINICAL EXAMINATION AND HEMODYNAMICS
x
7:00 AM - 7:04 AM Introduction To Veins At VEITH
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
7:05 AM - 7:10 AM Classification Of Chronic Venous Disease: CEAP, VCSS And Beyond
  Presenter(s):Marc A. Passman, MD  
  View Slides in PDF      
7:11 AM - 7:16 AM Prevalence And Risk Factors For The Chronic Venous Disease – ZEUS Study
  Presenter(s):Tomasz Urbanek, MD, PhD  
  View Slides in PDF      
7:17 AM - 7:22 AM Venous Flow And Pressure-Modern Concepts
  Presenter(s):Seshadri Raju, MD  
  View Slides in PDF      
7:23 AM - 7:28 AM Physiology Of Venous Return
  Presenter(s):Brajesh K. Lal, MD  
  View Slides in PDF      
7:29 AM - 7:34 AM Lower Limb Venous Kinetics And Impact On Venous Drainage
  Presenter(s):Sergio Gianesini, MD, PhD  
  View Slides in PDF      
7:35 AM - 7:40 AM Summary Of Thermal Ablation RCTs
  Presenter(s):Bo G. Eklof, MD, PhD  
  View Slides in PDF      
7:41 AM - 7:46 AM Venous Symptoms Consensus (SYM Vein)
  Presenter(s):Armando Mansilha, MD, PhD, FEBVS  
  View Slides in PDF      
7:47 AM - 7:52 AM Understanding Effects Of External Positive And Negative Pressure On The Venous System
  Presenter(s):Seshadri Raju, MD  
  View Slides in PDF      
7:53 AM - 7:58 AM Evidence Summary On The Pathophysiology Of Varicose Veins
  Presenter(s):Thomas W. Wakefield, MD  
  View Slides in PDF      
7:59 AM - 8:04 AM What Is The Significance Of Venous Signs And Symptoms In Chronic Venous Disease
  Presenter(s):Andrew N. Nicolaides, MS, FRCS  
  View Slides in PDF      
8:05 AM - 8:10 AM Quality Of Life Tools Reflect Disease Severity, But They Can Be Improved
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh  
  View Slides in PDF      
8:11 AM - 8:16 AM Analysis Of Biofluids From Patients With CVD
  Presenter(s):Sarah Onida, MD, PhD  
  View Slides in PDF      
8:17 AM - 8:22 AM Panel Discussion
END OF SESSION 63
 
SESSION 64 SCHEDULE
Thursday
SESSION 64: VENOUS IMAGING TECHNIQUES
x
8:23 AM - 8:28 AM Optimization Of Duplex Exam Image
  Presenter(s):Jan M. Sloves, RVT  
  View Slides in PDF      
8:29 AM - 8:34 AM Can You Predict Venous Severity Based On Reflux Time
  Presenter(s):William A. Marston, MD  
  View Slides in PDF      
8:35 AM - 8:40 AM Identifying Reflux Pathways With Duplex Ultrasound Mapping
  Presenter(s):Neil M. Khilnani, MD  
  View Slides in PDF      
8:41 AM - 8:46 AM C1 Feeding Vein Treatment Based On The 18mhz US Diagnostics And Imaging: A Valuable Management Approach When Transillumination Or Virtual Reality Imaging Is Not Sufficient
  Presenter(s):Tomasz Urbanek, MD, PhD  
  View Slides in PDF      
8:47 AM - 8:52 AM How To Recognize Variants On The Venous Duplex Exam
  Presenter(s):Neil M. Khilnani, MD  
  View Slides in PDF      
8:53 AM - 8:58 AM How To Grade Iliac Vein Stenoses
  Presenter(s):Seshadri Raju, MD  
  View Slides in PDF      
8:59 AM - 9:04 AM Aspect Ratio: A New Concept For Grading Venous Stenosis
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh  
  View Slides in PDF      
9:05 AM - 9:10 AM The VIDIO Trial Comparing IVUS vs. Multiplanar Venogram For Diagnosing Iliofemoral Vein Obstruction
  Presenter(s):Paul J. Gagne, MD  
  View Slides in PDF      
9:11 AM - 9:16 AM What Do The Recent Meta-Analyses Tell Us Of The Effect Of Venoactive Medications On Individual Symptoms In Chronic Venous Disease
  Presenter(s):Andrew N. Nicolaides, MS, FRCS  
  View Slides in PDF      
9:17 AM - 9:22 AM Surveillance After Venous Stenting: How And When
  Presenter(s):Kenneth Ouriel, MD, MBA  
  View Slides in PDF      
9:23 AM - 9:28 AM MRV And Major Venous Interventions
  Presenter(s):Mark G. Davies, MD  
  View Slides in PDF      
9:29 AM - 9:34 AM Thrombus Aging Using MRI
  Presenter(s):Stephen A. Black, MD  
  View Slides in PDF      
9:35 AM - 9:40 AM Getting A Look At Inflow With Duplex Ultrasound Prior To Endovascular Reconstruction Of Post-Thrombotic Iliocaval Disease
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
  View Slides in PDF      
9:41 AM - 9:46 AM Panel Discussion
END OF SESSION 64
 
SESSION 65 SCHEDULE
Thursday
SESSION 65: SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
x
9:47 AM - 9:52 AM Cryo-Laser And Cryo-Sclerotherapy Techniques (CLACS)
  Presenter(s):Kasuo Miyake, MD, PhD  
  View Slides in PDF      
9:53 AM - 9:58 AM Is It Safe To Do GSV Ablation, Phlebectomy And Cosmetic Sclerotherapy All At Once
  Presenter(s):Gutenberg A. Gurgel, MD  
  View Slides in PDF      
9:59 AM - 10:04 AM Step-By-Step: Phlebectomy
  Presenter(s):Paul Pittaluga, MD  
  View Slides in PDF      
10:05 AM - 10:10 AM Do You Need To Treat EHIT Or EnHIT 2
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh  
  View Slides in PDF      
10:11 AM - 10:16 AM Venous Ulcers – An Algorithm For Treating Deep And Superficial Venous Occlusion And Incompetence – Study Completed
  Presenter(s):Peter F. Lawrence, MD  
  View Slides in PDF      
10:17 AM - 10:22 AM Treatment By ASVAL/Saphenous Sparing Technique
  Presenter(s):Paul Pittaluga, MD  
  View Slides in PDF      
10:23 AM - 10:28 AM Panel Discussion
END OF SESSION 65
 
SESSION 66 SCHEDULE
Thursday
SESSION 66: THERMAL AND NON-THERMAL ABLATION
x
THERMAL AND NON-THERMAL ABLATION – PART 1
10:29 AM - 10:34 AM Ultrasound Guided Foam Sclerotherapy: What We Should Know
  Presenter(s):Jean Luc Gerard, MD  
  View Slides in PDF      
10:35 AM - 10:40 AM RFA (VenClose): What We Should Know
  Presenter(s):Edward G. Mackay, MD  
  View Slides in PDF      
10:41 AM - 10:46 AM RFA (RFiTT): What We Should Know
  Presenter(s):Isaac K. Nyamekye, MD, FRCS  
  View Slides in PDF      
10:47 AM - 10:52 AM Secure Trial Update
  Presenter(s):Mark A. Adelman, MD  
  View Slides in PDF      
10:53 AM - 10:58 AM Proprietary Polidocanol Microfoam: What We Should Know
  Presenter(s):Edward G. Mackay, MD  
  View Slides in PDF      
10:59 AM - 11:04 AM Glue Ablation For Recurrent Truncal Reflux After Thermal Ablation
  Presenter(s):Kursat A. Bozkurt, MD  
  View Slides in PDF      
11:05 AM - 11:10 AM Using Cyanoacrylate Without Compression: Short And Midterm Outcome
  Presenter(s):Kathleen D. Gibson, MD  
  View Slides in PDF      
11:11 AM - 11:16 AM Contraindications And Limits: Cyanoacrylate
  Presenter(s):Raghu Kolluri, MD  
  View Slides in PDF      
11:17 AM - 11:22 AM Contraindications And Limits: MOCA
  Presenter(s):Michel M.P. Reijnen, MD, PhD  
  View Slides in PDF      
11:23 AM - 11:28 AM Contraindications And Limits: Laser
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
  View Slides in PDF      
11:29 AM - 11:34 AM Contraindications And Limits: Proprietary Polidocanol Microfoam
  Presenter(s):Kathleen D. Gibson, MD  
  View Slides in PDF      
11:35 AM - 11:40 AM Contraindications And Limits: Radiofrequency Ablation
  Presenter(s):Alan M. Dietzek, MD, RPVI, FACS  
  View Slides in PDF      
11:41 AM - 11:46 AM Panel Discussion
THERMAL AND NON-THERMAL ABLATION – PART 2
Moderator(s): Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh / Lowell S. Kabnick, MD, RPhS, FACS, FACPh  
11:47 AM - 11:52 AM Mechanochemical Ablation: The Five-Year Outcome Of A Prospective Trial On 100 Patients With GSV Incompetence
  Presenter(s):Michel M.P. Reijnen, MD, PhD  
  View Slides in PDF      
11:53 AM - 11:58 AM Quality Of Life After SeCure PERFect
  Presenter(s):Kathleen D. Gibson, MD  
  View Slides in PDF      
11:59 AM - 12:04 PM Comparison Study Of Radiofrequency Procedures
  Presenter(s):Isaac K. Nyamekye, MD, FRCS  
  View Slides in PDF      
12:05 PM - 12:10 PM Results Of The EVRA Randomized Clinical Trial
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh  
  View Slides in PDF      
12:11 PM - 12:16 PM Commentary: Results Of The EVRA Randomized Clinical Trial
  Presenter(s):Raghu Kolluri, MD  
  View Slides in PDF      
12:17 PM - 12:21 PM Panel Discussion
12:22 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 66
 
SESSION 67 SCHEDULE
Thursday
SESSION 67: VENOUS SOCIETAL AND GOVERNANCE
x
1:00 PM - 1:05 PM CMS Policy Update On Nonthermal Ablation
  Presenter(s):Harold J. Welch, MD  
  View Slides in PDF      
1:06 PM - 1:11 PM Appropriateness In Venous Care: Challenges And Solutions
  Presenter(s):Elna M. Masuda, MD  
  View Slides in PDF      
1:12 PM - 1:17 PM RUC And Revaluation Of Phlebectomy: Why, How, And Outcome
  Presenter(s):Sean P. Roddy, MD  
  View Slides in PDF      
1:18 PM - 1:23 PM What Do You Need To Know About MACRA
  Presenter(s):Kathleen J. Ozsvath, MD  
  View Slides in PDF      
1:24 PM - 1:29 PM Is The Vein Center Accreditation Important For MACRA
  Presenter(s):Kathleen J. Ozsvath, MD  
  View Slides in PDF      
1:30 PM - 1:35 PM Update On Deep Venous Accreditation
  Presenter(s):Alan M. Dietzek, MD, RPVI, FACS  
  View Slides in PDF      
1:36 PM - 1:41 PM New European College Of Phlebology Guidelines For Truncal Ablation
  Presenter(s):Kursat A. Bozkurt, MD  
  View Slides in PDF      
1:42 PM - 1:47 PM From Standard Vein Center To High Tech Venous Endovascular Suite: Moving Towards The Future
  Presenter(s):Kasuo Miyake, MD, PhD  
  View Slides in PDF      
1:48 PM - 1:53 PM Can VQI Be Used As A Benchmark For Setting Ethical Standards
  Presenter(s):Nicholas H. Osborne, MD, MS  
  View Slides in PDF      
1:54 PM - 1:59 PM The Principal Agent Dilemma: A Conflict of Interest In Endovascular Surgery
  Presenter(s):S. Scott Tapper, MD  
  View Slides in PDF      
2:00 PM - 2:05 PM Panel Discussion
End of Program J
END OF SESSION 67
 
SESSION 68 SCHEDULE
Thursday
SESSION 68: MORE HOT OR LATE BREAKING TOPICS RELATED TO DISEASES OF THE AORTA OR ITS BRANCHES (4 ½ MINUTE FAST PACED TALKS)
x
2:25 PM - 2:30 PM DEBATE: Why It Is Time To Abandon 2 Branch F/EVAR For 3 Or 4 Branch F/EVAR
  Presenter(s):Eric L.G. Verhoeven, MD, PhD  
  View Slides in PDF      
2:30 PM - 2:35 PM DEBATE: Not So: 3 And 4 Branch F/EVARs Should Be Avoided If Possible Because They Result In Higher Complication And Mortality Rates: From The UK GLOBALSTAR Registry
  Presenter(s):S. Rao Vallabhaneni, MD, FRCS  
  View Slides in PDF      
2:35 PM - 2:40 PM Causes Of Lower Extremity Neurologic Impairment After F/EVAR: Prevention And Treatment
  Presenter(s):Joseph L. Mills, MD  
  View Slides in PDF      
2:40 PM - 2:45 PM How Onyx Can Eliminate Gutter Endoleaks After Parallel Grafts Used In AAA Repairs: When To Fix And Technical Tips
  Presenter(s):Ralf R. Kolvenbach, MD  
  View Slides in PDF      
2:45 PM - 2:50 PM Surveillance Protocol And Reinterventions After F/B/EVAR
  Presenter(s):Rocco Giudice, MD  
  View Slides in PDF      
2:50 PM - 2:55 PM Redo F/EVAR For Failed F/EVAR Due To Aortic Neck Degeneration And Dilatation: Technical Tips And Results
  Presenter(s):Afshin Assadian, MD  
  View Slides in PDF      
2:55 PM - 3:00 PM Panel Discussion
3:00 PM - 3:05 PM Value Of Parallel Grafts To Treat Chronic TBADs With Extensive TAAAs: Technical Tips And Results
  Presenter(s):Edward Y. Woo, MD / Tareq Massimi, MD  
  View Slides in PDF      
3:05 PM - 3:10 PM Octopus Technique To Treat Urgent Or Ruptured TAAAs With OTS Components: What Is It, Technical Tips And Results
  Presenter(s):Jason T. Lee, MD  
  View Slides in PDF      
3:10 PM - 3:15 PM How To Predict Aortic Wall Damage And Rupture In Aortic Disease: The Role Of Turbulence And How To Measure It
  Presenter(s):Erno Remsey-Semmelweis, MD  
  View Slides in PDF      
3:15 PM - 3:20 PM Celiac Compression Syndrome: Myth Or Reality: How To Diagnose It And Treat It
  Presenter(s):Michael G. Wyatt, MD  
  View Slides in PDF      
3:20 PM - 3:25 PM Median Arcuate Ligament (Or Celiac Compression) Syndrome: Is It Real And What To Do If There Is Intrinsic Celiac Axis Disease
  Presenter(s):John F. Eidt, MD  
  View Slides in PDF      
3:25 PM - 3:30 PM Panel Discussion
END OF SESSION 68
 
SESSION 69 SCHEDULE
Thursday
SESSION 69: MORE HOT OR LATE BREAKING TOPICS RELATED TO DISEASES OF THE LOWER EXTREMITY; OPEN SURGERY OR NEW TECHNIQUES (4 ½ MINUTE FAST PACED TALKS)
x
3:30 PM - 3:35 PM DEBATE: All SFA Lesions Can Be Treated Endovascularly: Should They Be: Open Bypass Should Rarely Be Used
  Presenter(s):Maxime M.S. Sibé, MD  
  View Slides in PDF      
3:35 PM - 3:40 PM DEBATE: Distal Bypasses Have An Important Role In The Treatment Of CLTI In The Endovascular Era: What Is That Role
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
  View Slides in PDF      
3:40 PM - 3:45 PM How To Treat Acute Limb Ischemia (ALI) With Only Duplex Ultrasound Control And No Angiography: Feasibility And Advantages
  Presenter(s):Enrico Ascher, MD / Natalie A. Marks, MD, RPVI, RVT, FSVM  
  View Slides in PDF      
3:45 PM - 3:50 PM Unusual Open Surgical Exposures Of Lower Extremity Arteries When Primary Approaches Are Scarred Or Infected: They Facilitate Redo Open Procedures
  Presenter(s):Neal S. Cayne, MD / Enrico Ascher, MD / Frank J. Veith, MD  
  View Slides in PDF      
3:50 PM - 3:55 PM Impact Of Glucose Control And Its Regimen On Limb Salvage In Patients Undergoing Endo Or Open Interventions For CLTI
  Presenter(s):Adam Beck, MD  
  View Slides in PDF      
3:55 PM - 4:00 PM Panel Discussion
4:00 PM - 4:05 PM How The BEST-CLI Trial Has Changed Our CLTI Practice
  Presenter(s):Vincent L. Rowe, MD / Fred A. Weaver, MD  
  View Slides in PDF      
4:05 PM - 4:10 PM Optimal Anticoagulation Regimen For Patients Being Treated For ALI
  Presenter(s):Timothy K. Liem, MD, MBA  
  View Slides in PDF      
4:10 PM - 4:15 PM Dorsalis Pedis Entrapment: What Is It And What Is Its Clinical Importance
  Presenter(s):Roberto Ferraresi, MD